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0A short primer about this thesis
Neuroreceptors are membrane proteins responsible for nervous signal transduction between neurons and
every part of the body. At synaptic ends, they receive the signal from the presynaptic cell in the form of a
neurotransmitter and respond with the opening of an ion channel located on the postsynaptic cell, leading
to transmission of the signal across the nervous ending. Dysfunction of neuroreceptors is associated to
several disorders of the central nervous system includingmyasthenia gravis, epilepsy, addiction to nicotine
and alcohol and several cognitive and mental disorders such as schizophrenia, Alzheimer’s and Parkinson’s
diseases. ey are also involved in general anesthesia mechanisms.
In this work, I focused on the latter, trying to understand the open question of general anesthesia
mechanisms at the atomistic scale. General anesthetics have been shown to target neuroreceptors, in
particular the pentameric Ligand-Gated Ion Channel (pLGIC) family. As a threedimensional structure of
an eukaryoticmember of this family is particularly dicult to solve, numerous groups worldwide focus now
on prokaryotic members on this family, including Gloeobacter violaceus Ligand-gated Ion Channel (GLIC).
GLIC is a homopentameric ion channel the opening of which is controlled by pH variations. Since its
rst crystallization in 2009, several high resolution structures of this bacterial channel have been resolved,
including mutants, open, locally closed and closed conformations, and co-crystals with modulating ions,
alcohols, benzodiazepines, local and general anesthetics.
My work is primarily based on crystals of general anesthetics propofol, desurane and bromoform
bound to GLIC in open and locally closed conformations. I attempt to characterize anesthetics behavior
while bound to allosteric sites in conformations close to the crystal structures thanks to in silicomethods
such as Molecular Dynamics (MD) simulations and Free Energy of Binding (FEB) calculations.
is manuscript is structured as follows.
Chapter 1, “Biological Background”, briey introduces basic notions on the nervous signal transduction
in the human body, followed by a short history on the development of anesthesia. I then focus on the
structure and function of human neuroreceptors before concluding with the state-of-the-art of the study
of bacterial and unicellular members of the pLGIC superfamily.
In Chapter 2, entitled “Molecular Modeling: eory And Practice”, I shortly introduce the main
methods I applied in the context of this project: MD simulations and free energy calculations. I then
develop some of the principal recurring diculties that have to be faced calculating MD simulations of
biomolecules.
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Chapter 3, “High-Performance Computing And Large Scale Data Analysis”, deals with the answer I
found to methodological issues I faced on a daily basis, mainly related to high-performance computing
and large scale data analysis. In particular, I present the Epock soware, which I implemented during my
PhD project and that aims to eciently calculate protein pocket volumes.
e next two chapters are devoted to the characterization of general anesthetics behavior bound to the
GLIC channel.
Chapter 4, “Probing pLGICs with bromoform reveals many interconnected anesthetic binding sites”,
aims to describe the bromoform interactions with GLIC while bound to several binding sites. For this
purpose, I combine three complementary simulation strategies, trying to answer three principal questions:
i) are bromoform crystallographic binding sites spontaneously accessible? ii) how does bromoform
dynamics evolve while bound to these sites? iii) what is bromoform’s anity for each binding site?
In the next chapter, ‘Propofol & desurane simulations provide new insights into anesthetic action at
the atomic scale”, I extend the problems addressed in studying bromoform to general anesthetics propofol
and desurane. I aim to check whether hypotheses I established for bromoform are veried on other
general anesthetics that exhibit quite dierent properties compared to bromoform. I also address several
additional issues such as the symmetry of anesthetic binding and the extensive characterization of pocket
volume.
e work is then concluded with nal remarks and a general perspective. Supplementary information
is provided in the appendix.
1Biological Background
1.1 The human nervous system, a central player in general anesthesia
Here I will briey describe in a top-down manner the structure of relevant parts of the human nervous
system in relation to general anesthesia. e nervous system is an ensemble of structures that coordinates
an animal’s voluntary and involuntary actions and transmits signals to dierent body areas. In vertebrates,
it consists of two main parts, called the Central Nervous System (CNS) and the Peripheral Nervous
System (PNS). e CNS consists of the brain and the spinal cord. e PNS consists mainly of nerves,
which are long bers that connect the CNS to every part of the body. e PNS also includes peripheral
ganglia and the enteric nervous system, a semi-independent part of the nervous system that controls the
gastrointestinal system.
1.1.1 Overall structure
e nervous system is made of two main categories of cells: neurons and glial cells.
Neurons, or nerve cells, are distinguishable from other cells in a number of ways but their most
fundamental property is that they communicate with other cells through specialized intercellular adhesion
sites called synapses. A typical neuron has four morphologically dened regions: the cell body, dendrites,
axon and presynaptic terminals as shown in gure 1.1. Dendrites provide a highly branched, elongated
surface for receiving signals. e axon conducts electrical impulses rapidly over long distances to their
synaptic terminal, which releases neurotransmitter onto target cells (Kandel et al., 2000). An axon can
extend to dierent parts of the body and make thousands of synaptic contacts. A nerve is a bundle of
axons.
All neural cells that lack the capacity of transmitting rapid signals in the form of an action potential
(see section 1.1.3) are categorized into a broad class termed glia. In mammals, glial cells include microglia,
astrocytes, Schwann cells and oligodendrocytes (gure 1.2). ey ensure a wide range of functions, some of
them probably unknown yet, including homeostasismaintenance, neuron support, nutrition and insulation
to speed up electrical communication (Allen and Barres, 2009). Glial cell are an essential component of
the nervous system and can constitute the major part of a brain: human brain has about 90 % glial cells,
an elephant’s brain 97 %.
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Figure 1.1 –e structure of a neuron.e cell body and nucleus of a spinal motor neuron are surrounded
by a double-layered membrane, the nuclear envelope, which is continuous with the endoplasmic reticulum.
e space between the two membrane layers that constitutes the nuclear envelope is continuous with the
lumen of the endoplasmic reticulum. Dendrites emerge from the basal aspect of the neuron, the axon
from the apical aspect. From Kandel et al. (2000).
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Figure 1.2 – Dierent types of glia interact with neurons and the surrounding blood vessels. Oligo-
dendrocytes wrap myelin around axons to speed up neuronal transmission. Astrocytes extend processes
that en-sheath blood vessels and synapses. Microglia keep the brain under surveillance for damage or
infection. From Allen and Barres (2009).
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Figure 1.3 – e chemical synaptic transmission. A) An action potential arriving at the presynaptic
terminus causes voltage-gated Ca2+ channels on the presynaptic membrane to open. B)e opening of the
Ca2+ channels causes high concentration of intracellular Ca2+ which causes synaptic vesicles containing
neurotransmitter molecules to fuse with the presynaptic membrane and transmitters to be liberated in
the synaptic cle. C)e released neurotransmitter molecules diuse across the synaptic cle and bind
the neuroreceptor on the postsynaptic membrane. As ion channels open, the membrane potential of the
postsynaptic cell changes. Adapted from Kandel et al. (2000).
1.1.2 The synapse - creating the right interconnections
e synapse is a specialized structure thatmediates a functional interaction between twoneurons orbetween
a neuron and another cell type. Synapses may be of chemical as well as electrical nature. Chemical and
electrical synapses dier not only by themechanism of information transfer, but also in theirmorphological
organization. At electrical synapses, the pre- and postsynaptic cells communicate through gap junctions,
cell-to-cell pores that serve as a conduit between the cytoplasm of two cells. Consequently, the space
between the two cells, called the synaptic cle, is on the order of 2 to 4 nm wide. In contrast, in the much
more common chemical synapses, the synaptic cle is wider, on the order of 20 to 40 nm (Hormuzdi et al.,
2004).
Chemical synaptic transmission depends on the diusion of a neurotransmitter across the synaptic
cle. Neurotransmitter molecules are contained in synaptic vesicles. At arrival of an electrical signal,
voltage-gated Ca2+ channels at the presynaptic terminus open, allowing Ca2+ ions to enter the cell. e
rise of intracellular calcium initiates synaptic vesicle fusion with the presynaptic membrane, therefore the
neurotransmitter liberation in the synaptic cle (gure 1.3). e neurotransmitter diuses and binds to
its receptor on the postsynaptic membrane, which responds by opening and letting ions pass from the
extracellular environment to the cytosol. If the ion ow is adequate, it will provoke a depolarization of
the postsynaptic membrane which will be transmitted through the axon of the receptor cell. Importantly,
chemical synapses can amplify the signal they receive since one synaptic vesicle releases thousands of
neurotransmitter molecules that can open thousands of ion channels on the target cell. A small presynaptic
nerve which generates a weak electrical current can therefore depolarize a large postsynaptic cell.
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Figure 1.4 –e action potential.e sequential opening of voltage-gatedNa+ andK+ channels generates
the action potential. From Kandel et al. (2000).
1.1.3 The action potential
An enormous amount of work has been realized by Hodgkin and Huxley (1952) leading to the detailed
comprehension of the sequence of events that constitute the action potential. As described in section 1.1.2,
the neurotransmitters binding to their receptor lead to the opening of ion channels, therefore the entering
of ions in the intracellular space. Consequently, the membrane potential changes, rising if cations enter
(depolarization), declining if anions enter (hyperpolarization). If the depolarization is sucient, i.e.
exceeds a threshold value1, voltage-gated Na+ channels rapidly open resulting in an inward Na+ current.
is current causes further depolarization, thereby opening more Na+ channels, resulting in a further
increase of the inward current. e opening of Na+ channels causes the rising phase of the action potential
(gure 1.4). e depolarization gradually inactivates the voltage-gated Na+ channels and opens, with some
delay, voltage-gated K+ channels, resulting in an outward K+ ow that tends to repolarize the membrane.
As these channels remain open for some time aer the resting potential has been reached, this current leads
to a transient shi of the membrane potential to values more negative than the resting potential (Kandel
et al., 2000). e combined eect of this increase in K+ conductance combined with the inactivation of
Na+ channels underlies the absolute refractory period, the brief period aer which an action potential
cannot be triggered. As some K+ channels begin to close and some Na+ channels recover from inactivation,
the membrane enters the relative refractory period, during which an action potential can be triggered
by applying stronger stimuli that those normally required to reach threshold. e membrane potential
returns to its resting value as all the K+ channels nally close and the initial concentration of intracellular
ions is restored by nongated and gated ion channels responsible for maintaining ion balance at rest.
1.1.4 Medical implications: general anesthesia
e development of general anesthesia
General anesthesia has several purposes:
1e action potential obeys the all-or-none principle: stimuli below the threshold do not produce an action potential while
stimuli above the threshold all produce an action potential with the same amplitude. e intensity of the stimulus aects the
action potential frequency.
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• analgesia i.e. loss of response to pain,
• amnesia i.e. loss of memory,
• unconsciousness,
• immobility i.e. loss of motor reexes,
• relaxation of skeletal muscles.
In contrast, local anesthesia does not provoke amnesia or unconsciousness. Furthermore, the eect of a
local anesthesia is restricted to a small part of the body. In a strict sense, local anesthesia refer for example
to a tooth or an area of the skin. Any larger region such as leg or arm is covered under the term regional
anesthesia. Usually, a local anesthetic cannot be used as general anesthetic and conversely.
e rst attempts of anesthesia presumably occurred during prehistory through the administration
of herbal remedies. Opium and alcohol were used in the Antiquity as narcotic and sedative, respectively,
although the question of which people are at the origin of this usage is still debated (Krikorian, 1975).
Interestingly, a Chinese legendwants that a Chinese physician successfully used herbal decoctions to render
patients unconscious for several days and practice surgery upon them. e exact formula he used likely
disappeared at his death. For centuries, physicians used oral as well as inhaled anesthetics in therapeutics
in the form of herbal mixtures, oen composed in part of Papaver somniferum, a plant from which opium
is prepared.
Several notable advances in anesthesia, local and general, were made during the 19th century. e rst
documented successful use of general anesthesia is generally considered as Hanoka Seishu mastectomy on
13 October 1804 (Izuo, 2004). is Japanese surgeon, aer years of eorts, nally developed a formula
which he named tsusensan composed of several plants from which, by the way, opium is not present. e
same year, Friedrich Sertürner isolated morphine from opium, a molecule still commonly used as an
analgesic. Along the 19th century, several uses of diethyl ether, the analgesic properties of which have been
described in the 16th century, are reported for local as well as general anesthesia. In the middle 1800s,
chloroform was discovered in Europe and rapidly replaced ether in Europe andWestern countries, but
was discarded because of its tendency to cause fatal cardiac arrhythmia. Most modern anesthetics have
been developed by pharmaceutical labs, including propofol and desurane; their action mechanism will be
discussed in chapter 5. e development of most anesthetics has been primarily empirical, even sometimes
fortuitous.
Hypotheses on general anesthetics action
Several theories have been formulated on general anesthetics action, always relative to the modulation
of membrane proteins in the neuronal membrane. Paul Ehrlich (1854–1915) rst proposed the concept
of highly specic interactions between drugs and receptors, stating that a drug acts only when bound
to its target (Weir, 2006). As this theory was judged hardly applicable to general anesthetics because of
their chemical and structural diversity (gure 1.5), theories implying nonspecic perturbations of neurons
have been formulated. In the early 20th century, HH Meyer and CE Overton independently reported
a correlation between the solubility of narcotics in olive oil and their anesthetic power: the greater the
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lipid solubility of the compound, the greater its anesthetic potency. is relation became known as the
Meyer-Overton correlation, rened by Meyer’s son in Meyer, 1937. eories have then been developed
mentioning that anesthetic solubilization in neuronal membranes alters the function of ion channels.
However, these theories suer several weaknesses:
• several compounds with structures similar to anesthetics and high lipid solubility do not act as
anesthetics (gure 1.6A,B),
• general anesthetic ability to perturb membranes in vitro can be reproduced by a temperature drop
to less than 1 ○C, a change well within the physiological range and clearly not sucient to induce
loss of consciousness,
• some enantiomers of general anesthetics do not produce identical clinical eects, although they
have the same properties in lipid bilayers, (gure 1.6C)
• there appears to be a cuto eect above a certain molecular volume which is indicative of anesthetic
agents interacting with binding site(s) of nite dimensions (Bradley et al., 1984).
Finally, it has been demonstrated that a range of general anesthetics act as competitive antagonists
on the rey luciferase, a soluble protein (Franks and Lieb, 1984). Remarkably, inhibition of luciferase
was directly correlated with anesthetic potency, providing persuasive evidence that general anesthetic
drugs could selectively interact with proteins. However, some groups still argue that anesthetics may alter
membrane properties which would play a role in anesthesia (Bahri et al., 2007; Baenziger et al., 2008;
Hansen et al., 2013).
In vitro experiments demonstrated that general anesthetics alter the function of several neurotrans-
mitter receptors at clinically relevant concentrations (Weir, 2006) including the GABA Receptor of type
A (GABAAR), the Nicotinic Acetylcholine Receptor (nAChR), the Glycine Receptor (GlyR) and the
5-HydroxyTryptamine Receptor (5-HTR) of subtype 3 (5-HT3R).
1.1.5 Neuroreceptors, a likely target for general anesthetics
Neuroreceptors are membrane proteins localized on the postsynaptic membrane that share a few common
properties, including the binding of neurotransmitters.
A major second property is that, in contrast to molecular pumps, the ux of ions through the channel
is passive. It is therefore determined not by the channel itself, but rather by the electrostatic and diusional
driving forces across the membrane. Finally, those channels are selective, which means that they allow
particular types of ions to cross the membrane. Most channels are selective to only one type of ion that
is usually present is the extracellular environment. Anion channels conduct only one physiological ion,
chloride (Cl-). Cation channels are selective to Na+, K+, or Ca2+. e eect of a synaptic potential, i.e.
excitatory or inhibitory, depends on the type of ion that permeates into the postsynaptic cell: cations, that
increase the membrane potential, trigger action potentials while anions cause an inhibition of the signal.
Neurons can receive signals from both excitatory and inhibitory synapses. Although some transmitters
can produce excitatory as well as inhibitory potentials, most transmitters produce a single type of response
because they bind the same type of channel wherever they are met in the body. Excitatory synaptic action
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Figure 1.5 – Structure of common general
anesthetics. A) Propofol. B) Ketamine. C) Des-
urane. D) Isourane. E) Chloroform (not used
clinically anymore). F) Sodium thiopental (also
known as sodium pentothal).
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B
Figure 1.6 – Examples of compounds that
do not obey Meyer Overton’s rule. A) 2,3-
dichlorooctauorobutane has very high lipid
solubility and properties similar to anesthetic
but do not provoke anesthetia. B) Enurane
(isomere of isourane – gure 1.5C – that is 45
to 90 percent less potent than isourane). C)
Etomidate (R etomidate is 10 times more potent
that S etomidate).
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Neurotransmitter Receptor Receptor type Signal Type
Acetylcholine nAChR ionotropic excitatory
Glutamate iGluR ionotropic excitatory
ATP P2XR ionotropic excitatory
Glycine GlyR ionotropic inhibitory
GABA GABAAR ionotropic inhibitory
GABA GABABR metabotropic excitatory
Serotonin* 5-HTR metabotropic excitatory
Table 1.1 – Example neurotransmitters and associated signal type. Examples of common neurotrans-
mitters associated with their most common receptor type and action on the signal.
* Serotonin receptors are metabotropic receptors with the notable exception of the 5-HT3 receptor which is a ligand-gated Na+
and K+ channel. 5-HT receptors are excitatory receptors with the exception of subtypes 5-HT1 and 5-HT5 .
is usually mediated by ionotropic glutamate and nicotine receptor channels that are permeable to sodium
and potassium. Inhibitory synaptic action is usually mediated by GABA and glycine receptors that are
permeable to chloride, as summarized in table 1.1.
Neurotransmitters control the opening of ion channels on the postsynaptic cell either directly or
indirectly, by acting on dierent types of receptors.
Receptors that gate ion ow indirectly, known as metabotropic receptors, include for example the
serotonin receptor (5-HTR) and the GABA receptor of type B. ey are usually made of a single subunit,
at most two, that are distinct from the ion channel they regulate. Activation of these receptors stimulates
the production of a second messenger, cAMP for instance, which activates a protein kinase, an enzyme
that phosphorylates dierent substrate proteins. In many cases, the protein kinases directly phosphorylate
ion channels, leading to their opening or closing (Kandel et al., 2000). ese several steps account for the
delay in the synaptic transmission compared to direct gating.
Ligand-gated channels, or ionotropic receptors, gate ion ow directly by opening upon neurotrans-
mitter binding. ey are composed of three to ve identical or homologous subunits symmetrically
arranged around a central ionic pore. e channel displays an Extracellular Domain (ECD) where the
neurotransmitter binds and a Transmembrane Domain (TMD) that forms an ion-conducting pore (see
gure 1.7A-B). Besides the pentameric channels, this family includes the trimetric P2X receptors and the
tetrameric glutamate receptor2. e pentameric superfamily comprises the nAChR, the GABAAR and
the GlyR. e pLGICs are also named Cys-loop receptors due to the presence in the extracellular domain
of a dening loop of approximately 13 residues anked by two canonical cysteines linked by a disulde
bridge. Most signaling between neurons in the CNS involves ionotropic receptors, as well as synapses at
the neuromuscular junction which involve exclusively nAChRs.
To date, the only complete structure of an animal3 Cys-loop receptor available is that of the nAChR
from Torpedo marmorata (gure 1.7; Unwin, 2005). It was solved at a 4Å resolution by cryoelectron
microscopy, a resolution at which a high uncertainty exists on side chain localization. Besides, this structure
2e glutamate channel from Caenorhabditis elegans (GluCl) is pentameric and chloride selective (see section 1.2.2).
3Apart from that of the nematode C. elegans (see section 1.2).
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Figure 1.7 –e structure of the nicotinic receptor fromTorpedomarmorata.A) Side view of the whole
structure represented in cartoon. e extracellular, transmembrane and intracellular domains are colored
in brown, purple and pink, respectively. B) Top view of the transmembrane domain colored by subunit
type (α, γ, α, β, δ). Each subunit contributes four helices, the M2 helix lining the channel pore. C) View of
the extracellular half of the TMD in space lling representation showing the numerous gaps induced by
the low packing between helices (see also appendix A.1).
is, to date, highly controversial since important gaps exist between the TMD helices (gure 1.7C), gaps
that are hardly compatible with the hypothesis according to which they are lled with water as originally
assumed (Miyazawa et al., 2003) because of the strong density visible at these locations in the density
map used to obtain the structure of the nAChR TMD (PDB-id 1OED) and the hydrophobic nature of
the residues surrounding these gaps. Brannigan et al. proposed that these gaps are actually lled with
cholesterol, since they successfully docked cholesterol into it (Brannigan et al., 2008) and since cholesterol
is required for nAChR’s proper function (Dalziel et al., 1980). Furthermore, the lack of resolution of
electron microscopy data led to the introduction of residue assignment errors in helices in the rst atomic
model of the TMD alone (Miyazawa et al., 2003), in which residues are shied by one helical turn from
their correct position. e error became evident inspecting homologous structures (see section 1.2) and has
been formally proven from direct experimental testing (Mnatsakanyan and Jansen, 2013). As the raw data
from Unwin’s work have not been released, further renement is made impossible and the uncertainties
concerning this model have not been dissipated.
1.2 Bacterial and invertebrate homologues to the human nicotinic receptor
1.2.1 Why study channels from bacteria?
In 2004, Tasneem et al. searched for distant representatives of the Cys-loop family in organisms outside
the animal lineage, faced with the fact that ancestors of voltage-gated potassium and sodium channels have
been identied in non-animal eukaryotes, as well as numerous prokaryotes. Interestingly, this indicates
that these channels were used in other signaling contexts by a variety of organisms way before the origin
of the animal nervous system (Ito et al., 2004). As Tasneem et al. argue that the TMD is compositionally
biased and tends to recover false positives in iterative sequence searches, they used only the ECD for their
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Figure 1.8 – GLIC: a bacterial homologue to the human nicotinic receptor. A) Side view of the GLIC
channel. Compared to the nAChR (see gure 1.7), GLIC’s structure lacks the intracellular domain, the
helices at the top of the ECD and the two cysteines that border the signature loop (not visible here). B)
Topology of one ofGLIC’s ve identical subunits, which is the same as for ELIC andGluCl. C)Organination
of the transmembrane domain. Each subunit (represented with dierent colors) contributes to four helices
named M1 to M4. M2 helices line the channel pore.
queries. ey used PSI-BLAST to search in all organisms with genomic sequence data available at that
time, with initial queries such as the human acetylcholine receptor α7 chain or the human GABA receptor
α4 chain. In addition to animal sequences, these searches recovered sequences from bacteria such as the
cyanobacteria Gloeobacter violaceus and the γ-proteobacteria Erwinia chrysanthemi4, among others.
1.2.2 A conserved general receptor organization
e work by Tasneem et al. turned out to be a breakthrough in the study of pLGICs. Several groups started
focusing on bacterial members of the superfamily, despite the debate on the applicability of discoveries
from prokaryotes to eukaryotes. Intensive eorts lead to the crystallization of two bacterial pLGICs, namely
ELIC from Erwinia chrysanthemi (Hilf and Dutzler, 2008) and GLIC from Gloeobacter violaceus (Bocquet
et al., 2009; Hilf and Dutzler, 2009). e structure of the eukaryotic glutamate-gated chloride channel
GluCl, from Caenorhabditis elegans, has been solved few years later in complex with the positive allosteric
modulator ivermectin (Hibbs and Gouaux, 2011).
ese structures show an important similarity with the nAChR although being simpler (gure 1.8).
e ECD is structured in a β-sandwich fold stabilized through conserved hydrophobic residues (Corringer
et al., 2012) but lack the N-terminal helix and the two cysteines that border the signature loop. e TMD
of each protomer is made of four helices named M1 to M4 (gure 1.8B). e M2 helices form the pore of
the channel and are thus critical segments of the ion conduction pathway (gure 1.8C). In contrast to the
nAChR, they do not display a cytoplasmic domain.
Despite this conserved general organization, the structure and length of loops connecting β-sheets
in the ECD vary along pLGICs although they are critical for the quaternary assembly of the receptor
(the sequence similarity between those pLGICs is notably low, as shown in table 1.2). e evolutionary
4Recent taxonomic revisions have caused the bacteria Erwinia chrysanthemi to be renamed Dickeya dadantii (Samson et al.,
2005).
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GLIC ELIC GluCl nAChR
GLIC – 45 (22) 36 (23) 41 (19)
ELIC – – 39 (21) 41 (23)
GluCl – – – 42 (26)
Table 1.2 – Sequence similarities of non-human pLGICs. Sequence similarities calculated with protein-
protein BLAST. Percentages of identity are given between parentheses. Sequence accession ids areQ7NDN8,
P0C7B7, Q17328, and Q9UGM1 for GLIC, ELIC, GluCl, and nAChR respectively.
explanation for these dierences is that these loops are believed to play a crucial role in the binding of the
agonist and the transduction of the signal to the TMD. Similarly, connecting loops in the TMD play a
determinant role for the channel function, such as the M2-M3 loop that actively participates to the signal
transduction (Corringer et al., 2012).
1.2.3 Key features of an ion channel: opening and closing
e comprehension of an ion channel’s transition from open to closed state, named gating, is essential
for the understanding of the mechanics of signal transduction. Based on normal modes analysis, Taly
et al. suggested that nAChR gating involved a quaternary twist-motion rearrangement of the ECD and
the TMD (Taly et al., 2005). is analysis, later performed on the crystal structures of GLIC and ELIC,
suggested that this gating mechanism was applicable to both prokaryotic channels (Bocquet et al., 2009;
Cheng et al., 2009).
However, the detailed function of a channel’s gating mechanism can hardly be understood without
knowing how to activate and inactivate it. GluCl, by denition, is gated by glutamate. GLIC’s natural ligand
was known even before the resolution of its crystal structure: the proton, meaning that GLIC opens at
acidic pH and closes at neutral pH (Bocquet et al., 2007). On the other hand, ELIC’s detailed investigation
was slowed down by the fact that activating ligands were unknown until a list of several primary amines
that include GABA were found to activate the receptor (Zimmermann and Dutzler, 2011). Notably, GLIC
is a cation channel with similar permeabilities for Na+ and K+ (Bocquet et al., 2007). Its conductance is
8 pS. At −60mV, GLIC permeates only 3 to 4 ions per microsecond, making this process very expensive
in terms of computational cost to study thanks to MD simulations (see sections 2.2 and 3.1.2).
A second prerequisite to understand atomic details of a channel’s gating mechanism is to obtain the
structures of both its open and resting state, the endpoints of the gating transition. Based on the calculation
of the channel pore radius, one can determine whether a channel is in a conducting conformation or not,
i.e. if ions can pass through the pore. GLIC and GluCl display very similar open conformations, while
ELIC displays a closed pore.
Several attempts have been made to model the gating transition from GLIC’s open state to ELIC’s
closed state, assuming that ELIC is a good model for GLIC’s resting form (Zhu and Hummer, 2009, 2010;
Nury et al., 2010; Calimet et al., 2013), an assumption that is still debated today considering the low
sequence identity between the two proteins (see table 1.2). Furthermore, it is not clear whether ELIC’s
crystal structure represents the resting state as channels may adopt dierent closed conformations, in their
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desensitized state for example (Gonzalez-Gutierrez and Grosman, 2010). However, the work by Nury
et al. is interesting from several points of view. First, as GLIC is sensitive to pH, they induced the channel
closure by modifying the protonation state of selected residues. Second, they simulated a fully atomistic
model of the GLIC system for one microsecond, leading to the closure on only two over ve subunits,
which suggests that at least another microsecond would be required to simulate GLIC’s full closure. Finally,
they proposed that GLIC’s closure starts by the formation of a hydrophobic gate between residues 9’ and
16’ in prime notation5, with a twist motion of the top of M2 helices. ese ndings revealed particularly
consistent with crystal structures of open and nonconductive GLIC as discussed below.
Concerning GluCl’s gating, it turns out that, upon ivermectin removal, the channel closes at the
hundred nanosecond timescale (Calimet et al., 2013; Yoluk et al., 2013). is transition is probably too
swi to be biologically relevant, as a full gating event is assumed to take place on the millisecond timescale.
is swiness probably indicates a bias in the crystal structure and/or the simulation setup. However,
several observations made during the transition of GluCl from open to closed state are consistent with the
quaternary model proposed in the light of recent high resolution structures of GLIC.
Among all pLGICs, GLIC is currently probably the best structural model to study transitions from
open to closed state since it has been crystallized in three distinct conformations, rstly at acidic pH in an
open conformation (Bocquet et al., 2009; Hilf and Dutzler, 2009), later mutants have been crystallized
in a Locally Closed (LC) conformation (Prevost et al., 2012; Gonzalez-Gutierrez et al., 2013), and very
recently an X-ray structure of Wild-Type (WT) GLIC in its resting state has nally been released (Sauguet
et al., 2014). e LC form shares most structural features with the open state but displays a closed pore as
a result of the concerted bending of the extracellular part of its M2 helices. It was recently demonstrated
that WT GLIC can adopt the LC form and that the open and LC forms coexist at acidic pH (Sauguet et al.,
2014), consistently with the assumption that the LC form can represent a late intermediate in the course of
activation. ese structures allowed to conrm that GLIC’s gating involves a marked twist motion of the
ECD, coupled with an inward tilt motion. e structure of the resting state shows that the conformation
of M2 helices is remarkably dierent from that observed in ELIC: GLIC’s pore appears closed due to a
concerted bending of the upper part of its M2 helices (gure 1.9). is motion is independent of M3 helix
orientation, unchanged compared to the open form. In ELIC, the M2 helix axis appears straight and M2
and M3 helices seem strongly attached to each other.
1.3 pLGICs are modulated by a variety of molecules
Over decades of research, pLGICs turned out to be modulated by numerous compounds with very dierent
physico-chemical properties. I chose to present some of the most important related studies, sorting the
compounds by the localization of the binding site.
5e prime notation has been introduced decades ago and aims to number residues that line the channel pore. Hence, residues
with the same prime number have the same location on the M2 helix, residue 1’ being located on the intracellular end of M2.
16 Chapter 1. Biological Background
M2M3 M2M3
GLIC Open pore GLIC Closed pore ELIC Closed pore
M2M3
Figure 1.9 – Comparing GLIC and ELIC closed state. Top: enlarged views of the pore. e solvent-
accessible region is shown by a green mesh, the side chain of the pore lining residues are shown as
sticks with polar and hydrophobic residues colored in green and yellow, respectively. Bottom: schematic
representation of the M2 and M3 helix relative positions. Adapted from Sauguet et al. (submitted).
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1.3.1 Modulation through the sites in the ECD
pLGICs are modulated by benzodiazepines, a class of widely prescribed drugs that display anxiolitic,
anti-convulsive and sedative properties, targeting mainly GABA receptors. ey have been shown to bind
ELIC’s ECD in two distinct sites with associated opposite modulation eects (Spurny et al., 2012):
• activation through an intrasubunit site at low concentration,
• inhibition through an intersubunit site at high concentration.
Notably, the intersubunit site matches a site previously described on GABAAR (Ramerstorfer et al., 2011).
Divalent cations such as Ca2+ or Zn2+ have been suggested to play an important role in a biological
context. Ca2+ can potentiate nAChRs (Vernino et al., 1992; Mulle et al., 1992) and inhibit 5-HTRs (Peters
et al., 1988), while Zn2+ can have potentiating or inhibiting eects, depending on its concentration and
the type of pLGIC (Laube et al., 1995; Palma et al., 1998). Divalent ions have been shown to inhibit ELIC
(Zimmermann et al., 2012), with a binding site at the interface between two subunits.
A 2.4 Å structure of GLIC allowed to detect Br-, Cs+ and Rb+ at several binding sites in the vestibule
edge region of the ECD (Sauguet et al., 2013b). In the same study, the authors suggest two binding sites for
acetate, one overlapping the benzodiazepine binding site identied in ELIC, the second at the interface
between two subunits.
A nal study should be mentioned here. Pan et al. (2012) proposed a binding site for the General
Anesthetic (GA) ketamine located at the interface between subunits in GLIC’s ECD. Interestingly, this
structure is, to my knowledge, the only crystal structure of a GA bound to a pLGIC extracellular domain.
However, further investigation in Marc Delarue’s group highlighted several structures with unattributed
densities at the same location, even in absence of ketamine. e same group used these data to try
to propose an inhibition mechanism of GLIC by ketamine, using the Perturbation-based Markovian
Transmission model (Mowrey et al., 2013a). is work has, in my opinion, two weaknesses: i) the doubts
that still exist on the structure of ketamine bound to GLIC and ii) the lack of dynamic analyses to conrm
the validity of the paths from ECD to TMD that would explain ketamine’s action.
Importantly, most of these binding sites, especially ion ones, are still largely unexplored, as most groups
focused on the modulating sites in the TMD. A summary of anesthetics and alcohol binding sites found
by X-ray crystallography in pLGICs is given in table 1.3.
1.3.2 Modulation through the sites in the TMD
e TMD is the target of general and local anesthetics, alcohols and several cations.
Modulation sites for alcohols and GAs have been characterized experimentally by combining photola-
belling (Hamouda et al., 2013), site-directed mutagenesis and electrophysiology (Olsen et al., 2013; Howard
et al., 2011b). ree principal binding sites for GAs and alcohols have been identied within the TMD: i)
an intrasubunit pocket located within the M1-4 helix bundle, ii) an intersubunit pocket located roughly
at the same height than the intrasubunit pocket and iii) a channel site located at the extracellular end of
the pore, between the M2 helices. pLGICs crystal structures have been solved in complex with GAs and
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Protein Ligand Resolution (Å) Reference
GAs
GLIC propofol 3.3 Nury et al. (2011)
GLIC desurane 3.1 Nury et al. (2011)
GLIC (F238A) bromoform 3.1 Sauguet et al. (2013a)
GLIC bromoform 2.7 Sauguet et al. (2013a)
ELIC bromoform 3.7 Spurny et al. (2013)
Alcohols
GLIC (F238A) ethanol 2.8 Sauguet et al. (2013a)
GLIC (F238A) 2-bromo-ethanol 3.1 Sauguet et al. (2013a)
Channel
blockers
GLIC bromo-lidocaine 3.5 Hilf et al. (2010)
GLIC tetra-ethyl-arsonium 3.5 Hilf et al. (2010)
GLIC tetra-methyl-arsonium 3.6 Hilf et al. (2010)
GLIC tetra-butyl-antimony 3.7 Hilf et al. (2010)
GLIC picrotoxine 3.4 Hibbs and Gouaux (2011)
Table 1.3 – Crystal structure of general anesthetics, alcohols and channel blockers bound to amember
of the pLGIC family. Adapted from Sauguet et al. (submitted).
A B
P1B1
B2 W3
W1W2B1
W3
W1W2
P1
B2
Figure 1.10 – Location of the anesthetic binding sites highlighted in pLGICs transmembrane domain.
Top (A) and side (B) views of one and a half subunit transmembrane domain showing the three intrasubunit
binding sites (W1 to W3), the intersubunit site (B1) present in the GlyR and in GLIC F238A mutant, Nury
et al.’s linking tunnel (B2) and the pore site (P1).
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alcohols, covering these three sites. For convenience, we introduce here a nomenclature for these binding
sites that will be consistently numbered as summarized in gure 1.10 and referred to by their number.
A brominated variant of the local anesthetic lidocaine, which is known for its pore blockage properties,
as well as several cations were co-crystallized with GLIC few years ago (Hilf et al., 2010). Docking based
data suggestedGLIC’s pore blockage by propofol and isourane with amicromolar anity (Brannigan et al.,
2010; LeBard et al., 2012). More recently, the co-crystal structure of ELICwith bromoform provided another
experimental evidence that anesthetics can bind pLGIC’s pore (Spurny et al., 2013). Inhibition through
the pore can be understood intuitively and two distinct mechanisms probably coexist. Open-channel
blockers, such as lidocaine, are most oen charged molecules that carry the same charge as the permeating
ion and block the pore by mimicking ion permeation up to the point where they sterically prevent ion
conduction and jam the channel in an open conformation. On the other hand, general anesthetics such
as propofol, desurane or isourane are mostly believed to block the pore in an allosteric fashion, either
selecting or favoring, then stabilizing a closed conformation. However, from a mechanistic point of view,
the hypothesis that pore blockage/closing alone is at the origin of the anesthetic-induced eects is dicult
to reconcile with mutagenesis data indicating that mutations in the intrasubunit pocket region aect
anesthetic action (Nury et al., 2011). Binding sites in this region should therefore closely be examined, too.
Propofol, desurane and bromoform bind the intrasubunit pocket in GLIC (Nury et al., 2011; Sauguet
et al., 2013a; Chiara et al., 2014). While propofol and desurane binding poses are virtually the same,
bromoform adopted three distinct poses in the cavity: site W1 (the W standing for within the subunit)
overlaps the propofol and desurane binding site; site W2 lies closer to the M1 helix and partially overlaps
site W1; site W3 is deeper inserted in the cavity, between the M1 and M2 helices, at the interface between
the intra- and intersubunit regions. Ethanol, 2-bromo-ethanol and bromoform were found to bind an
intersubunit cavity in the structure of a GLIC ethanol sensitive variant, namely the mutant F238A. Ethanol,
2-bromo-ethanol and bromoform were shown to bind an ethanol-sensitive variant of GLIC, namely the
mutant F238A, by docking in an intersubunit cavity (Sauguet et al., 2013a) that will be referred to as
site B1 (the B standing for between the subunits). is site had been previously suggested for ethanol
binding to the glycine receptor by MD simulations (Murail et al., 2011). GAs and alcohols binding to
these sites produce opposite eects on channel function. In GLIC, the intersubunit site B1 is thought to be
potentiating (Sauguet et al., 2013a; Brömstrup et al., 2013; Murail et al., 2012; Howard et al., 2011a) while
the intrasubunit W1 site is inhibitory (Nury et al., 2011). Another intersubunit site has been suggested for
propofol binding to GABAAR by photolabelling at the ECD and the TMD interface (Yip et al., 2013), that
had been suggested for desurane based on MD data (Nury et al., 2011). is site will be referred to as site
B2.
A founding hypothesis of my work is that anesthetics modify the equilibrium between the channel
open and closed states, complying with the denition of an allosteric modulator (gure 1.11). However, it
should be mentioned that some experts believe that anesthetics block ion ow by sterically obstructing
the channel. A consensus exists for some anesthetics such as lidocaine which is believed to be an open
channel blocker. On the other hand, some anesthetics such as propofol for example have been proven to
bind to GLIC’s intrasubunit pocket (Nury et al., 2011) and suggested to bind the pore as well (LeBard et al.,
2012). Propofol is therefore believed by some to be a steric channel blocker and not an allosteric inhibitor.
e emerging picture is that modulation is the eect of competitive binding between the intersubunit
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Activation by agonist
Inbibition by anesthetic(cationic channels)
Potentiation by anesthetic(anionic channels)
Open channel Closed channel
Neurotransmitter
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Figure 1.11 –Hypothesis of anesthetic action on the function of ionotropic channels.Neurotransmitters
as well as anesthetics are believed to change the equilibrium between the channel conformations i.e. open
and closed. e neurotransmitter modies the equilibrium in favor of the open state. At excitatory
channels, anesthetics favor the closed state, preventing cations to enter the cell therefore the increase of the
membrane potential. At inhibitory channels, they favor the open state, allowing anions to enter the cell
which have the eect of decreasing the membrane potential. At excitatory as well as at inhibitory channels,
anesthetic action is therefore to inhibit the transmission of the action potential.
potentiating site and the intrasubunit inhibitory site, which is consistent when applied to mammalian
pLGICs since GAs and alcohols potentiate inhibitory channels GABAARs and GlyRs, while they inhibit
the excitatory nAChRs. Although, despite the accumulation of crystal structures of general anesthetics
bound to a member of the pLGIC family, the molecular mechanism of allosteric inhibition by anesthetics
binding to intra- and intersubunit pockets is still poorly understood. Regarding the probable existence of
general anesthetic binding sites in pLGICs pore, channel modulation is to be regarded as the combined
eect of binding to the intra, inter, and pore regions.
1.4 Context in October 2010
In the next few lines, I attempt to provide some context for the choices I made when I started to work on
the project, in October 2010.
A close collaboration was initiated in 2009 between Marc Delarue’s group at Institut Pasteur and my
PhD supervisor, Marc Baaden. In January 2011, Marc Delarue’s group released the rst structure of general
anesthetics bound to GLIC (Nury et al., 2011). His group co-crystallized propofol and desurane bound to
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GLIC’s intrasubunit pocket.
As electrophysiology measurement showed marked dierences in the modulation of several GLIC
mutants by these GAs, Marc Baaden was in charge of running MD simulations aiming to understand
this phenomena. ese simulations yielded interesting but incomplete data on anesthetic dynamics while
bound to the receptor, mainly suggesting that channel closure could be caused by the repetitive contacts
between GAs and the M2 helices.
We decided to center the start of my thesis on three principal aspects: i) the extensive characterization
of desurane and propofol dynamics bound to the crystallographic site; ii) understanding why propofol
inhibits more the T255A mutant than the WT GLIC; iii) understanding why desurane has an opposite
eect than propofol on this mutant, i.e. it is less eective on the mutant than on the WT.
In early 2013, our collaborators at Institut Pasteur came back to us with several structures of bromoform
bound to GLIC, displaying among other previously unseen sites, a bromoform molecule bound to the
pore of GLIC in LC conformation. As I had developed a suite of tools that allowed me to rapidly launch
MD simulations on a system of interest and eciently analyze the results, our collaborators asked us to
characterize GLIC’s inhibition by bromoform.
In the next two chapters, I will introduce the methods I used and developed during this project. e
characterization of GLIC’s inhibition by bromoform will be detailed in chapter 4. e following chapter
will be devoted to the study of propofol and desurane dynamics while bound to GLIC. Finally, I will end
the present manuscript with some concluding remarks.

2Molecular Modeling: Theory AndPractice
In this chapter, I introduce the principal method I have been using in this work: molecular modeling.
Molecular modeling includes a wide range of methods, from mixed experimental-theoretical to purely
theoretical ones.
As an example of a so-called mixed method, Nuclear Magnetic Resonance (NMR) and X-ray crys-
tallography are widely used to determine the three-dimensional structures of molecules. Both methods
have a strong in vitro component including protein expression, purication and raw data acquisition.
Since none of these techniques routinely allow to precisely determine the position of atoms from raw
data, in silicomodels are used to t atoms in the signal acquired from the machines (Trabuco et al., 2008;
Brünger et al., 1998). Pure in silicomethods developed during the last decades faced with the lack of in
vitromethods able to describe molecule dynamics at the atomistic scale. MD simulations are a member of
the large family of pure in silicomethods, further including Brownian Dynamics, Normal Modes Analysis,
or docking for example. ese methods belong to the family of molecular mechanics methods that require
the use of a force eld (see section 2.1) to describe the interactions between a system of particles. Despite
their empirical nature, these methods have proven their ability to reproduce data obtained from “wet lab”
experiments and are used to answer questions that in vitro and in vivo procedures cannot.
In 2013, the Nobel Prize in Chemistry was awarded jointly to Martin Karplus, Michael Levitt and Arieh
Warshel for the development of multiscale models for complex chemical systems, an acknowledgment that in
silicomethods are to be considered as an essential tool that can, together with in vitro and in vivomethods,
address some of the most challenging questions of our time.
is chapter is divided into four sections. e rst three sections briey introduce respectively the
concepts of force eld, MD simulation and free energy calculations. Finally, the fourth section will be
devoted to challenges mostly related to the simulation of biological systems.
2.1 Force Fields
As opposed to quantum mechanical representations that aim to describe the dual particle-like and wave-
like behavior of energy and matter, molecular mechanics representations use classical mechanics to model
a molecular system. Molecular mechanics methods require the use of a force eld that describes the
interactions between a system of particles with contributions of processes such as the stretching of bonds,
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Figure 2.1 – Equation of potential energy and schematic representation of the various contributions.
e total potential energy is the sum of bonded (bonds, angles, torsions) and non-bonded (steric, electro-
static) interactions.
the opening and closing of angles, the rotations about single bonds and non-bonded interactions between
particles.
It should be noted that some methods do not account for all these components. As an example, in rigid
docking bonded interactions are oen ignored while classical spring network models do not explicitly
account for electrostatic interactions (Tirion, 1996; Bahar et al., 1997; Hinsen, 1998).
e classical form of a molecule’s potential energy is shown in the illustrated equation of gure 2.1.
For each component, energy penalties are associated with the deviation from equilibrium values. e
resolution of these equilibrium values, even when based on experimental data, is oen adjusted to t a
molecule’s macroscopic properties that can be measured thanks to in vitro experiments. is process is
called parametrization. For example, during the parametrization of small molecules such as anesthetics, it
is common to use the density of a pure solution of this molecule and the solvation energy of this molecule
in water as target properties. As another example, lipids are oen parametrized in such a way that the
order parameter of each carbon atom ts in vitro data.
As a consequence and since force elds are parametrized to t a nite set of properties that can be
dierent from one force eld to another, it is not surprising that a given force eld may perform better
reproducing certain properties compared to another one (and conversely). It is then crucial to choose
with precaution which force eld is the most appropriate to reproduce the properties one wants to study.
For example, several studies highlight the fact that the Amber03 force eld overstabilizes helical structures
(Cino et al., 2012; Lindor-Larsen et al., 2012) while it has been suggested that the OPLS-AA force eld
may be biased in favor of bends over helices (Cao et al., 2011; Cino et al., 2012; Vamparys, 2013).
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Initialize ri and vi
Fi = −∂V
∂ri
ai = Fi
mi
Update ri and vi
repeat as long as
needed
Figure 2.2 –e algorithm underpinning molecular dynamics simulations.With ri the cartesian coor-
dinates of the atom i, vi its velocity, Fi the net force acting on it, V the potential energy applied to it, ai the
acceleration applied to it and mi its mass.
2.2 Molecular Dynamics Simulations
Molecular Dynamics (MD) is a computer simulation method that integrates Newton’s laws of motion to
calculate successive congurations of a system, resulting in a trajectory of atom coordinates and velocities
over time.
e second law of motion states that the acceleration of a body depends directly upon the net force acting
upon the body, and inversely upon the mass of the object. us F = ma, where F is the net force acting on
the object, m its mass and a its acceleration. anks to a force eld, F can be calculated for each particle of
a system. Since the particle mass is known, its acceleration can be calculated, therefore its position at the
next iteration can be deduced. is process, called integration of equations of motions can be performed
several times to obtain a trajectory for each particle in the system (gure 2.2).
e integration of motion equations can be done thanks to several integrators, each one having specic
properties. Next I will develop a few examples of such integrators.
Because MD is an in silicomethod, the soware used to run the calculations plays a central role in
the data acquisition. During my thesis these issues proved important. In this part I will introduce some
dierences that exist in the main two soware suites that I used for MD simulations, namely NAMD and
GROMACS.
2.2.1 Equation of motion integration algorithms
is part could lead us into the deepest pits of classical physics and mathematics. I chose to present only a
few key concepts in order to highlight some of the most important properties that should be considered
before running an MD simulation.
ere are a variety of algorithms that can be used to solve ordinary dierential equations. e most
basic methods are probably the Euler method, named aer Leonard Euler who proposed it in the late 17th
century, and its generalization by C. Runge and M. W. Kutta, called the Runge-Kuttamethod.
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Figure 2.3 – Sympletic vs non-symplectic integrators. Energy evolution of a water tetramer simulated
by the symplectic Verlet scheme (solid line) versus the non-symplectic Runge-Kutta integrator (dashed
line) at two time steps (0.1 and 1 fs). From Schlick (2010).
ese methods are quite intuitive and easy to implement, but do not feature one of the most important
properties an integrator should have in MD: they are not symplectic integrators. Sympletic integrators
are integrators that preserve specic properties associated with the Hamiltonian system of dierential
equations, including its value i.e. its energy (Schlick 2010, section 14.2). In practice, the total energy is not
preserved exactly but the energy error remains contained over time, which is dierent from non-symplectic
integrators which display a systematic energy dri over time. Runge-Kutta or Euler integrators are therefore
not to be used in MD.
e most popular methods for integrating Newton’s laws of motions derives from the Verlet method
(Verlet, 1967) in which the positions are given by
r(t + ∆t) ≈ 2r(t) − r(t − ∆t) + F
m
∆t2 (2.1)
with ∆t the time between two snapshots. e velocities are given by
v(t) = r(t + ∆t) − r(t − ∆t)
2∆t
+O(∆t2) (2.2)
with O(∆t2) being the interpolation error. NAMD implements the velocity-Verlet algorithm (Phillips
et al., 2005) while GROMACS’ default MD integrator is leap-frog (Pronk et al., 2013). GROMACS also
implements a variety of integrators which are mostly variants of either leap-frog or velocity-Verlet, each
one aiming to either increase accuracy or eciency under certain circumstances.
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2.2.2 Integration time step
e upper limit for the integration time step ∆t in the integration scheme depends on the fastest motions
in the system. For biological systems under biological temperature and pressure conditions, these motions
are light-atom bond vibrations, which are on the order of 10 fs (Schlick 2010, section 14.2.3). It is usually
accepted that ∆t has to be one order of magnitude lower than the fastest motions in the system, i.e. 1 fs in
this case. As the amount of CPU-time1 a user can spend calculating an MD simulation is xed and since
the computation time of one time step is constant, it is therefore useful to be able to increase the value of
∆t to speed up the simulation: computing 1,000,000 simulation steps with ∆t = 1 fs will output a 1 ns long
simulation trajectory, while, with ∆t = 2 fs, 2 ns can be calculated in the same amount of time.
e integration time step can be increased by treating bond stretching degrees of freedom as rigid.
e traditionnal algorithm to constrain bonds, implemented in NAMD, is SHAKE (Ryckaert et al., 1977).
e LINCS algorithm (Hess et al. 1997, a default in GROMACS), has proven of higher eciency and
presents better convergence properties. Both algorithms solve the same problem i.e. resetting coupled
constraints aer an unconstrained update. Interestingly, a third algorithm optimized for rigid water
molecules, named SETTLE (Miyamoto and Kollman, 1992), has been implemented in both soware
packages and is commonly used in the simulations of biological solutions.
An alternative scheme to treat high-frequency vibrational modes is to separate the calculation of the
force on a particle into two components: short-range and long-range forces, the underlying idea being
that long-range forces vary more slowly than short-range forces. is technique, known asmultiple-time-
stepping, allows to use dierent time steps for bonded and non-bonded interactions. NAMD implements
this idea separating bonded forces, Lennard-Jones and short-range electrostatic forces and nally long-
range electrostatic forces in three dierent loops. Typical multiple time step example values would be 2 fs,
2 fs and 6 fs. Multiple-time-stepping is not yet implemented in GROMACS.
2.2.3 Non-bonded interactions under periodic boundary conditions
Periodic boundary conditions
Without specic boundary conditions, the simulation of a molecular system would take place in vacuum:
particles at the system’s border are surrounded by nothing. At a moderately short time scale, this would lead
to serious artefacts because the whole system would diuse in the innite space of cartesian coordinates.
e solution to this issue is to circumscribe the system in a box just large enough to encompass every
particles of the system. But this would lead to other artefacts: border particles would repeatedly collide
with the box, which would strongly impact their behavior. Because the size of the systems that can be
currently simulated with MD is still so small, the abnormal behavior of border particles would nally
impact little by little every components of the system. A solution to this problem is to periodically repeat
the simulation cell, a technique known as Periodic Boundary Conditions (PBC). A particle exiting on one
side of the cell enters from the opposite face with the same velocity (gure 2.4). Besides, border particles
on one side of the cell interact with particles at the opposite side. is technique therefore simulates an
1Cost of a simulation, expressed as the amount of time for which a Central Processing Unit (CPU) was used processing
instructions of a computer program (denition from wikipedia.org). For example, a calculation that was run on 128 CPUs and
lasted 2 hours consumed t = 2 × 128 = 256 CPU-hours.
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Figure 2.4 – Periodic boundary conditions.e initial cell (central) is replicated in each direction so
that border particles interact with particles from the neighboring cell. Particles that exit a cell on one side
enter the cell on the opposite side.
innite system, but interactions with contributions from an innite number of neighboring images have
to be calculated, with consequences on computational eciency.
Non-bonded interactions
e complexity of computing non-bonded interactions isO(N2) where N is the number of atoms. is
is because non-bonded interactions have to be computed between all pairs of atoms. Such a complexity
implies a huge computational cost: Schlick (2010) estimates to roughly 2 years the CPU-time required
to calculate a single nanosecond of a 10,000-atom system. Fortunately, techniques have been developed
to reduce the dramatic cost of computing non-bonded interactions without decreasing the accuracy of
simulations of biomolecules in solvent.
e rst technique is to use a spherical cuto scheme, which is easy to implement and cheaper than brute
calculation (O(N)). ere are three categories of cuto techniques, all of them setting the contribution of
atoms remote from each other of a distance r > b to 0. e dierence between the techniques are their
behavior when r <= b (gure 2.5):
• the truncation approach does not change the value of the energy when r <= b, therefore abruptly
sets the interaction energy to 0 when r > b,
• switching schemes smoothly change the energy value for a <= r <= b,
• shi functions alter the function for all r < b.
In simulations of biomolecules, spherical cuto schemes are mostly used for representing van der Waals
interactions, which are quite short-range interactions.
Electrostatic interactions are long-range interactions that play a critical role in biomolecules. e
Particle Mesh Ewald (PME) approach has revolutionized biomolecular simulations, reducing the computa-
tional cost of calculating long-range interactions fromO(N2) toO(N logN) (Darden et al., 1993). is
technique, which has been developed specically to be used under PBC, employs direct calculation for
short-range interactions while long-range interactions are calculated in reciprocal space thanks to Fast
Fourier Transforms (FFT).
2.2. Molecular Dynamics Simulations 29
orig.trunc.switchshift
7 8 9 10 11
x 10-30
-2
-4
-6V
dW 
pote
ntia
l (kc
al/m
ol)
r (Å)
a b0.00
-0.06
-0.04
-0.02
4 6 8 10
Figure 2.5 – Spherical cuto schemes for non-bonded interactions. Van derWaals potential for various
cuto schemes with buer region 6-10 Å. Example of a Cβ − Cβ interaction with parameters taken from
the CHARMM program. Adapted from Schlick (2010).
2.2.4 Statistical ensembles: thermostats and barostats
Biological organisms live under strict conditions of temperature and pressure. To mimic a biological
environment, it is fundamental to be able to reproduce the atomic vibrational movement associated with a
given temperature and pressure. It is therefore very common for simulations of biological interest to run
in the NPT ensemble, i.e. an ensemble where the Number of particles, the Pressure and the Temperature
are retained constant.
Temperature coupling
e temperature T of a system is related to its kinetic energy, which is given by:
Ekinetic = 12
N∑
i=1
miv
2
i = 12νkT (2.3)
where ν is the number of degrees of freedom, i.e. 3 per atom (velocities along x, y and z axes)2minus the
number of constraints applied to the system. For example, for a system of N atoms with xed bond length
and center of mass momentum removal, ν = 3N − Nbonds − 3. Controlling the temperature can therefore
be done by a simple scaling of the velocities at each time step. However, algorithms coupling to an external
bath are oen preferred because they allow the temperature to uctuate about the desired temperature.
e Berendsen weak-coupling scheme (Berendsen et al., 1984) is a widely used algorithm. It has
been implemented in several MD soware packages such as NAMD and GROMACS. However, while it
performs fast temperature equilibration, it does not generate rigorous canonical averages (Leach, 2001).
Dierent canonical algorithms are therefore oen used for the production phase, such as the Andersen
thermostat (Andersen, 1980) or the Nosé-Hoover scheme (Nosé, 1984; Hoover, 1985). GROMACS also
implements a velocity rescaling method which is very similar to a Berendsen thermostat with an additional
stochastic term that ensures a correct canonical ensemble (Bussi et al., 2007).
2ere are 6 degrees of freedom per atom in the system, 3 for its velocity components plus 3 for the positions. As the kinetic
energy does not depend on atomic positions, here each atom accounts for 3 degrees of freedom.
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Pressure coupling
e instantaneous pressure p(t) is computed as the trace
p = 1
3
Trace P (2.4)
of the pressure tensor
P = 2
V
( 1
2
N∑
i=1
mivi ⊗ vi − Ξ) (2.5)
from the virial tensor
Ξ = − 1
2
∑
i< j
ri j ⊗ Fi j . (2.6)
Constant pressure simulations require periodic boundary conditions (see section 2.2.3). Pressure
is controlled by adjusting the volume, tuning both the particle coordinates and the box vectors at each
time step. e box size can be adjusted in dierent ways. For the simulation of membrane proteins, the
box’s dimension are oen constrained to vary semi-isotropically i.e. the X and Y dimensions are adjusted
identically while the Z dimension is adjusted independently.
Both NAMD and GROMACS implement the Berendsen pressure coupling. It is to be noted that,
according to the GROMACS manual, although this algorithm yield to the correct average pressure, it does
not yield the exact NPT ensemble and it is not yet clear exactly what errors this approximation may yield.
GROMACS implements two alternatives: the Parrinello-Rahman approach (Parrinello and Rahman, 1981;
Nosé and Klein, 1983) and the MMTK approach (Martyna et al., 1996), that can be used only with specic
integrators. As forNAMD, it provides constant pressure simulation using amodiedNosé-Hoovermethod
in which Langevin dynamics is used to control uctuations in the barostat.
In the last few sections, I intended to highlight some dierences that exist between two widely used
soware packages forMD simulations, NAMD and GROMACS. e implicit idea behind this comparison
is that it may be dicult to run simulations with the exact same setups using these programs, as they
oen do not implement the same algorithms on the one hand, and as even when they do, dierent
implementations of the same algorithm may lead to numerical dierences e.g. due to rounding, which
can have dramatic consequences in numerical simulations. As an example, Marc Baaden’s group has
been the rst one to my knowledge to raise an important issue concerning the simulations of the GLIC
channel. He and Samuel Murail, noticed that in all simulations calculated with the NAMD soware,
water molecules escape GLIC’s pore aer approximately one hundred nanoseconds, which is not the case
when running simulations with GROMACS in which case the pore remains hydrated on the microsecond
timescale. Detailed investigations have, to date, not allowed to precisely determine the origin of these
dierent behaviors (see also section 2.5.4).
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2.3 Free energy calculations
e free energy is a highly desirable quantity to compute because it describes quantitatively the thermody-
namical equilibrium. It allows especially to probe states of a system that are not accessible experimentally.
As an example, several hypotheses coexist on the location of GLIC binding sites for anesthetics. Alchemical
transformations constitute a precious tool to calculate free energies of binding, potentially allowing to
discriminate binding sites with a lower anity from high-anity ones.
In this work, free energy calculations were performed using the thermodynamic integration method
that allows to calculate free energy dierences between two states of a system. As depicted by gure 2.6,
while the free energy of binding of a ligand to a receptor cannot be directly computed, this quantity is
accessed employing a thermodynamic cycle. e thermodynamic method requires independent simu-
lations in which the HamiltonianH of the system slowly changes from that describing system A to that
describing system B. is modication ofH is a function of a coupling parameter λ that ranges from 0
whereH(p, r; 0) = HA(p, r) to 1 whereH(p, r; 1) = HB(p, r), where p is the particle momenta and r is
the particle cartesian coordinates.
e free energy F of a system at thermodynamical equilibrium is related to the partition function Q of
the system of an NVT ensemble (constant number of particles, volume and temperature):
F(λ) = − 1
β
lnQ with β = 1
kBT
(2.7)
Q = c∬ exp [−βH(p, r; λ)] dpdr with c = 1h3NN! (2.8)
where kB is Boltzmann’s constant, T is the temperature, N is the number of particles in the system and h is
Plank’s constant. e HamiltonianH(p, r; λ) gives the total energy of the system in a given conguration,
i.e. a given set of momenta and coordinates at a given value of coupling constant λ (Christ et al., 2010).
Compared to the free energy F, the Gibbs free energy is related to the partition function ∆ of an NPT
ensemble, which, at thermodynamical equilibrium, is
G(λ) = − 1
β
ln ∆ (2.9)
∆ = c∭ exp [−βH(p, r; λ) − βpV] dpdrdV (2.10)
where p and V are the pressure and the volume of the system, respectively. e dierence in free energy
between states A and B of the system are
∆GBA(p, T) = ∫ 1
0
⟨∂H
∂λ
⟩
NpT ;λ
dλ (2.11)
e value of ∆GBA can be calculated by running several independent simulations with dierent values
of λ. e energy variations between states is calculated in each window using the Bennett’s Acceptance
Ratio (BAR) method (Bennett, 1976) and the total energy variation is ∆GBA = ∑i ∆Gi , with i the window
index. Free energy of binding calculations are no exception to the ergodicity principle: the value obtained
is expected to be accurate as long as the sampling is adequate. e number of steps computed in each
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Figure 2.6 – A thermodynamic cycle for the computation of the free energy of binding of a ligand to
a receptor. ∆Gbind can be accessed by calculating ∆G1 and ∆G3. Adapted from Brömstrup et al. (2013).
frame has therefore to be adjusted to the system (the bigger a system is, the longer a simulation has to be
run to obtain the necessary sampling).
2.4 Application: bromoform force field parameterization
2.4.1 Principle
e algorithm of the simulation of a biped walking could be constructed from two steps that would repeat
endlessly: 1) move le foot, 2) move right foot. Now to extract data from such a simulation as for example
“how long would it take the biped to walk from Paris to Strasbourg?”, parameters have to be provided to the
simulation such as the biped speed and step size for example. For this very basic example, the parameter
(i.e. the biped speed) can be measured accurately. However, it is not always the case for molecules.
As for all numerical simulations, MD simulations obey similar rules and the representation of the
molecules that compose a system requires parameters such as the bond distances, the valence angles, the
dihedral angles, the atom charges and van derWaals radii, etc. Several of these parameters can be measured
experimentally with more or less accuracy. For the purposes of biological simulations, molecule force eld
parameters are usually adjusted so that the molecule’s macroscopic properties match the experiment, as
developed in section 2.1.
As it is oen the case for small molecules that are not widespread in the biological medium, bromoform
parameters were not available in any of the common force elds and had therefore to be computed.
2.4.2 Methods
e parameters I chose to target for bromoform were its density at 25 ○C, its vaporization enthalpy and its
solvation free energy, which is classic for such small molecules.
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Density at 25 ○C
e density of bromoform at a given temperature can be accessed thanks to simulations of pure bromoform
solutions, i.e. composed only of bromoform molecules. As both the number of bromoform molecules in
the box N and the box volume V are known, the density of the solution at equilibrium is given by
ρ = N ×M
NA × V (2.12)
whereNA is Avogadro’s constant (NA =6.02 × 1023mol−1) andM is themolarmass (Mbromoform = 253.73 g/mol).
To calculate bromoform density, I chose to run a single simulation of 1000 bromoform molecules in a
5 × 5 × 5 Å box for 5 nanoseconds.
Vaporization enthalpy
e vaporization enthalpy can be easily calculated from the simulation of a pure bromoform box. It
corresponds to the sum of non-bonded energies divided by the number of bromoform molecules in the
box. Vaporization enthalpy was extracted from the same simulation as the density.
Solvation free energy
Solvation free energy can be accessed thanks to a thermodynamical integration. A single bromoform
molecule is solvated and simulated in a water box. Bromoform charges and steric interactions with water
are slowly turned o. e energy dierence between the initial and the nal states corresponds to the
solvation free energy.
A single bromoform molecule was solvated in a cubic water box containing 343 water molecules. Free
solvation energy was calculated using similar setup as developed in section 2.6.3.
2.4.3 Results
e nal parameters are the result of successive iterations and parameter renements to match as well as
possible the desired properties.
e parametrization results I obtained are summarized in table 2.1. Some simulation values, such as
the density or the vaporization enthalpy match experimental values quite well. Notably, the value of the
dipole moment, which can be calculated from the molecule geometry, is very sensitive to the set of atom
charges and to the angle between Br-C-Br atoms. We therefore judge this dierence of 29% acceptable,
since a dierence of more than 20% is observed for the dipole moment of TIP3P water, a well established
model of water molecule. Furthermore, it is recommended that force eld parameters for MD simulations
of condensed phase properties overestimate the gas-phase dipole moment of a given molecule by as much
as 20% (Vanommeslaeghe et al., 2009).
e van der Waals parameters of bromoform carbon and hydrogen atoms have been taken from the
Amber99sb-isbn force eld atom types CT and H1, respectively. Bromine van der Waals parameters come
from the OPLS force eld. Atom charges have been calculated thanks to the R.E.D tools (Dupradeau et al.,
2010). Bond lengths have been taken from Lide (2003) as well as the value of the Br-C-Br angle. e value
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Experience Simulation ∆ (%)
Density at 25 ○C 2.879 g/cm3 2.932 g/cm3 1.8
Vaporization enthalpy 46.05 kJ/mol 42.03 kJ/mol −9.6
Solvation free energy −8.9 kJ/mol −6.2 kJ/mol −43.5
Dipole moment 0.99D 1.39D 28.8
Table 2.1 – Bromoform parametrization result summary.
of the Br-C-H angle has been calculated to match a perfect tetrahedron, according to the Br-C-Br angle.
e corresponding GROMACS parameter (.itp) le is available in appendix B.1.
2.5 Difficulties
Biological solutions are intrinsically complex and crowded mixtures. Some groups aim at modeling such
systems in their full complexity, as illustrated by a snapshot of a recent simulation by McGuee and Elcock
(2010) endeavoring to understand diusion properties of the bacterial cytoplasm (see gure 2.7). However,
such studies are currently limited to simplied approaches, such as Brownian Dynamics of rigid molecules.
Focusing on the case of GLIC, I discuss in this part several challenges for the study of biological
membrane protein solutions. Simplications are necessary in constructing the model, in dening the
composition of the system and in choosing the concentration of each species. Uncertainties remain since
neither experiments nor calculations can resolve issues such as reliably choosing the protonation states of
each of GLIC ’s titratable groups. I discuss intrinsic properties of the models that remain unclear at this
time such as the behavior of water in hydrophobic nanoconnement.
is part has been largely inspired by a review article I wrote and published in Laurent et al. 2013 (see
appendix B.2).
2.5.1 System composition
Biological solutions of interest contain several ingredients including proteins, nucleic acids, sugars, ions,
water and other small molecules (alcohols, anesthetics, etc.). Depending on the goal a study aims to achieve,
it might be necessary to include all these compounds in a model used for MD simulations.
Cells communicate with each other thanks to membrane-embedded receptors whose hydrophobic
transmembrane domains are stabilized by the membrane environment. Hence, lipid bilayers or bilayer
mimetics have to be included in a realistic model. Typical biological membranes are themselves complex
ensembles composed of lipids, carbohydrates, proteins and cholesterol in the case of eukaryotic cell (van
Meer et al., 2008). e proportion of each molecular species depends on the cell type. Furthermore,
dierent types of phospholipids are mixed in the membranes, with proportions again depending on the
cell type and possible leaet asymmetry. Matrix protein networks may further structure the membrane. To
make the membrane picture more intricate, microdomains enriched in cholesterol, also called lipid ras,
could play a role in the cellular function by compartmentalizing specic lipids and membrane proteins.
However the existence and role of such microdomains are very controversial.
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Figure 2.7 – Biological solutions are crowdedmixtures. Snapshot of a bacterial cytoplasm model whose
dynamics has been studied by Brownian Dynamics (courtesy of Dr. Adrian Elcock; McGuee and Elcock
2010).
Molecule Approx. percentage
cholesterol 29
phosphatidylcholine 28
phosphatidylethanolamine 26
phosphatidylserine 10
phosphatidylinositol 2
sphingomyelin 2
glycolipids 3
Table 2.2 – A human synaptic membrane composition.Approximative ratios as described byWood et al.
(1989)
Although some MD simulation studies now attempt to accurately model the complexity of e.g. the
Escherichia coli bacterial membranes (Piggot et al., 2011), generally speaking such a complexity is very
dicult to reproduce and the composition of the membrane is oen simplied by using a single type of
phospholipid. As an example, the GLIC simulation system is composed of the protein embedded in a fully
hydrated phosphatidylcholine membrane, whereas a typical synaptic plasma membrane composition is
diversied as described in table 2.2
Unfortunately, our knowledge about lipid compositions of various organisms and cell types is still very
limited, yet it is established that lipid building blocks have the potential to generate up to tens of thousands
of dierent molecular species (Shevchenko and Simons, 2010). is situation may improve with recent
eorts in the eld of lipidomics (Alex Brown, 2012).
On the order of 150 mMNaCl or KCl ions are typically added to mimic physiologic electrolyte concen-
tration. Sometimes higher concentrations up to 1M are used to enhance the probability of processes such
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Figure 2.8 – System set-up used to study ion permeation through GLIC according to the double
bilayermethod.e two compartments display dierent ion concentrations that create an electric potential
between them, driving the ions through the channel. Only three of the ve protein subunits and half of
the membrane are represented in order to expose the pore interior, displayed as a blue transparent surface.
as ion permeation. ese processes may be driven by cross-membrane potentials which are typically in
the range of −90 to −40mV. To reproduce such a potential in the simulation may require special methods
such as applying an electric eld using additional forces on all charged particles (Gumbart et al., 2012).
Maintaining a charge imbalance between two solution compartments has initially been proposed by Sachs
et al. (2004). is approach has subsequently been used by several groups to study the permeation of ion
channels (Kutzner et al., 2011; Lee et al., 2008). Herrera and Pantano (2009) proposed a variation of the
method where ionic motion is restricted anisotropically to one side of the system. Finally, Bostick and
Berkowitz (2003) used vacuum slabs to separate the compartments of a single unit cell. A setup to study
ion permeation through GLIC using the double bilayer approach is shown in gure 2.8.
2.5.2 Concentrations
Dening molecular concentrations at the microscopic level is not straight forward. Most simulation studies
aim to match experimental conditions. Yet, due to limited computational resources, simulation boxes are
typically designed as small as possible, focusing on the immediate membrane environment of the channel
of interest and minimizing the bulk solvent part. is introduces a bias in the calculation of concentrations.
In many experiments involving membrane proteins, a salt concentration of about 150 mM NaCl
is required to warrant an appropriate osmotic pressure. e number of Na+ and Cl− ions to add to a
simulation systemmay be calculated using equation 2.13 with Cwater = 55M. e calculated number of ions
is adjusted to neutralize the global charge of the system (i.e. protein charges), hence in this case NNa ≠ NCl.
For the highly charged GLIC channel, there is an important imbalance between positive and negative
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ions, in our simulations typically about 90 Cl− and 50 Na+ are present. ese numbers correspond to a
concentration of about 150 mM when calculated on the basis of the Cl− ions or 80 mM on the basis of
the Na+ ions. If the system was much larger with an extensive bulk solvent part, this dierence would
progressively become negligible, tending towards NNa ≈ NCl.
NNa = NCl = Nwater × CNaCl/Cwater (2.13)
Ion concentration could in principle constitute a way to study the inuence of pH by explicitly adding
protons to the simulation system (Baaden et al., 2001). However, this approach is impractical in the
present case because a huge simulation box would be required: at pH 4.6, a box containing 2,189,589 water
molecules is necessary to observe a single H+ ion, i.e. 50 times the actual simulation box size we use for
GLIC. is echoes the fact that the number of water molecules in simulations is generally too low to mimic
dilute solutions. A higher ratio of water to (protein + membrane) would be required to properly account
for bulk concentrations.
Furthermore, concentration is a dynamic property. Brannigan et al. (2010) reported simulations in
which they ooded both GLIC and nAChR receptors with isourane, a general anesthetic. During the
simulation an important number of the hydrophobic isourane molecules partition into the lipid bilayer.
Hence, at the end of the simulation, the concentration of isourane in the solvent is signicantly lower
(< 10 mM) than when it started (> 100 mM). is process is depicted on gure 2.9 along with data for
alcohol partitioning (Murail et al., 2011).
Brannigan’s study implies that a long equilibration of the systemmay be necessary before concentrations
can be measured reliably in order to allow solute molecules to partition between aqueous and membrane
phases. It may be debated whether concentrations should be calculated with respect to the water phase
only, with respect to water and membrane or with respect to the entire simulation box.
2.5.3 Protonation state
Knowing the protonation state of ionizable residues is a key issue to reliably model a protein. e proto-
nation state depends on a residue’s local environment. Standard pKa values measured in bulk cannot be
applied to buried protein residues, in particular for membrane proteins with an environment that largely
diers from aqueous solution. GLIC is constituted of ve symmetric protomers and the location of its 81 ×
5 ionizable residues is shown in gure 2.10. We may consider that equivalent residues in each subunit bear
identical protonation states. is assumption leads to approximately 281 = 1019 possible combinations of
protonation states. Tang and coworkers suggest that the protonation state of some titratable groups may
be dierent from one protomer to another leading to up to 1098 dierent combinations (Cheng et al., 2010;
Willenbring et al., 2011), a gure exceeding the number of particles in the universe!
e development of methods for calculating pKa values of titratable groups in proteins was pioneered
by Tanford and Kirkwood (1957) who proposed to represent the protein as an impenetrable sphere, which
allows to analytically solve the Poisson-Boltzmann Equation (PBE). e increase in computing perfor-
mances has facilitated the development of many PBE solvers, including the widely used APBS soware
(Fogolari et al., 2002; Baker et al., 2001). Nielsen and coworkers showed that a Finite Dierence Poisson-
Boltzmann method yields better results when adding an explicit step to optimize the hydrogen bond
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Figure 2.9 – Isourane and ethanol partitioning along ooding simulations. Isourane (black and red)
and ethanol (green) partition into the membrane during the equilibration of a GLIC, a nAChR and a
GlyR system, respectively. e aqueous concentration of isourane (top) decreases for the benet of the
fraction in the membrane (bottom). e same behavior is observed for the partitioning of ethanol during
the equilibration of a GlyR system (green) but to a lesser extent. Due to its more hydrophilic properties,
ethanol concentration decreased to half the initial one (≈ 300 mM) at the end of the simulation. is is in
contrast to isourane: its concentration drops to less than 10% of the starting one (≈ 10 mM).
network (Nielsen et al., 1999). Ideally, protein conformational exibility should be taken into consideration
for calculating pKa values. Specic terms have been included in some algorithms (Alexov and Gunner,
1997) and, more recently, methods based on the λ-dynamics approach using constant pH MD and Replica
Exchange Molecular Dynamics emerged (Donnini et al., 2011; Williams et al., 2011; Meng and Roitberg,
2010). ese latter methods are currently still under development and have so far only been tested on
small non-membrane peptides or proteins. PROPKA (Li et al., 2005; Bas et al., 2008) may be one of the
most commonly used empirical approaches because it is very fast.
In order to setup simulations of the GLIC system, we assessed the results of several widely used
programs and web services. ese pKa predictions yielded widely varying pKa shis as illustrated in
gure 2.11. We settled on the use of the Yasara soware (Krieger et al., 2002) mixing Ewald summation and
hydrogen bonding network optimization to determine if a titratable group should be protonated or not
(Krieger et al., 2006). e Yasara results remain in a reasonable pKa shi range, whereas some of the other
methods suggest huge shis (gure 2.11). We applied a consensus approach, only protonating residues that
were simultaneously found to change ionization state in all ve subunits. Subsequent Brownian Dynamics
simulations suggested that a neutral H11’ residue is most compatible with ion permeation (data courtesy of
Prof. Toby Allen; not shown) and the inuence of this protonation state has been tested in more recent
simulations. Many eorts in improving the crystallization protocol for GLIC recently lead to a higher
resolution structure in which ion binding can be predicted between residue D86 and D88. is is a strong
indication that these residues should not be protonated (Sauguet et al., 2013b). ese ndings allowed us
to iteratively improve our protonation state estimate for GLIC.
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Figure 2.10 – Localization of ionizable residues shown in a cross-section of the GLIC ion channel
(grey).M2 helices, in cartoon representation, line the pore through which cations (pink) cross the mem-
brane (ochre).
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Figure 2.11 – pKa shi predictions with respect to standard values for all ionizable residues in GLIC
obtained using dierent soware packages. Residues are ordered according to ∆pKa = (pKa solution −
pKa calc) with respect to the Yasara soware (A) or the PROPKA soware (B), respectively. e bottom
part of each panel indicates the amino acid type of each residue.
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Figure 2.12 – Hydration traces of GLIC’s pore during two representative simulations.Minor changes
in the simulation parameters can make a noticeable dierence between a fully hydrated channel (A)
and a channel that dehydrates spontaneously in the upper part of the M2 helix-lined pore (B). For both
simulations, the protonation states were identical (Bocquet et al., 2009), the only dierences were the
forceeld and the MD soware used (amber99 and Gromacs for simulation A, vs. Charmm22 and
NAMD2 for simulation B).
2.5.4 Solvation in special/unusual environments
e complex shapes of proteins may feature channels and cavities providing special, potentially solvated
nano-environments. Water in such hydrophobic nanoconnement may be particularly unstable, a phe-
nomenon known as capillary evaporation. Several groups have observed and characterized dewetting
transitions in MD simulations, for example in the context of nanopores (Beckstein and Sansom, 2003;
Beckstein et al., 2001) or in the bacterial mechanosensitive channels MscL and MscS (Anishkin et al., 2010;
Anishkin and Sukharev, 2004). Roth and coworkers suggest that capillary evaporation could constitute an
intrinsic property of some channels (Roth et al., 2008) and may be a widespread biological mechanism.
In the case of GLIC, extensive sampling lead us to observe an unexpected pore dewetting behavior (see
gure 2.12A), as did several other groups (LeBard et al., 2012; Willenbring et al., 2011). Yet we cannot
currently conclude whether GLIC belongs to a family of bubble gated ion channels, since ongoing studies
in our lab suggest that subtle changes in the simulation parameters may prevent dewetting to occur (see
gure 2.12B). Another very recent study is more armative (Zhu and Hummer, 2012b). It should be noted
that forceeld parameters generally have not been tuned to reproduce the behavior of water in such special
environments, which is in part due to the lack of experimental data.
2.5.5 Sampling, statistics, timescale
A fundamental question before starting any computational study is how to best spend the limited amount of
available computing time. Strategiesmay vary in between two extremes: a) runningmany short simulations
from several starting points or b) running an extended one-shot simulation. Shaw et al. recently showed
that the result of the second approach matches experimental data very well, when the MD simulations are
long enough (Shaw et al., 2010).
In 2010, my PhD host lab studied GLIC gating in a 1 microsecond MD simulation suggesting a domino
gating mechanism in which subunits sequentially switch from an open to a closed conformation (Nury
et al., 2010). Despite the large amount of computational resources (approx. 10 months of calculations on
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Figure 2.13 – Sodium ion occupancy and related relative Boltzmann energy accumulated during a
one microsecond MD simulation. Ions are blocked in the upper part of the transmembrane domain.
a supercomputer in 2009, i.e. tens of years on a recent desktop machine), only two protomers had fully
undergone this transition to a closed state at the end of the simulation, suggesting that a much longer
simulation was required to achieve a complete gating transition in all ve protomers. Longer simulations
are also needed to characterize processes such as ion permeation. Since GLIC has a low conductivity
of 8 ps, one should observe an estimated passage of only 3 ions per microsecond at −65mV. A cheaper
alternative is to map the anity of ions for a certain position along the channel pore. Such a graph was
determined previously from the 1 microsecond gating simulation for a non-conductive state with a central
barrier (gure 2.13). It is usually admitted that a simulation should be run at least 10 times longer than the
slowest timescale of interest (Zuckerman, 2011). is is oen impossible since many relevant biomolecular
timescales exceed 1 microsecond. Typically, the neuromuscular acetylcholine receptor’s gating is expected
to be in the range of 1 to 10 µs (Chakrapani and Auerbach, 2005) which implies MD simulations from 10
to 100 µs.
Running several short comparative simulations may be more appropriate for ligand binding studies,
for example involving drugs and anesthetics as illustrated in the results of this PhD thesis. An advantage of
such short simulations is to remain close to a well dened state, e.g. a crystal structure, rather than moving
away from the experimentally backed conformation to some transient intermediate state. Furthermore one
may reduce the number of unproductive runs where the drug may diuse out of the binding pocket into
the solvent. Many short simulations with slightly dierent ligand starting conformations improve statistics
and sampling. We employ such an approach to study two general anesthetics, propofol and desurane, that
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have recently been co-crystallized with GLIC (Nury et al., 2011). is study revealed a binding site in the
upper part of the transmembrane domain of the protein. Other binding sites for general anesthetics and
alcohols, including transmembrane, extracellular and pore sites have been suggested (Cheng et al., 2010;
Chen et al., 2010; Brannigan et al., 2010; Howard et al., 2011a). Channel blocking by charged quaternary
ammonium compounds, divalent ions and lidocaine has been shown using electrophysiology and X-ray
crystallography (Hilf et al., 2010), also suggesting binding sites located in the pore of the channel. ese
observations pose the problem of sampling from a combinatorial point of view: multiplying the number
of sites by the number of ligands, then by the number of mutants one wishes to test quickly leads to an
intractable required total simulation time.
Lipids are crucial for the structure and function of membrane proteins. Bilayers with complex com-
positions pose a particular sampling challenge (Soares and Straatsma, 2008). A misplaced lipid in a
simulation setup might have consequences on the whole trajectory, in particular if it were to play a specic
biological role. With a diusion coecient of the order of 10−8 cm2/s, a lipid embedded in a membrane is
expected to have a mean-square displacement of 4 nm2 for a one microsecond long simulation. In our
GLIC simulations, convergence for this value sets on beyond 100 ns and fully stabilizes at about 500 ns.
Hence, the timescale of most current studies does not allow for an extensive reorganization of lipids
around membrane proteins. Parton et al. recently addressed this problem while simulating a whole vesicle,
demonstrating the importance of lipid diusion for protein aggregation (Parton et al., 2011). e authors
however highlight that the coarse grained models are highly simplied and inevitably approximate the
nature of the protein-lipid and protein-protein interactions. de Meyer et al. (2010) previously suggested
the role of cholesterol in protein clustering using dissipative particle dynamics Monte Carlo and a more
simplied model.
At last, the problem of simulation convergence should be raised briey. Methods for the quantication
of sampling have been proposed for several decades, yet none has been widely adopted. In 2000, Berk
Hess proposed a method based on principal component analysis (Hess, 2000) that has been used by other
groups to evaluate the convergence of a set of MD simulations (Faraldo-Gómez et al., 2004; Grosseld
et al., 2007). Faraldo-Gómez and coworkers focus on convergence of membrane protein simulations, and
although the timescale is relatively short by today’s standards, their main ndings are likely still valid.
eir work concludes that structured transmembrane domains converge relatively fast, even on a 10 ns
timescale, but more mobile parts are under-sampled. Grosseld et al. calculated 26 independent 100 ns
molecular dynamics runs of rhodopsin and found similar results (Grosseld et al., 2007). To date, despite
new method proposals (Grosseld and Zuckerman, 2009; Zhang et al., 2010; Zhu and Hummer, 2012a),
sampling quality is oen tentatively assessed based on several simple criteria. A single descriptor may be
monitored along a simulation until it reaches a stable value. e Root Mean Square Deviation (RMSD),
which is a descriptor for molecular deformation, is a common but controversial criterion. A variation
consists in stopping a simulation aer a descriptor reaches an experimental reference value and remains
close to it for a certain time. Another approach is to use several independentMD simulations with dierent
starting points. When these simulations converge to a similar state, sampling is considered sucient.
44 Chapter 2. Molecular Modeling: eory And Practice
2.6 Setups and methods used in this work
In this subsection I rst describe the simulation setups that form the basis for this thesis, representing
a total of over 1600 nanoseconds sampling accumulated on the anesthetic-bound GLIC system. At the
end I highlight a few non-standard methods used to calculate condence intervals on these data sets,
characterize the location of the anesthetic in a given binding site and determine binding pocket volume.
is work reports MD simulations of three dierent anesthetics bound to GLIC. Molecular models
of propofol (PFL) and desurane (DSF) bound to GLIC were built using a pre-equilibrated system of
GLIC embedded in a fully hydrated lipid bilayer. GLIC’s initial conguration was based on PDB ID 3EAM,
in which protein conformation is virtually identical to the later released high resolution structure 4HFI
(RMSD on heavy atoms is 0.4 Å), and then equilibrated without restraints for several tens of nanoseconds.
GLIC’s conformation at the end of the equilibration phase displayed an RMSD relative to 3EAM of 2.5 Å
(calculated and tted on the protein Cα atoms).
For bromoform, molecular models of open GLIC were built from PDB ID 4HFI (wild-type) and 4HFD
(F238A). e system was equilibrated with harmonic constraints on the protein backbone for 200 ns.
Residue protonation state was assigned in the same fashion as in previous simulations (Nury et al.,
2011) on the basis of pKa calculations with the Yasara soware (Krieger et al., 2012) to represent the most
probable pattern at pH 4.6, with residues E26, E35, E67, E69, E75, E82, D86, D88, E177 and E243 being
protonated. All histidines were doubly protonated (unless stated otherwise). e models were inserted
in a fully hydrated palmitoyl-2-oleoyl-sn-glycerol-phosphatidylcholine (POPC) lipid bilayer. e net
charge of the system was neutralized with Na+ and Cl- counter ions. e NAMD (Phillips et al., 2005) and
GROMACS (Pronk et al., 2013) soware suites were used for short and long MD simulations, respectively.
2.6.1 Short 8 ns long MD simulations
Anesthetic initial poses
e ligand was inserted into a previously equilibrated system of GLIC embedded in a fully hydrated lipid
bilayer. Bromoform (MBR) poses have been generated by randomly moving and rotating bromoform
molecules around the crystallographic binding site. Propofol and desurane poses have been generated by
taking the largest clusters from a 30 ns longMD simulation of the GA bound to GLIC. Previous coordinates
were calculated using the GROMACS g_cluster programwith the gromos algorithm. e cuto distance
for the clustering has been determined empirically to t the number of starting conformations we needed
i.e. approximately 125.
GA molecules were assigned dierent conformations in each of the ve GLIC subunits and in each of
the 25 systems that were simulated achieving a total of 125 dierent poses, which maximizes anesthetic
sampling in the binding pocket.
Each system was then minimized for 1000 steps and ran for 8 ns using the run parameters described
below.
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Anesthetic GLIC variant Conformation* Binding site† Sampling (ns) Total sampling (ns)
MBR WT Open W1 25 × 8 = 200 1000
MBR WT LC P1 10 × 8 = 80 80
MBR F238A Open B1 25 × 8 = 200 1000
DSF WT Open W1 25 × 8 = 200 1000
DSF WT LC W1 25 × 8 = 200 1000
DSF T255A Open W1 25 × 8 = 200 1000
DSF T255A LC W1 25 × 8 = 200 1000
PFL WT Open W1 25 × 8 = 200 1000
PFL WT LC W1 25 × 8 = 200 1000
PFL T255A Open W1 25 × 8 = 200 1000
PFL T255A LC W1 25 × 8 = 200 1000
Table 2.3 – Systems simulated by means of short MD simulations. Each GLIC protomer hosts a GA.
Considering that each GA molecule is independent from the ones in the neighboring subunits, an MD
simulation of 5 GAs bound to GLIC therefore provides 5 times the sampling.
* LC conformation is dened in section 1.2.3. †Site numbering is dened in section 1.3.2.
MD run parameters
MD simulations were performed using the CHARMM27 (MacKerell et al., 1998) force eld. Temperature
and pressure were maintained using Langevin dynamics (Kubo et al., 1992) and a Langevin Piston (Feller
et al., 1995), respectively, at 310 K and 1 bar. Short-range non-bonded interactions were computed using a
potential switching from 8.5 to 10 Å. Long-range interactions have been treated using PME (Darden et al.,
1993). e same protocol has been used for each system for which short MD simulations were calculated
(table 2.3).
2.6.2 Long MD simulations beyond the hundred nanoseconds timescale
e ooding simulation setup was carried out by my colleague Samuel Murail.
For long MD simulations a previously equilibrated system containing GLIC, 246 POPC lipids, 29141
water molecules, 170 Cl- and 135 Na+ ions (i.e. a total of 146,000 atoms) in an hexagonal box was used to
create the system with 200 bromoform molecules. It was equilibrated for 50 ns with position constraints
on GLIC Cα atoms with the 4HFI structure as a reference. en four iterations were used to add slowly the
bromoform and avoid aggregates due to its low solubility. In each iteration, 50 molecules of bromoform
were added by replacing random water molecules 10Å away of protein and 4Å away of the membrane. e
system was then minimized for 10,000 steps and equilibrated with position constraints on GLIC Cα atoms
with the 4HFI structure as a reference. In the two rst iterations, equilibrations were 50 ns long, and 100 ns
long in the two following. In a last step bromoformmolecules which were bound in the intrasubunit cavity
were replaced in the water phase and the system was minimized for 10,000 steps. is equilibrated system
was then used as starting point for the three ooding simulations. For simulation of F238A, the phenyl
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side chain was removed manually from the system and a minimization of 10,000 steps was run. In each
of the three simulations, a supplementary equilibration step was used consisting in a 10 ns equilibration
with position constraints on heavy atoms, and 20 ns with position constraints on Cα atoms. Reference
structures used were, for WT open, WT LC, and F238A open simulations, respectively, PDB:4HFI, the
structure presented in chapter 4 and PDB:4HFD. Production runs were nally carried out for 1 µs without
any constraints. Simulations were performed using GROMACS 4.6.3 using virtual interaction sites, 5 fs
time steps, and all bond lengths constrained with the LINCS algorithm (Hess et al., 1997). Electrostatics
interactions were computed using particle mesh ewald summation at every step. A 10Å cuto was used
for non-bonded interactions and the neighbor list was updated every 5 steps. ree baths (protein, water
and ion, membrane) were coupled to a temperature of 310 K using the Bussi velocity rescaling thermostat
with a time constant of τ = 0.1 ps. e x/y dimensions were scaled isotropically with a Berendsen weak
barostat and the z dimension independently to reference pressures of 1 bar, τ = 5 ps and compressibility of
4.5 × 10−5 bar−1. During equilibration position restraints of 1000 kJ/(mol nm) were used.
2.6.3 Free energy calculations
irdly, we calculated the bromoform anity for each of the 6 binding sites in WT, F238A, open and LC
variants of GLIC using alchemical free energy calculations (gure 2.14). e bromoform poses displayed in
the crystal structure were used when available. e bromoform pose in intersubunit site B2 was extracted
from a short MD simulation. Bromoform was inserted into a previously equilibrated system of GLIC
embedded in a fully hydrated lipid bilayer. MD simulations were performed using the CHARMM36
(Huang and MacKerell, 2013) force eld. e system was minimized for 10,000 steps. Two successive
equilibrations with constraints on a reference structure, typically a crystal structure, were performed:
5 ns constraining protein heavy atoms and bromoform, then 20 ns constraining protein Cα atoms and
bromoform. During these two equilibration steps, constraints were also applied on the dihedral angle
between Y197 C-Cα-Cβ-Cγ atoms ensuring an angle of 173.5° in GLIC open form and 91.8° in the locally
closed conformation. ese values correspond to the two principal modes of the angle distribution
observed along short MD simulations. A thermodynamic cycle was then applied to calculate free energies
of binding of bromoform to GLIC using a similar protocol as that described in (Brömstrup et al., 2013),
however as a large number of such calculations was carried out, we optimized the protocol in terms of
number of windows and sampling times. Coulombic and van der Waals interactions were decoupled
using a decoupling parameter λ linearly increasing from 0 to 1. Coulombic interactions were decoupled
along 11 independent steps while 21 steps were necessary to decouple van der Waals interactions. At each
λ-point, the system was minimized for 5000 steps, equilibrated for 10 ps in the NVT ensemble, then
equilibrated for 100 ps in the NPT ensemble. Bromoform positions were harmonically constrained during
these two equilibration steps with a force constant of 1000 kJ/(mol nm2). Production simulations were
run using the sd3 integrator with a time step of 2 fs. During the production phase, bromoform positions
were restrained using an umbrella potential with a force constant of 100 kJ/(mol nm2). For coulombic
interaction decoupling, 2 ns were carried out. For van der Waals interactions, 3 ns were carried out for the
rst 14 λ-points (initial λ < 0.7) and 10 ns for the remaining 7 points (initial λ >= 0.7). e same protocol
was applied for decoupling bromoform in water. e calculation of the binding free energy was carried out
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GLIC Variant
Pore state
Binding site
OpenLocally-Closed
WT
W1-2 W3B1 B2 P1W1-2 W3B1 B2 P1
OpenLocally-Closed
F238A
W1-2 W3 B1B2 P1W1-2 W3B1 B2 P1
Figure 2.14 – Extensive screening of bromform’s anity for GLIC. Bromoform’s free energy of binding
was calculated for 5 binding sites in GLIC wild-type, mutant F238A, in both open and locally closed
conformation.
using the BAR method (Bennett, 1976) as implemented in the g_bar program from the GROMACS suite.
2.6.4 Confidence interval on means calculation
Comparing two means extracted from MD simulations requires a robust methodology that is not well
established in the eld. A classical method such as the Shapiro-Wilk test is oen not applicable in MD
because this test, as well as most parametric tests, require the data to be normally distributed and have
equal variances, which is oen not the case inMD. Non parametric tests, such as the Kolmogorov-Smirnov
test, are therefore a better choice but, as well as the parametric tests by the way, are biased by the number
of observations: they will return signicant p-values if the number of observations is important, even if
the dierence between the distributions is minimal. In MD, it is very common to calculate a mean on
hundreds or thousands of steps of a simulation. Another approach has therefore to be used to calculate
robust means with condence intervals.
I chose to use the bootstrapping method. is method consists in calculating an estimator, typically
the mean, of a distribution using a random resampling of the distribution with replacement. Numerous
resamplings have to be done, to nally obtain as many estimators extracted from the slightly dierent
subsamples extracted from the original data set. is method has several advantages, especially to calculate
means with condence intervals. First, it can be used on non normally distributed data since the ensemble
of means that is calculated will most likely be normally distributed itself. Second, this method is sensitive
to variance in the initial distribution which means that two sets of data centered on the same value but
with dierent variances will yield dierent condence intervals.
In my case, I chose to use 1000 resamplings.
2.6.5 Binding site occupancies
Binding sites occupancies have been computed by calculating the distance between the anesthetic and
a reference position taken from relevant crystal structures. e occupancy of site B2, which is not a
crystallographic site, has been calculated with respect to a position extracted from a short MD reference
simulation. A site is dened as occupied at a time t if the distance between the center of mass of the
anesthetic molecule and the reference position are within a cuto. e cuto value I chose is 4 Å, which
is quite restrictive considering the volume of the intrasubunit pocket. It is therefore important to note
that the analysis may indicate that the anesthetic does not occupy any binding site strictly speaking while
3e sd integrator implemented in GROMACS is an accurate leap-frog stochastic integrator which also acts as a thermostat.
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being inside the pocket.
Occupancy maps have been calculated with Visual Molecular Dynamics (VMD)’s volmap tool, using
a classical van der Waals radius, combining all frames and averaging the data.
2.6.6 Pocket volume calculation
Binding pocket volume calculations have been carried out using the Epock soware (see section 3.3).
To calculate the volume of the intrasubunit pocket, only frames with anesthetic molecules closer than
4Å from sites W1, W2 or W3 have been taken into account.
e nal volume average value and corresponding condence interval have been calculated by boot-
strapping (see section 2.6.4.) considering the last 3 nanoseconds of simulation.
2.6.7 Contacts
Contacts between the anesthetic and the protein residues have been calculated with the VMD measure
contacts procedure. A contact with a residue is counted if any atom from the anesthetic is closer than
4Å of any atom of the residue. e number of contacts with a residue at a time t is summed over the ve
subunits of the protein. e nal percentage of contacts between the anesthetic and a residue is dened as
the sum of the number of contacts at each frame divided by the number of frames in the simulation. is
percentage is therefore the probability that any of the ve anesthetic molecules present in a simulation
contacts the correspondind residue on any of the ve GLIC chains.
3High-Performance Computing AndLarge Scale Data Analysis
e founding principle of statistical physics concerns ergodicity stating that the time average of one
sequence of events is the same as the ensemble average. Hence, as any statistical analysis, data obtained
from MD simulations can only be trusted if numerous uncorrelated events have been observed. As
discussed in section 2.5.5, there are basically two ways one can apply this principle to MD simulations: a)
running an extended one-shot simulation; b) running many short simulations from several starting points.
Depending on the study focus, the rst, second or both methodologies may apply. For example, a study
that aims to describe the process of binding of a ligand to a protein would most probably require long
simulations in which the ligand is not bound to the protein at the start as opposed to the description of the
interactions between a protein and a bound ligand, which would require many short simulations to avoid
the ligand unbinding. Nowadays, it is very common to run one to two long simulations since, as will be
justied in this chapter, it oen implies less work.
A major aspect of this work has been the description of the dynamics of GAs bound to GLIC. I chose
the second approach, i.e. the calculation of several short simulations to achieve extensive sampling of the
ligand dynamics while bound to the protein.
In this part, my goal is to introduce the main technical diculties I have been facing. e rst section
will be devoted to the specic hurdles related to the approach I used, while the following is related to the
system’s size.
3.1 Computing the simulations
3.1.1 The need for high-performance computers
As GLIC is a membrane protein, a minimum system for studying this channel at an all-atom resolution is
made of several molecule types, leading to a total number of approximately 200,000 atoms (see table 3.2).
e simulation of such a number of particles remains challenging and requires computational power that
is oen not accessible locally. Supercomputers are therefore required to produce data in a reasonable
time. As an example, using 184 cores on jade@cines.fr1 allows to run an MD simulation at a speed of
10 ns/24h. While computing 10 ns of simulation takes one day on jade, it would virtually take 46 days to
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get the same amount of data on a recent desktop computer.
I focused on 12 subsystems including dierent GLIC mutants in dierent conformations with dierent
GAs bound to it. Since 25 simulations of 8 ns each have been run for each system, I calculated the equivalent
of 9600 ns, which would have been done in a total of 960 days if they had been run one aer the other on
a super computer, and more than 120 years on a recent desktop computer, pointing out the essential need
for supercomputers in theoretical biophysics. e total amount of CPU-time2 spent on this aspect of the
project is estimated to 4,377,528 jade equivalent CPU-hours3.
3.1.2 Optimizing the available resources
e number of CPU-hours available for a project is nite, obviously. To best spend the limited amount
of available computing time, it is necessary to run several benchmarks to avoid loosing time by running
a suboptimized simulation. e procedure to nd the set of parameters that gives the best computation
speed is well dened and should be carried out every time one starts to work on new machines or a new
system since this set of parameters depends both on the topology of the system and the architecture of the
machines.
e very rst step to optimize a simulation is to reduce to the minimum the number of particles that
compose a system. e size of the simulation box (see section 2.2.3) has therefore to be well chosen not
being too large, which will increase the number of lipids (in the case of a membrane protein) and solvent
molecules, but also not being too small to avoid contacts between protein periodic images or articial
structuring of the membrane.
e second step is to run several very short simulations (on the order of 100 ps) varying the number of
cores used that will allow to estimate the speed a simulation is computed at (i.e. number of nanoseconds
calculated per day), and the computing time consumed. e optimal number of processors and cores
(recent processors have up to 16 cores, and, sometimes, leaving one core available yields better results) can
then be dened according to the project needs. A number of processors which is a power of two usually
yields better performance. However, NAMD developers advise for a maximum speed to use a number of
cores proportional to the system’s size. For instance, it can be deduced from gure 3.1 that the maximum
speed (number of nanoseconds computed per day) is reached at 544 CPUs. It is then a waste of resources,
again for this particular system on this particular machine, to run a simulation using 1024 CPUs, as no
speed-up is achieved. e second element that will inuence the choice of the number of cores to use
is the number of nanoseconds that can be computed with a certain amount of CPU-hours, 300,000 for
instance. is amount is inversely proportional to the number of cores used. It is clear on gure 3.1, that, at
maximum speed (i.e. 512 CPUs), only 500 ns can be computed while more than 700 ns can be computed
with 128 CPUs. On the other hand, the 500 ns would be obtained in X days only with 512 CPUs, whereas
Y days are required with the more economical 128 CPUs for 700 ns.
Last but not least, the program options should be in their turn optimized. In NAMD, for instance,
1
jade is a supercomputer located at Centre Informatique National de l’Enseignement Supérieur (CINES, Montpellier).
2See denition on page 27.
3e simulations were dispatched on jade@cines.fr, turing@idris.fr, babel@idris.fr, ada@idris.fr,
vargas@idris.fr and curie@tgcc.fr. is value is the number of CPU-hours that would have been consumed if all the
simulations had been carried out on jade@cines.fr.
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Total number of cores
Figure 3.1 – Benchmarking the speed of a simulation on a machine.e total number of cores is the
product of the number of CPUs and the number of cores on each CPU. Benchmark realized with NAMD
in 2011 on jade@cines.fr.
dividing patches4 in halves oen leads to better results. e PME calculation (electrostatic interactions)
can be optimized by dening the dimension of the grid for PME decomposition and dening the number
of processors on which PME should be computed and reserve them for PME only. Several other options
can be adjusted and will not be developed here.
Table 3.1 compares some French supercomputer performances. Although it may seem illogical, the
fastest machine is not necessarily the one to use for all purposes. For instance, curie@tgcc.fr’s cores are
slightly less ecient to run an MD than ada@idris.fr’s but, on the other hand, curie’s overall speed is
higher than ada’s since it has more cores: 80,640 cores vs 10,624 on ada. is reduces the waiting time
between jobs and may allow to run more jobs in parallel, depending on a given supercomputer’s policy.
Furthermore, more cores could be used on curie than on ada speeding-up the simulation (but increasing
the cost of a simulation in CPU-hours/ns). As as second example, turing@idris.fr is one order of
magnitude slower than every other supercomputer listed in table 3.1. However, this machine turned out to
be suitable to run short MD simulations (8 ns). e specic rules of the computer centers have to be taken
into account. At IDRIS, the number of jobs a user can run at the same time is limited to 3, and the number
of jobs the same user can have in queue is also restricted. is rule can strongly slow down a project’s
proceedings when numerous jobs have to be run. To compute 20 dierent free energies of binding of
bromoform to GLIC (see section 2.6.3), I had to run a total of 640 jobs. For the reason stated above, most
of these jobs (in the limit of the available CPU time) were run on curie to benet of the unrestricted
number of jobs a single user can run at the same time on this machine. e remaining jobs were run with
a special priority on the adamachine, thanks to the assistance of the IDRIS support team.
3.1.3 Data storage
e storage of these data has to be considered as amajor concern, sincemore than 6 TB have been produced
carrying out this part of the project. Besides, safety demands storing at least two copies of the data in
4e patch is used by NAMD as the fundamental unit of spatial decomposition.
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Machine Number of cores Speed (ns/day) ns/100,000 CPU hours days/µs
turing@idris.fr 256 3.54 58 283
ada@idris.fr 256 57.66 938 17
curie@tgcc.fr 256 53.03 863 19
jade@cines.fr 256 43.61 710 23
hades@lbt.ibpc.fr 180 35.88 865 28
Table 3.1 –Comparing common supercomputers.Benchmark realizedwithGROMACS 4.6.3 on a system
made of 146,182 particles.
dierent places, allowing to recover data if one copy is damaged or deleted.
e original data have been stored on gaya@idris.fr, that oers a capacity of 6.6 PB of taped storage.
Copies had to be stored locally. However, the lab’s current storage setup imposes limits on the recurrent
backup of such large quantities of data. e solution I found is to switch from the original NAMD dcd
format to the GROMACS xtc format, which has been optimized for oating point numbers compression.
Hence, an xtc le is more than 3 times smaller than a dcd le and displays a negligible precision dri. It
therefore turns out a very good choice for original data backup and everyday analyses. Finally, xtc les
generated for this part of the project constitute a total of 1.9 TB of data.
From a more general point of view, I think that GROMACS’s xtc format should always be used to store
system trajectories for numerous reasons. e rst reason is the impressive gain of space detailed above.
e second reason is that GROMACS can perform a variety of operations on xtc les such as ltering,
tting, translating, etc. e third reason is that dealing with smaller les will signicantly impact the time
a program will require to run an analysis, even its capacity to run an analysis. As an example, the VMD
soware loads into memory the whole trajectory at start. Obviously, the larger the le, the longer the
loading, which can become critical if the le size exceeds 1 GB.
Finally, backup soware run time considerably depends on the number of les to save. Some MD
soware, such as OPEP (Chebaro et al., 2012), store the system trajectory as Protein Data Bank (PDB)
formatted les at a rate of one le per frame. One trajectory could therefore be stored as several thousands
(millions) of les which will take a considerable amount of time to backup. is may even be more critical
at supercomputer centers, as the number of available inodes on the le system may be limited.
Dealing with such a volume of data divided into 400 independent simulations is not trivial. Improving
the eciency and the scaling of the analysis processes turned out to be unavoidable.
3.2 Scaling and parallelization of the analysis processes
Handling several similar simulations at the same time can reveal itself time consuming and many mistakes
can slip into the process if some slight changes have to be made from one simulation to the other. Since
most recent studies favor the calculation of one to a handful (< 5) of long simulations upon the calculation
of many short ones, no soware has been developed to perform this kind of specic task.
A good knowledge of Unix tools combined with programming skills allowed me to handle 400
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Molecule type Number of molecules Number of atoms
Protein 1555 residues (5 chains of 311 residues) 25,385
Lipids 301 41,138
Water 43,882 131,646
Ions 143 143
Total – 198,312
Table 3.2 – Composition of a minimal GLIC system. minimal is to be understood as that contains the
minimum number of species to calculate an all-atom simulation. We estimate that the total number of atoms
can be further reduced by ≈ 25% by agressively optimizing the simulation box shape.
independent simulations very eciently considering both time concerns and risk minimization. As an
example, a script aiming to get each simulation ready to run on a supercomputer is shown in appendix C.1.
e script creates one directory per simulation with all the materials required to run the MD simulation
on a cluster. It implements the possibility of choosing on which cluster the simulations have to be ran and
adapts the submission scripts in consequence. Such kind of scripts are not major progresses in the eld
but have to be implemented when running tens (hundreds in my case) of similar simulations that may
vary by a handful parameters.
e same kind of approach had to be applied to the simulation analysis. I chose to write one specic
Makefile for each analysis which allowed me to take advantage of the multi-threaded nature of the make
program and to run up to 12 analyses at the same time, which became critical when analyses have to be
run on hundreds of simulations. Furthermore, by writing scripts as exible as possible, running a new
analysis turned out a matter of minutes, even on hundreds of simulations.
3.3 Efficient Analysis Software Need: The Epock Software
is part is adapted from Laurent et al. (submitted) and specically adresses the development of a pocket
volume analysis tool in the context of handling more and more massive amounts of MD data.
Owing to recent advances in hardware and soware, MD simulations enable the study of the evolution
of biomolecular systems of increasing size and complexity over time. Repeatedly D.E. Shaw showed the
possibility of breaking the millisecond barrier using the Anton supercomputer and the Desmond computer
program (Lindor-Larsen et al., 2011). e drawback of this progress is the generation of increasingly
large MD datasets (see section 3.1), with consequences for subsequent analysis. It is therefore crucial to
develop improved soware tools able to analyze these datasets in a reasonable time.
e volume of an internal protein pocket is of fundamental importance to ligand accessibility and
mobility inside the pocket. Along years, several programs and algorithms that aim to quantify the volume
of a protein cavity have been developed and, among them, only few are designed to eciently manage
dynamic data fromMD. Limited performance oen prohibits their use on large datasets. To tackle this
issue, I developed Epock, a program that allows ecient measurement of the evolution of protein pocket
volume during MD trajectories.
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3.3.1 Program features
Epock is a command-line program that requires input in the form of a system topology and an MD
trajectory in GROMACS xtc format (Pronk et al., 2013), which can be either atomistic or coarse-grained.
An Epock conguration le species a set of parameters for each cavity to be characterized, including a
maximum encompassing region for the cavity (MER). e MER provides explicitly dened bounds for
each cavity by combining simple 3D objects (spheres, cylinders and cuboids) to create complex shapes (a
concept known as “solid constructive geometry”). is allows to unequivocally follow a priori determined
cavities over time, whereas Epock is not intended for cavity searches. My implementation extends the
method proposed by Durrant and coworkers in the POVME program (Durrant et al., 2011). e Epock
Tcl/Tk plugin for VMD (Humphrey et al., 1996) provides an intuitive way to choose and position shapes
to dene the MER (see gure 3.3A-B) 5.
For each pocket, Epock calculates the space accessible to a probe, called “free space”, which is the set of
all grid points with a distance to protein exceeding the user-dened probe radius (typically, 1.4 Å). e
number of grid points that overlap each residue is stored and can be outputted as “residue contribution”.
e volume of the so-called free space is then calculated at higher precision using a ner grid.
Epock outputs pore proles by calculating the radius of the largest disc that can t the previously
detected free space along the Z axis. e results are similar to those obtained with the Hole soware (Smart
et al. 1993. see gure 3.2) 6.
Epock produces several output les, including the computed trajectory of free space over time, a feature
inspired by the trj_cavity soware (Paramo et al., 2014). is trajectory is directly readable in VMD,
which makes the relationship between pocket volume and protein conformation highly intuitive. Epock
results for pocket volume, residue contribution and pore prole can be plotted directly in VMD using the
plugin, or by running the Python scripts that are freely distributed with Epock.
3.3.2 Application: the GLIC ion channel
e Gloeobacter violaceus Ion Channel (GLIC) previously introduced in this PhD manuscript features
numerous pockets, including a binding site for general anesthetics (Nury et al., 2011). It is a challenging
test case because of its size, 1555 residues, and the presence of multiple pockets that oen connect to each
other and/or to the central pore. e volume of a single pocket was computed over an 800-frame trajectory
of the protein (25385 atoms, 75 MB) on Mac OS 10.6.8 with 2 × 2.93 GHz Quad-Core Intel Xeon processors
and 8 GB 1066 MHz DDR3 memory.
Examples of Epock output are shown in gure 3.3. e chosen analysis example shows that the cavity
volume dramatically decreases aer c.a. 1500 ps, (see red curve in gure 3.3C). Epock’s residue contribution
analysis shows a particularly high variability for residue Y197 (see cyan curve in gure 3.3C, and gure 3.3D).
Simultaneous visualization of the protein trajectory alongside the pocket free space in VMD (gure 3.3E-F)
conrms that movement of the Y197 side chain is largely responsible for the volume decrease.
5e VMD plugin has been developed by Matthieu Chavent and Caroline Dahl from the Structural Bioinformatics and
Computational Biochemistry Unit, Department of Biochemistry, University of Oxford, UK
6e pore prole feature has been developped by Tristan Cragnolini, Laboratoire de Biochimieéorique, CNRS UPR 9080,
Univ. Paris Diderot, France
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Figure 3.2 – Calculation of a pore prole with Epock. A) GLIC transmembrane domain (protein back-
bone is represented as white cartoon, Epock’s pore surface as red wireframe). e pore prole has been
calculated given a 14 Å-radius cylinder as include region and a superimposed 7 Å-radius cylinder as
contiguous seed (see Epock’s manual for more information). e surface has been calculated from Epock’s
output using the VMDVolmap tool. B) Comparison of the average prole of the GLIC pore of a 800-frame
trajectory. Epock (red) and Hole (blue) results are very similar.
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Figure 3.3 – From Epock setup to result analysis. A) Graphical interface for dening the MER using
the VMD Epock plugin. e MER consists of a combination of volumes to include (spheres in red) and
exclude (spheres in purple), giving rise to a custom complex geometric shape for analysis. B) Grid points
that compose the MER. C) Pocket volume (red) and residue contribution of Y197 (cyan) during an MD
simulation. D) Standard deviation of residue contribution ordered from highest to lowest. E-F) Protein
conformation and pocket (protein surface in grey mesh, backbone as white tube, Y197 as spheres colored
by atom type, pocket accessible space as red spheres) at t = 1500 ps (E) and t = 3500 ps (F).
We comparedEpock execution speed to two existing programs: i)mdpocket (Schmidtke et al., 2011) that
uses Voronoi diagrams and has been specically designed to calculate pocket volume for MD simulations
and ii) POVME (Durrant et al., 2011) which implements an algorithm similar to Epock for free space
detection but with dierences in the free space volume calculation. e same input grid can be given for
all three programs, allowing for meaningful performance comparisons. Epock ran in 5 seconds. is is
a dramatically higher speed than both mdpocket and POVME, which feature computing times on the
hour timescale (5 and 3 hours, respectively). We hypothesize that POVME’s execution time is largely
related to its implementation in Python which is known for being slower than the corresponding C++
executable. e reason why Epock is faster than mdpocket may be due to the numerous additional analyses
that mdpocket performs during a run, and that can not be disabled.
3.3.3 Making Epock public
e source code distribution
A distributed soware requires protection against abusive use such as copy and distribution for commercial
use. I strongly believe in open-source projects, especially for science, as well as Epock co-developers. We
decided to make Epock’s source code accessible to anyone so that developers could enhance the program
over years or build a new program inspired by it. As it is crucial for us to assure the accessibility of the
source code of any program inspired by Epock, Epock source code is distributed under the CeCILL license,
a modied version (and still compatible with it) of the GNU General Public License (GPL).
To encourage developers to contribute to Epock, its source code is versioned with mercurial, a dis-
tributed source control management system. is technology allows a developer to access all past code
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modications and keep track of new code modications while developing a new feature. If a developer
wants to contribute to Epock, his changes can be pulled into Epock’s mother repository so that the whole
history of the new feature development is then accessible from it.
Epock’ source code is hosted by bitbucket.org and is available at
http://bitbucket.org/epock/epock.
e soware distribution
Nowadays, besides the publication of an article or application note in a scientic journal, it is crucial for
a soware to be visible on the Internet, so that, in the case of Epock for example, anyone looking for a
program for pocket volume measurement in molecular dynamics can reach Epock. Part of the time I spent
on the Epock project was therefore naturally devoted to the creation of a website explaining the method
underlying Epock, its usage and a series of application examples.
As writing HTML code can be time consuming, I have been looking for a solution allowing me to
write text les with a simplied markup language and translate them to HTML. e best solution I found
is the Sphinx tool that was originally created for the new Python documentation, and, from a general
point of view, is particularly adapted to the code documentation. In the case of Epock, I did not want to
document the code itself but only to build a showcase allowing to download the package, access the online
manual and read more about Epock.
Sphinx inputs are, besides a conguration script, text les in reST format, a markup language that
allows high eciency during the writing process since reST les are much simpler to write than HTML
code. It can be guessed from gure 3.4 (that shows the reST input le and the corresponding webpage)
that reST is a very powerful language that can produce very rich content: this thesis manuscript could
perfectly have been written in reST and rendered into a PDF document thanks to Sphinx! A few more
hours were also required to customize the page layout and, more importantly, write the CSS les for a
stylized and original website.
Epock’s website is hosted by bitbucket.org and is available at
http://epock.bitbucket.org.
e methodological aspect of this project has now been covered. In the next two chapters, I will
focus on the results I obtained on the study of general anesthetic action at the atomic scale. e accurate
characterization of binding pocket volumes did play an important role in these investigations.
3.4 BioSpring: an Augmented Spring Network Simulation Engine
As has already been discussed, MD simulations of GLIC require consequent computational power and a
simulation may run for weeks, if not months. Here I will describe BioSpring, a computational tool for
much faster - but also more approximate - simulations of macromolecular systems. BioSpring is not an
alternative to MD simulations, but a useful complementary tool to characterize a molecular system.
58 Chapter 3. High-Performance Computing And Large Scale Data Analysis
Figure 3.4 – Writing Epock’s website.e reST source code (le) that, aer processing by Sphinx, will
produce the HTML that can be rendered in any web browser (right).
3.4.1 Principle
BioSpring is a calculation engine allowing to run molecular simulations of spring network models. Spring
networks are a simplied representation in which the system structure is maintained by interactions
mimicking springs: harmonic potentials are created between neighbor particles so that the more the
distance di j between two particles i and j is distant from their equilibrium distance d0i j, the greater is the
associated energy. e equilibrium distance d0i j is dened as the distance between particles i and j at t0.
By denition, this force tends to drive the system back to its equilibrium state: the initial conguration of
the system.
Biospring has two major originalities. First, it takes into account non-bonded interactions between
particles which can allow the system to reach metastable states dierent from its initial conguration.
Second, Biospring implements an interface to Interactive Molecular Dynamics (IMD), a technique in
which a user can input forces to the system manually as the simulation is going on thanks to a dedicated
input device. is input device can be a simple mouse or a haptic device that allows to send back forces to
the user. IMD therefore allows to very intuitively dock a ligand on a receptor or fold a protein. Another
application has been demonstrated recently by Molza et al. (2014) in a study where the authors use a map
extracted from Small-Angle X-ray Scattering (SAXS) experiments to run a targeted folding thanks to
BioSpring.
3.4.2 My contribution
BioSpring development was initiated by Nicolas Férey in 2008. He implemented BioSpring’s core plus
several associated tools.
My initial thesis project included several BioSpring-IMD experiments on GLIC including docking of
anesthetics and studies of the channel gating. e current BioSpring force-elds turned out unsuitable to
reproduce hydrophobic interactions with sucient accuracy, so anesthetic docking tries were unfruitful
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as were tests on GLIC’s gating. In the latter case because the spring network revealed itself too rigid to
properly reproduce the motions of the M2 helices. To make these tests, I nevertheless regularly improved
BioSpring in dierent ways I will develop in this part.
Input/Output
BioSpring input les are
• the simulation conguration le (containing time step, number of steps. . . ),
• the system topology.
e system topology le contains the parameters for all the particles of a system including coordinates,
radius, charge, etc. Reading andwriting tabulatedles can raise problems, especially for format specication.
BioSpring lead developers chose to use the NetCDF format for topology les in which data are stored
as arrays (gure 3.5). I improved NetCDF reader and writer classes already existing in BioSpring by
performing numerous sanity checks to make sure the le format behaves as expected, a crucial step
to avoid unauthorized memory access, which can turn out very dicult to debug. I also implemented
methods to automatically write NetCDF binary les and implemented BioSpring support for the newest
versions of the NetCDF library.
Associated tools
Initially, BioSpring conversion tools from PDB format to NetCDF format oered limited exibility. In the
context of scientic experiments using BioSpring, it is very common that the spring stiness between two
particles or two groups of particles has to be adjusted, some springs have to be removed, others have to be
added, etc. Despite the diculty of the task, these operations had to be done manually, which was time
consuming and a potential source of errors. As an example, to add a single spring between two particles,
the user had to
1. nd the id number of the two particles (this part was usually done using VMD, making sure the
serial parameter of VMD corresponds to the actual particle id in BioSpring),
2. add 1 to the dimension spring_number,
3. add the two particle ids to the springs array
4. add the appropriate stiness for this spring to the springsstiffness array,
5. add the appropriate spring equilibrium distance to the springsequilibrium array (note that the
spring stiness and equilibrium parameters have to be inserted at the exact same position as the
spring is inserted in the springs array).
I developed three tools named pdb2spn, editspn and mergespn to deal with most use cases and
signicantly reduce both the time spent on the topology tuning and the probability of making mistakes
during the process.
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netcdf model {
dimensions:
spatialdim = 3 ;
particle_number = 2 ;
particlename_length = 4 ;
chainname_length = 4 ;
resname_length = 4 ;
springdim = 2 ;
spring_number = 1 ;
variables:
float coordinates(particle_number, spatialdim) ;
coordinates:units = "angstrom" ;
coordinates:long_name = "Particle coordinates" ;
float charges(particle_number) ;
charges:long_name = "Particle charge id" ;
charges:units = "electron" ;
float radii(particle_number) ;
radii:units = "A" ;
radii:long_name = "Particle radius" ;
float epsilon(particle_number) ;
epsilon:units = "kJ.mol 1" ;
epsilon:long_name = "Particle epsilon for Lennard Jones" ;
float mass(particle_number) ;
mass:units = "Da" ;
mass:long_name = "Particle mass" ;
...
int springs(spring_number, springdim) ;
springs:long_name = "Spring between particle referenced by 2 particle id
s" ;
float springsstiffness(spring_number) ;
springsstiffness:long_name = "Spring stiffness" ;
float springsequilibrium(spring_number) ;
springsequilibrium:long_name = "Spring distance equilibrium" ;
data:
coordinates = 0, 0, 0,
2, 0, 0 ;
particleids = 0, 1 ;
particlenames = "N", "N" ;
charges = 0.4157, 0.4157 ;
radii = 1.824, 1.824 ;
epsilon = 0.17, 0.17 ;
mass = 14.01, 14.01 ;
surfaceaccessibility = 0, 0 ;
hydrophobicityscale = 0.112, 0.112 ;
resnames = "VAL", "VAL" ;
resids = 1, 2 ;
chainnames = "A", "A" ;
dynamicstate = 0, 1 ;
springs = 0, 1 ;
springsstiffness = 1 ;
springsequilibrium = 2 ;
}
Figure 3.5 –e NetCDF array-oriented format. Example of a NetCDF text le for a system containing
two particles. BioSpring input is the binary version of this le that can be created thanks to the ncgen
program distributed along with the NetCDF library.
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pdb2spn is a utility that converts a PDB formatted le to a binary NetCDF formatted le. Prior to the
development of this tool, text les were generated. ey had to be converted to a binary in a second time,
thanks to a tool distributed with the NetCDF library. e creation of a binary le is the only new feature of
pdb2spn but it is incorporated within a framework in which BioSpring topology les should not be edited
by hand.
editspn allows to edit BioSpring binary topology les. It implements features such as spring creation
from a cuto, add or remove springs thanks to a selection language, modify particle positions. . .
mergespn aims to merge two BioSpring binary topology les. is is particularly useful for creating a
system in which several parts have dierent exibility levels. Two spring network models can be created
for two distinct molecules of a system, with dierent spring cutos and/or spring stiness thanks to two
calls to pdb2spn. ey are gathered together in a second time thanks to mergespn which can additionally
create springs between the two structures.
e compilation process
BioSpring soware is made of 98 source les representing a total exceeding 20,000 lines of C++ code.
It has several dependencies such as the NetCDF library and a few more libraries. e build process can
therefore not be managed by hand.
For decades, developers used the GNU build system known as Autotools, a suite of programs designed
to generate a configure script for the project. is script, to be executed by the user prior to compilation,
generates the Makefile that will produce the soware targets (programs, libraries, etc.) by invoking
the command make (gure 3.6). is system has proven both its robustness and diculty of use since
Autotools input les have a very particular syntax that makes writing them tough and improvement even
tougher since the whole le has to be read again and understood before being modied. e CMake
soware was developed in this context in the early 2000s, with a main objective to simplify the writing
of conguration les. e developer has to write basically a single input le and CMake generates the
appropriate Makefile. Notably, CMake conguration variables are very easy to modify, so the build
settings can be tuned very quickly. CMake is now used by thousands of developers to compile hundreds
of projects including very large projects such as KDE, a Unix desktop environment, MySQL, a database
management system and BioSpring!
BioSpring lead developers chose CMake as build process management system, facing the fact that the
less time is spent on the compilation, the more is spent on the actual code development. My contribution
to the build process has been to improve the CMake input le by adding several options to customize the
build process and make the input le clearer from a general point a view. A very interesting CMake feature
is the package search: CMake can search for libraries, programs or any kind of dependency a project has. I
wrote several CMake search scripts that were not already included in the CMake package, such as for the
NetCDF and the MDDriver libraries for example.
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Figure 3.6 – GNU autoconf and automake process for generating makeles. From
http://www.wikipedia.org
4
Probing pLGICs with bromoform
reveals many interconnected
anesthetic binding sites
is chapter is devoted to the characterization of general anesthetic bromoform binding sites described in
Sauguet et al. (2013a). I characterize the three sites and an additional pore site described in a new crystal
structure of GLIC in locally closed conformation. I combine several computational approaches to address
three key questions: (i) are the crystal binding sites spontaneously accessible? (ii) can bromoform travel
from one site to another? (iii) what is the bromoform anity for each binding site? Molecular dynamics
simulations of ooding the receptor with bromoform recover most of the experimentally observed sites,
with a modulated occupancy between the open and the locally closed conformations. Sixty short MD
simulations were carried out to extensively explore the binding pockets, providing data on possible routes
connecting them. ese simulations furthermore highlight residues such as Y197 that may play key roles in
controlling the interaction between anesthetic and receptormolecules. FEB calculations indicate signicant
anity for all crystallographic binding sites in open and locally-closed conformations, in some cases
modulated by pH. ey support the critical role of Y197 into anesthetic binding.
e chapter is largely inspired by a scientic article currently in preparation. I am the rst author
of this article. Furthermore this work features contributions from Ludovic Sauguet and Marc Delarue
(Institut Pasteur) who covered the X-ray crystallography part of this project, my colleague Samuel Murail
who carried out the setup of microsecond timescale MD simulations as well as the main part of their
analysis, and Marc Baaden who supervised the project. I was in charge of writing the article, managing the
dierent contributions, running and analyzing all short MD simulations, running and analyzing all FEB
calculations as well as partly analyzing long MD simulations.
4.1 Results
4.1.1 Bromoform-bound crystal structure of the GLIC channel in its locally-closed con-
formation
In order to study the properties of bromoform-binding to the GLIC receptor in its locally-closed confor-
mation, we grew crystals of the GLIC K33C L246C variant in the presence of bromoform. GLIC K33C
L246C variant is a particularly adapted model for this study as it is known to crystallize in a locally-closed
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Figure 4.1 – A bromoform-bound structure of GLIC in its locally closed conformation. A) Top view
of GLIC TMD. Bromoform densities, shown in ochre wireframe, are present in the intrasubunit site of
four over ve subunit, and in the new pore site. B) Location of bromoform (sticks) in the pore site. Two
M2 helix backbones of the LC and open conformations are represented in pink and white, respectively.
Water molecules detected in GLIC high resolution structure are represented as red spheres. C-D) Side
and top view of one intrasubunit site in open (pink) and locally closed (white) conformations. Residues
possibly responsible for decrease of site W3 accessibility are showed as sticks.
conformation but shares indistinguishable electrophysiological properties with WT GLIC (Prevost et al.,
2012). Bromoform is an analogue of chloroform containing three bromine atoms that produce a specic
anomalous signal that can be observed by crystallography using X-rays with tunable wavelengths. e
bromoform-bound structure was determined at a 2.95 Å resolution (gure 4.1).
It was completely superimposable with the apo-form of GLIC K33C L246C with a root mean square
deviation of 0.77 Å over the 1555 Cα atoms. In the pore, a bromoform-binding site is indicated by a Fo-Fc
electron density peak (7.0 σ) that overlaps with a bromine-specic anomalous peak (10.0 σ). Bromoform
binds in the middle part of the pore between the I240 (I9’) and S236 (S6’) rings of residues (gure 4.1B),
two critical rings of residues that are repectively involved in gating and ion permeation (Sauguet et al.,
2013b). is bromoform-binding site in GLIC is novel and is specically occupied when the channel pore
is closed. In contrast, when the channel pore is open, this location is lled of ordered water molecules
that were found to be critical for ion permeation. Interestingly, bromoform was found to occupy a similar
location in ELIC ’s closed pore (Spurny et al., 2013). A previous study revealed that bromoform occupies
alternatively three poses in the intrasubunit cavity of the GLIC open-channel structure (named W1 to
W3). In contrast, this intrasubunit cavity is remodelled in the GLIC locally-closed structure thus aecting
the previously described bromoform binding sites (gure 4.1C-D). Indeed, despite the presence of an
intrasubunit bromine anomalous signal in four out of ve subunits, the absence of interpretable Fo-Fc
dierence electron density supports the possibility that bromoform may also bind at positions W1 andW2,
but with too low occupancy or too high mobility to allow for condent model building. is is caused
by the side chain of residue Y197 that alternates between two conformations. e second one induces a
steric clash that prevents binding of bromoform at W1 and W2 sites (gure 4.2). In addition, the revolving
motion of the M2-M3 loop partly occludes the intrasubunit cavity and prevents bromoform-binding at
position W3. In summary, bromoform binding-sites are dierent in the locally-closed versus the open
GLIC structures: while a novel site is observed in the pore, binding to the intrasubunit cavity is discouraged
in the locally-closed form.
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A B C
Figure 4.2 – Two distinct conformations of residue Y197.A) In open conformation (top), Y197 side chain
(space lling representation colored by atom type) does not overlap any of the 3 intrasubunit bromoform
binding sites (pink, purple andmagenta spheres), while in down conformation (bottom) it partially overlaps
site W2 and W3. B-C) Inuence of Y197 side chain orientation on the intrasubunit pocket accessible
volume (represented with red spheres and calculated with the Epock soware, see section 3.3). e protein
surface is represented as a white wireframe, its backbone as a grey tube.
4.1.2 Molecular Dynamics simulations to explore and quantify anesthetics binding
I combine three complementary simulation strategies to explore bromoform binding to GLIC. Firstly, I
used data from several one microsecond long MD simulations of membrane inserted GLIC in an over-
saturated bromoform solution to assess the spontaneous exploration of the system by the anesthetic and
identify preferential bromoform binding sites. We subsequently refer to this type of simulations as ooding
experiments. ree forms of GLIC were used, WT GLIC in open and LC conformation and the GLIC
mutant F238A in the open conformation. Secondly, we ran 25 unconstrained 8-ns long MD simulations of
GLIC F238A in open conformation starting from anesthetic locations in sitesW1-2 and site B1. Considering
that, at this timescale, the ve subunits are independent, we accumulated a total of 25 × 5 × 8 ns sampling
per system. is one microsecond dataset for each location yielded an extensive exploration of both the
intra- and the intersubunit binding pockets and allowed us to observe transitions between sites. Ten 8-ns
simulations were run for GLICWT in the LC form starting with bromoform in the pore site P1. irdly,
we determined the bromoform anity for each of the 6 binding sites in WT and F238A mutant for both
open and LC variants of GLIC using alchemical free energy calculations. Sampling times are given in
table 4.1, full technical details of all the simulation approaches are provided in section 2.6.
4.1.3 Crystallographic sites are spontaneously reachable
Flooding experiments reveal that all binding sites (i.e. W1, W2 W3, B1, B2, and P1), are spontaneously
reachable in at least one of the three simulations. By design, the ion channel in the short MD simulations
remains very close to the crystal structure, which makes for straightforward comparison with experiment.
e observed occupancies for sites W1 and W2 are equivalent as was observed in the crystal (respectively
0.41 and 0.38, table 4.2). In contrast, the equilibrium is shied in favor of the membrane exposed W1
site in ooding simulations. In both short and long MD simulations, the occupancy of the W1-2 sites is
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Sequence Form Bromoform pore Sampling time
Long MD simulations
F238A Open Flooding 1 µs
WT LC Flooding 1 µs
WT Open Flooding 1 µs
Short MD simulations
F238A Open Site W1-2 25 × 8 = 200 ns
F238A Open Site B1 25 × 8 = 200 ns
WT LC Site P1 10 × 8 = 80 ns
FEB calculations
F238A Open
W1-2, W3, B1, B2, P1
32 windows sampled for
3 to 10 ns each
F238A LC
WT Open
WT LC
Table 4.1 – Sampling time and studied systems for bromoform characterization.
markedly higher than that of site W3, which is consistent with crystallographic data. During ooding
simulation of WT GLIC in LC conformation, site W3 occupancy was lower by one order-of-magnitude
compared to the simulation starting from the open form and displayed a particularly low residence time
(3.4 ns in average), consistently with crystallographic data. As the intersubunit cavity B1 does not exist
in WT GLIC because of the presence of the bulky F238 residue sidechain, this site has only been reached
in the simulation of the F238A mutant. Spontaneously, the pore site P1 has been reached in the ooding
simulation of WT open GLIC only.
Site W1 Site W2 Site W3 Site B1 Site B2 Site P1
F238A – O Site W1 0.41 0.38 0.03 0.01 0.00 0.01
F238A – O Site B1 0.00 0.00 0.00 0.94 0.00 0.00
WT – LC Site P1 0.00 0.00 0.00 0.00 0.00 1.00
WT – O Flooding 0.56 0.43 0.35 0.00 0.12 0.49
WT – LC Flooding 0.45 0.24 0.03 0.00 0.00 0.00
F238A – O Flooding 0.46 0.23 0.25 0.02 0.19 0.00
Table 4.2 – Bromoform binding site occupancy along MD simulations.e 3 rst rows correspond to
short MD simulations with bromoform being placed in site W1, B1 or P1, respectively. e 3 last rows refer
to ooding simulations
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Figure 4.3 – Key residues of the intrasubunit pocket. Percentage frames in which a bromoformmolecule
contacts a residue of the intrasubunit pocket along short MD simulations.
4.1.4 All sites are interconnected, with gates between them
Considering the close vicinity of the experimentally observed sites W1,2,3 and B1, we characterized the
dynamics of bromoform bound to each site. e simulations furthermore generate data to examine possible
paths between these sites.
Site W1-2 may act as an entrance to other sites
In the ooding simulations, site W1 was the most occupied site mainly because it is exposed to the
membrane. During the second half of the production run around 95 % of bromoform molecules were
located in the membrane, as a consequence the W1 sites were the easiest to access and the rst to be bound.
In short simulations bromoform did not oen penetrate much deeper into the intrasubunit pocket as
depicted by both the low site W3 occupancy and the relatively low number of contacts with M2 residues
(gure 4.3). Concerning site W3, its occupation in the ooding runs was signicantly higher compared to
the short simulations but only in the open form of GLIC. In the simulation of LC GLIC, the occupation
of sites W1 andW2 were close to GLIC in open form, however site W3 was weakly occupied. In the LC
form, the conformation of the M2-M3 loop and of the top part of the M2 helix prevent occupation of site
W3, in particular residue T245 is in close contact with this site, preventing any binding (gure 4.4). A key
observation is that, once site W3 has been reached, bromoform was able to enter the upper intersubunit
B2 pocket, as previously mentioned. e same behavior was observed in ooding simulations of open
GLIC (WT and F238A), which is reected by the high occupancy of site B2.
Y197: a gate to the inner channel
Interestingly, Y197 which is not in the immediate environment of bromoform in the crystal structure,
appears to dramatically modulate the volume of the intrasubunit pocket (gure 4.2), as proposed by
Mowrey et al. (2013b). erefore Y197 might control access to sites W3 and B2. In the crystal structure,
the Y197 side chain is oriented toward the extracellular domain, the dihedral angle θ between Y197 C-
Cα-Cβ-Cγ atoms being equal to (167.6 ± 0.5)°. Notably, in available crystal structures of open GLIC, all
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Figure 4.4 –Bromoformexploration inooding simulations.Top (top pannel) and side (bottompannel)
views of a GLIC subunit in which bromoform occupancies are represented as yellow surfaces. Residues
Y197 and T244 are represented with sticks colored by atom type.
Y197 residues display this up conformation (θ = 165.6 ± 3.8°), while closed structures of subtypes I and
III respectively display four and two Y197 in down conformation, in which the Y197 side chain lies inside
the intrasubunit pocket (θ =60.4 ± 8.5°). During the MD simulations, θ oscillated around these values
with average orientations at 169.9° and 72.9° (gure 4.5). Notably, in down conformation, the Y197 side
chain plunges into the intrasubunit pocket and occupies a large volume there, overlapping sites W2 and
3, hindering bromoform entering the deeper intrasubunit pocket (gure 4.2), and therefore ultimately
prevents it from entering the intersubunit pocket. It is to be noted that the transition of the Y197 rotamer
is a rare event with an average of 10± 6 transitions per microsecond calculated on the ooding simulations
dataset.
Bromoform is conned within the intersubunit site
In the intersubunit cavity, bromoform mostly stays within 6.5 Å of the crystal structure location. rough-
out the one-microsecond dataset provided by short MDs, a single transition from site B1 to site B2 was
observed. Two residues, L241i and E243i-1, restrain the available space in this region and therefore hinder
crossing from site B1 to B2 (either way). During the F238A ooding simulation, the same inverse transition
(B2 to B1) was observed once (gure 4.6). In that case, the molecule has been traveling from the membrane
to the W1-2 site to W3, to B2, to nally reach site B1. Another intersubunit site was occupied by one
molecule for more than 800 ns. is site is located 5Å above B1 and slightly closer to the membrane. e
bromoform molecule reaches that site from site W2 and stays there for the rest of the simulation.
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Figure 4.5 – Y197 side chain orientation along ooding simulations.Distribution of the Y197 side chain
orientation along ooding MD simulations for each system namely wild-type (WT) open (O) and locally
closed (LC) and the F14’A mutant in open conformation (F14A-O). Densities have been calculated over
the a microsecond period with a time step of 0.5 ns, leading to a total of 10,000 points per density (2000
points per Y197 × 5 subunits).
800-810 ns811-836 ns836-840 ns840-860 ns861-1000 ns
W1-W2
W3B2
B1B1
B2
W3 W1-W2
membrane
membrane
Figure 4.6 – Transition of a bromoformmolecule from themembrane to the B1 site. Top (le) and side
(right) views of a GLIC subunit. Bromoform center of mass is represented as spheres colored according to
the time of the simulation. In 200 ns, this bromoform molecule could pass from the membrane to site
W1-2, W3, B2 and ultimately B1.
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Bromoform is stable in site P1
Short simulations of the locally closed form of GLIC with bromoform bound to the pore site P1 show that
the anesthetic molecule remains close to this site, never leaving the region delimited by residues T226
(T2’) and I233 (I9’), even in the absence of additional stabilizing bromoform molecules that were present
in the ooding simulations but not in the short runs. Flooding simulations of WT open GLIC showed
anesthetic molecules switching from the ECD vestibule to the pore site P1. As a result, the occupancy of
site P1 in that simulation reaches 0.49 (table 4.2), with a total of three bromoform molecules present in
the pore. One bound at the beginning of the simulation and stayed continuously in site P1 for more than
400 ns before binding an upper pore site (between I9’ and A13’) and coming back to site P1 twice for a
few nanoseconds. e two other molecules were observed binding the upper site in the pore, the rst one
came early (aer ∼ 100 ns) from the vestibule and stayed in the upper cavity for the rest of the simulation
with the exception of one 3 ns binding event in site P1 halfway through the simulation (∼ 500 ns). e
other molecule came from the intra subunit cavity (W1-2 for 205 ns then site W3 for 365 ns) at the very
end of the simulation (∼ 950 ns). In the LC form simulation, no anesthetics were shown to bind to the
pore site. During the F238A mutant simulation, no anesthetics were shown to bind in site P1, however one
molecule was binding the upper pore site in the second half of the simulation (∼ 550 ns). e molecule
came from the intra subunit cavity (W1-2 for 67 ns) and later an intermediate position between B2 andW3
for 63 ns. To be noted, none of the bromoform molecules, which bound in the pore, le the pore.
Bromoform binding anities are favorable for all binding sites
Bromoform anity for crystallographic binding sites ranges from −7.1 to −4.8 kcal/mol (gure 4.7). e
open form appears signicantly more favorable for sites W3, B1 and B2 with ∣∆∆G∣ ranging from 1.3 to
2.8 kcal/mol, while P1 displays a higher anity in the LC form than in the open form with ∣∆∆G∣ of 1.7
and 2.4 kcal/mol respectively for the WT and the F238A channel. It should be noted that the pore site P1
of both WT and F238A channels displays a favorable FEB, comparable to site W1-2 in open form and even
more favorable than W1-2 in the channel LC form.
Bromoform free energy of binding is sensitive to H235 protonation state.
e H235 residue is located on the pore-lining M2 helix (H11’ in prime notation), close to the B1 site
entrance. e protonation state of its side chain has been shown to be particularly dicult to determine
with condence (Laurent et al., 2013). To assess whether the protonation state of H235 modulates the
ligand binding anity, we compared bromoform free energy of binding for neutral and protonated H235
(table 4.3). When neutral, we observe a dierence of −1.9 kcal/mol between the WT intrasubunit site W1
(−6.3 ± 0.1 kcal/mol) and the F238A intersubunit site B1 (−8.2 ± 0.1 kcal/mol). When H235 is protonated,
the FEB to B1 reduces to (−6.1 ± 0.1) kcal/mol. No eect was observed on the more remote site W1.
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Figure 4.7 – Free energies of binding of bromoform to the ve binding sites. Energies are given in
kcal/mol. WT = “Wild-Type”; O = “Open”; LC = “Locally-Closed”. Error estimates are all below or equal
to 0.2 kcal/mol.
H235 + H235 n
Site W1 (intra) −6.6 −6.3
Site B1 (inter) −6.1 −8.2
∆ =W1 − B1 −0.5 +1.9
Table 4.3 – Free energy of binding of bromoform as a function of H235 protonation state Energies are
given in kcal/mol; “+” stands for double charged, “n” stands for neutral.
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4.2 Discussion
Globally, a picture of dynamically accessible and interconnected anesthetic binding sites emerges from
this computational study, in excellent agreement with the available crystallographic data. e calculations
reveal phenomena enriching the picture obtained from the experimental data such as the transitions
between sites or the possible modulation of anesthetic binding anities by pH.
4.2.1 Multi-site allosteric modulation, a delicate balance toward potentiation or inhibi-
tion
Evidence that anesthetics bind the intrasubunit site in the W1 region is strong. Crystal structures showed
that bromoform (Sauguet et al., 2013a), propofol and desurane bind to this pocket (Nury et al., 2011;
Chiara et al., 2014). e data collected in this work are in very good agreement, clearly showing that
intrasubunit sites are spontaneously accessible from the membrane and display favorable FEB, especially
for W1. Our data suggest that sites W1 and W2 should be considered as two marginally dierent poses of
the same site. e ligand may switch from one to another with equal probabilities as is the case in short
MD simulations. On a longer timescale, this equilibrium shis in favor of site W1, probably because of a
bias induced by its direct exposure to the membrane where most bromoform molecules accumulate.
In WT GLIC, site B1 does not exist since the presence of the bulky F238 side chain does not leave
enough room for an anesthetic molecule, as it leaves barely enough space for a single water molecule.
Interestingly the F238 residue is conserved in the human nicotinic acetylcholine receptor subunits α3,4,5
and β1,2 and 5-HTR subunits 3A,B. In the glycine and the GABAA receptors this residue is substituted by
less bulky residues, respectively Q and L/I. Howard and coworkers showed that this substitution creates
an intersubunit pocket (corresponding to the B1 binding site) in which ethanol can bind, explaining the
potentiating eect on the channel. We observe in this study that the articial intersubunit pocket created
in GLIC by the mutation F238A can be reached from intrasubunit site W1. Calculated free energies of
binding reect the high anity of bromoform for B1 in both open and locally closed forms of GLIC F238A.
is observation suggests that the anesthetics’ initial binding site could be site W1 for both inhibitory and
excitatory channels. e anesthetic would then migrate to B1 in inhibitory channels, in this way stabilizing
the open form, while remaining in the intrasubunit pocket in excitatory channels stabilizing the closed
form. Such a scenario would support hypotheses proposing that the dierence of action of anesthetics
(and alcohols) on inhibitory and activating Cys-loop receptors might be found in the accessibility of the
lower intersubunit pocket (Murail et al., 2012).
Besides transitions from site W1-2 to B1, our data show a high mobility of bromoform inside the
binding regions (see gure 4.8). Notably, we observe an important exchange rate between site W1-2 and
siteW3 over the microsecond period. e average occupancy of siteW3 appears signicantly lower than for
site W1-2 in both short and long MD simulations, which is in very good agreement with crystallographic
data. Importantly, we observe several transitions from site W3 to site B2, an intersubunit site described in
GLIC on the basis of MD simulations (Nury et al., 2011) and in GABAA by photolabeling (Yip et al., 2013)
with respectively desurane and ortho-propofol diazirine. As we observe bromoform occupying this site
on the microsecond timescale, we argue that site B2 is denitely occupied by antagonists at a timescale
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Figure 4.8 – Bromoform exploration of the intra- and intersubunit binding pockets in short MD
simulations. Side view from the pore. e protein TMD backbone atoms are represented as cartoon
colored by subunits. e area explored by the bromoform along short MD simulations are represented
with meshes colored according to the bromoform starting location (purple and orange for intra- and
intersubunit pockets, respectively). Two residues that seem to occlude the route between B1 and B2
intersubunit sites are represented with space lling spheres colored by atom type.
relevant for anesthesia. Still, the anesthetic has to be able to access site B2 through a route passing by sites
W1-2 and W3, a route that can be occluded by Y197.
4.2.2 A residue gating the access to anesthetic allosteric binding sites
Our data strongly suggest that the orientation of the Y197 side chain is critical for anesthetic binding and
insertion depth; therefore their transition to intersubunit cavities may be controlled in this way. e up
conformation of Y197 as described above appears highly conserved in all GLIC open structures, while
the down conformation is found in the majority of the locally closed structures. In addition, the M2
helices bending in the locally closed conformation move residues from the top of M2 and from the M2-M3
loop inside the intrasubunit pocket and in particular residue T245. erefore, site W3 is not accessible
anymore from site W1 in the locally closed channel conformation, as shown in the crystal structure of
bromoform bound to LC GLIC presented here. Free energy calculations corroborate these data showing
that site W1 is clearly more favorable to bromoform than site W3 and B2 in the LC structures, while in
GLIC ’s open form, this dierence is less clear (gure 4.7). Importantly, structural alignments reveal
that Y197 is highly conserved in Cys-loop receptors, including, nicotinic acetylcholine, 5HT3 and glycine
receptors (Sauguet et al., 2013a). Interestingly, in GABAAR, the tyrosine is substituted by a phenylalanine,
two residues with very similar side chains, especially considering their volume. We argue this residue
might play a critical role in Cys-loop receptors’ sensitivity to anesthetics. Our simulations show that Y197
orientation aects the F195 rotamer distribution. In the down conformation the Y197 residue prevents F195
from being in the same conformation, and vice versa. e F195 residue, given its direct interaction with
the M2-M3 helix, may be a key residue to modulate GLIC gating. is residue is a glycine in all GABAA
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Y197 side chain orientation GLIC subtype Site W1 Site W2 Site W3
Up
WT – Open 0.16 0.28 0.31
WT – LC 0.29 0.20 0.03
F238A – Open 0.36 0.22 0.25
Down
WT – Open 0.40 0.15 0.00
WT – LC 0.16 0.04 0.00
F238A – Open 0.10 0.01 0.00
Table 4.4 – Bromoform occupancy of intrasubunit sites along oodingMD simulations according to
the Y197 residue side chain orientation.
receptors except for subunit ρ and mutation of this residue G222F was aecting potentiation by propofol
and inducing faster desensitization (Engblom et al., 2002; Chang et al., 2003). Given the timescale involved
for the Y197 side chain transition, our simulations cannot accurately sample the two state populations as a
function of GLIC’s structural state (LC vs. open) or bromoform binding. However, even in open GLIC,
site W2 and W3 occupancies are correlated with Y197 side chain orientation (table 4.4). Further studies
need to be conducted to understand which factor induces the transition of Y197 toward one state or the
other. Interestingly, we nd that binding to site B1 can be aected by single residue properties, namely the
protonation state of H235.
4.2.3 H11’ protonation state impacts the potentiating site
GLIC ’s activity has been shown to be modulated by residue protonation state (Cheng et al., 2010). H235 is
located on the M2 helix and is close to the intersubunit site B1 entrance. Its protonation state is still highly
debated, some studies reporting neutralizing its side chain (Brömstrup et al., 2013; Prevost et al., 2012;
Zhu and Hummer, 2012b), while others report a doubly protonated H235 (Mowrey et al., 2013b; LeBard
et al., 2012; Bocquet et al., 2009). Free energy of binding calculations indicate that, when the H235’ side
chain is neutral, the most favorable location for bromoform is B1, favored over W1 by 1.9 kcal/mol (see
table 4.3), observation supported by Brömstrup et al., 2013). However, this dierence vanishes when H235
is doubly protonated (∣∆∆G∣ = 0.5 kcal/mol). e intrasubunit site W1 does not seem to be aected by
H235 protonation state. Importantly, several groups reported this residue as being critical for the channel
activity (Prevost et al., 2012; Wang et al., 2012). We demonstrate here that the protonation state of H235
may play a key role for ligand binding to the intersubunit site B1, reinforcing the hypothesis that this
residue might play a pivotal role for channel function and modulation. We hypothesize that the F238A
mutation perturbs the helix bundle. e double protonation of H235 might be an additional disruptive
factor that would explain the signicant dierence in bromoform free energy of binding compared to the
single protonated variant.
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4.2.4 The “pore binding site” hypothesis is supported by crystallographic and simula-
tion data.
Flooding simulations were carried out to assess the accessibility of the anesthetic binding sites. We
demonstrated that bromoform could spontaneously reach the pore site (P1) from the ECD vestibule or
from intra subunit site W1-2 and site W3/B2. Short MD simulations show that bromoform is stable in
P1, consistently with free energy of binding calculations indicating a relatively strong binding to this
site, especially in GLIC ’s LC form. Moreover at least one more binding site was observed in the pore.
While pore binding sites in pLGICs have been proposed both based on experimental (Hilf et al., 2010;
Spurny et al., 2013) and theoretical data (Brannigan et al., 2010; Chen et al., 2010; Murail et al., 2012), the
mechanism of action of pLGIC inhibitors is not yet proven. Considering the narrowness of the pore, it is
intuitive to think about inhibitors as “steric channel blockers”, molecules that bind and obstruct the pore
due to their size. is mechanism is particularly relevant for large inhibitors such as lidocaine that has
been described as an open channel blocker consequently to its blockage of ion passage in the channel open
state. However, an allosteric inhibition mechanism involving a pore site cannot be rigorously excluded.
Bromoform, by increasing the pore hydrophobicity, may dry it, which would cause M2 helix bending and
therefore channel closure. is hypothesis is supported by our MD data showing a spontaneous binding
to the open channel and is consistent with several works on GLIC ’s gating describing the channel drying
prior/simultaneous to channel M2 helix bending and channel closure (Nury et al., 2010; Zhu and Hummer,
2012b; Mowrey et al., 2013b). is hypothesis is consistent with the crystallographic structure presented
here, clearly displaying a bromoform molecule bound to GLIC ’s locally closed state. Hence, bromoform
may bind the channel resting state and stabilize it in the same fashion.
4.3 Conclusion
Supported by a high-resolution crystal structure of bromoform bound to the pore of the locally closed
GLIC channel, I show using extensive calculations that this site is not only spontaneously accessible from
the solvent, but is very favorable to bromoform binding. is is documented by free energy of binding
calculations and binding site exploration along unconstrained molecular dynamics simulations. ese
data suggest that pore-induced channel closure can be at least partly responsible for channel inactivation
by anesthetics. Data are however to be compared with calculations made in the same conditions on
allosteric binding sites. Results show comparable accessibilities and anities with the pore site. Since
mutagenesis data unambiguously showed an eect of mutations in allosteric binding site regions on
anesthetics action, the underlying allosteric mechanism might still be the key for a full understanding
of anesthesia mechanisms at an atomistic level. Molecular dynamics simulations reveal that parts of the
intrasubunit pocket are not accessible to bromoform in the channel locally closed conformation due to the
structure of the M2-M3 loop. is work highlights the crucial role of residue Y197 which is likely to act as
a gate for anesthetic binding to the intersubunit pocket by hindering its access via the intrasubunit pocket.
Finally, routes are revealed between intra- and intersubunit binding sites suggesting that the intrasubunit
pocket may act as an entrance to the channel.
e next chapter will investigate the binding of two other anesthetics to GLIC, propofol and desurane.
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ese additional simulations will provide further support to generalize the results on the possible molecular
mechanism of general anesthesia obtained for bromoform.
5
Propofol & desflurane simulations
provide new insights into
anesthetic action at the atomic
scale
Propofol and desurane are two widely used general anesthetics that have been shown to inhibit GLIC at
clinically relevant concentrations (Weng et al., 2010) and to bind the channel in the intrasubunit site W1
(Nury et al., 2011). Propofol and desurane inhibit WT GLIC with very similar eciency but their action
on the T255A GLIC mutant is opposite: propofol inhibits the GLIC T255A mutant more than WT GLIC
while desurane inhibits the T255A mutant dramatically less than WT GLIC (table 5.1).
I started my PhD project with the aim of understanding the role of the T255A mutation on GLIC’s
inhibition by anesthetics. For this purpose, I used the short MD simulation approach as developed in
section 2.6.1. To acquire an extended picture, I studied propofol and desurane bound to WT and T255A
GLIC variants in both open and locally closed conformations, leading to a total of 8 systems or 200
independent MD simulations. Furthermore, I have been interested in studying the inuence of the ligand
binding symmetry on both its dynamics and the protein geometry. I therefore simulated systems in which
only one anesthetic molecule was bound to GLIC, as opposed to all other short MD simulations I ran in
which ve anesthetic molecules were bound to the channel to maximize sampling.
As in January 2013 I switched to the characterization of bromoform’s interactions with GLIC because of
the novel crystallographic data that became available to me, I did not quite nalize this aspect of my project,
mainly because of the large amount of data I generated (see section 3.1.3) and the inherent complexity of
the statistical analysis of these data. is part is dedicated to highlighting some of the most important
results I obtained characterizing propofol and desurane interactions with WT and T255A GLIC variants,
Desurane Propofol
WT 27 ± 13 24 ± 6
T255A 1400 ± 1100 2 ± 1
Table 5.1 – Inhibition of GLIC by two general anesthetics. Half maximal inhibitory concentration of
desurane and propofol for modulation of WT and T255A GLIC given in µM. Values taken from Nury
et al. (2011).
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W1-2 W3 B1 B2 P1 Other
WT 0.48 0.05 0.00 0.01 0.00 0.45
WT-LC 0.56 0.02 0.00 0.00 0.00 0.42
T255A 0.58 0.04 0.00 0.01 0.00 0.37
T255A-LC 0.84 0.00 0.00 0.00 0.00 0.15
Table 5.2 – Propofol occupancy of crystallographic binding sites in short MDs.
in open and LC conformation.
5.1 Results
5.1.1 An extensive sampling close to the crystal structure
To ensure that GLIC’s conformation stays close to the crystal structure without restraining its movements,
we ran 25 slightly dierent short simulations of each system (see table 2.3). As each simulation is 8 ns
long, we nally get a sampling of 200 ns per system. Considering that each anesthetic molecule acts
independently from the ones in the neighboring subunits, a hypothesis that will be veried later on in this
chapter, each simulation actually accounts for 5 times the sampling i.e. a total of 1 µs per system.
As shown on gure 5.1, GLIC’s structure only dris very little at the timescale of the simulation. e
initial congurations of the propofol and desurane systems have been extracted from previous simulations
(section 2.6.1). As a result, the average structure RMSD value is in the order of 2 and 3 Å for the LC and
open structure, respectively. is dierence of stability between the two conformations can be easily
explained by the fact that in the locally closed conformation the top of the M2 helices is bent toward the
center of the pore, increasing the stability of the bundle compared to the open conformation in which
M2 helices are more mobile. In contrast, in the simulations of bromoform bound to GLIC, the systems
have been equilibrated with GLIC’s conformation constrained to the crystal structure. e RMSD tends
to increase along the simulation, which reects the adjustment of the channel to its environment which is
quite dierent from a crystalline packing. Importantly, the most exible regions are loops in the upper
part of the extracellular domain. e TMD remains very stable, especially the M2 helices bundle.
5.1.2 Anesthetics are mobile within the W1 binding site
Despite the large occupancy of site W1-2 (table 5.2), general anesthetics propofol and desurane show
high mobility within the intracellular binding pocket (gure 5.2). Notably, both anesthetics reached the
intersubunit site B2 in open GLIC. In locally closed conformation, the accessibility of site B2 through site
W3 appears jeopardized, as depicted with bromoform simulations.
However, marked anesthetic mobility dierences have been revealed. Propofol exploration of the
intrasubunit pocket is comparable to bromoform, in the sense that it explores mostly W1-2 andW3 regions
and rarely exits the intrasubunit pocket to bind the protein surface (table 5.4 and appendix D.2). Note
however that bromoform has markedly higher occupancy for site W1-2 compared to propofol.
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BA
Figure 5.1 – A sampling close to the crystal structure. RMSD and RMSD per residue calculated against
GLIC’s high resolution structure (PDB-id 4HFI). A) RMSD Timeline average for dierent systems. e
RMSD has been calculated on carbon α atoms of GLIC’s structured regions. Individual RMSD timelines
are shown in black transparent background, for visual perception of the raw data complexity. B) RMSD
per residue the reference structure and the average structure of simulations of propofol and desurane
bound to open GLIC. Color scale ranges from 0.0 (blue) to 5.0 (red).
W1-2 W3 B1 B2 P1 Other
WT 0.24 0.07 0.00 0.01 0.00 0.69
T255A 0.30 0.05 0.00 0.01 0.00 0.63
WT-LC 0.23 0.00 0.00 0.01 0.00 0.75
T255A-LC 0.54 0.00 0.00 0.00 0.00 0.46
Table 5.3 – Desurane occupancy of crystallographic binding sites in short MDs.
Desurane displays a dramatically increased mobility compared to the latters, as reected by its lower
occupancy of site W1, where it was initially posed (table 5.3). Desurane appears more subject to leave
the intrasubunit pocket and bind the surface of the protein in the TMD. More importantly, desurane
repeatedly entered an intersubunit region close to site B2, not passing through site W3 but between the
M2 and M3 helices, while propofol did not.
As expected because of the presence of a phenylalanine residue at position 238 (F14’) in both WT and
T255A variants of GLIC, no binding to the intersubunit site B1 has been observed during these MDs, for
none of both anesthetics.
5.1.3 Different mobilities impact the number of contacts with the receptor
To quantify the interactions between the anesthetics and GLIC, I calculated the number of contacts that
are made between the two parties during the simulations (gure 5.3).
e majority of contacts are made by the residues that are the closest in the crystal structure, with
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Figure 5.2 – Exploration of anesthetic molecules bound toW1. Exploration of propofol (A) and desu-
rane (B) bound to open, locally closed, WT and T255A variant of GLIC. e TMD of 3 subunits (blue and
green and purple) are represented here for clarity. 3 occupancies corresponding to as many occupancy
cutos are represented here: 0.1, 0.01 and 0.001 in red opaque surface, yellow mesh and white transparent
surface, respectively.
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W1-2 W3
Bromoform 0.80 0.03
Propofol 0.48 0.05
Desurane 0.24 0.07
Table 5.4 – Comparison of anesthetic occupancies of the intrasubunit pocket binding sites. Compar-
ison of W1-2 and W3 occupancies in WT open GLIC (desurane & propofol) and F238 open GLIC
(bromoform).
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Figure 5.3 –Anesthetics contacts with openGLIC.Most frequent contacts between anesthetics andGLIC
residues. A) Comparison between two anesthetics, propofol (PFL) and desurane (DSF) in the WT open
channel. B) Comparison of the contacts made by propofol in the WT and the T255A mutant channels.
Error bars represent standard errors calculated from standard deviations with signicance level α = 0.05.
contributions from M1 (I201, I202, M205, and L206), M2 (V242), M3 (Y254, T255, I258, and I259), and
from the β6-β7 loop (Y119, P120, and F121). Residues from the M4 helix (N307 and F303) appear less
contacted than what has been presumed from the crystal sructures. Notably, residue Y197, whose side
chain is oriented toward the ECD in the crystal structure and therefore does not seem to interact in any
way with the anesthetic, appears here to be one of the most contacted residues.
e dierence of mobility between propofol and desurane is not without consequences on the
contacts anesthetics make with the protein. Figure 5.3A shows numerous quantitative dierences in the
contacts desurane makes with GLIC compared to propofol. Propofol hits the 10 most contacted residues
signicantly more than desurane does. e same observation is made with T255A open GLIC, which
shows no clear dierence with the WT open form besides (gure 5.3B).
5.1.4 Ligand binding stretches the intrasubunit pocket
To investigate if anesthetic binding has an eect on the pocket geometry, I used the Epock soware (see
section 3.3) to calculate the volume of binding pockets along the trajectories.
e volume of the intrasubunit pocket W1 appears highly correlated to the anesthetic’s volume: the
larger the anesthetic, the wider the pocket (table 5.5 and gure 5.4). e same tendency is observed in the
crystal structures. Note that, at this timescale, the pocket volume calculated for GLIC crystal structures
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Anesthetic volume (Å3) Pocket crystal volume (Å3) Pocket MD volume (Å3)
Propofol 193 349 ± 22 408 ± 2
Desurane 88 325 ± 26 309 ± 3
Bromoform 83 309 ± 29 284 ± 1
Table 5.5 – Volume of the intrasubunit pocket W1 in open GLIC in presence of anesthetic molecules.
Average volume calculated on the last 3 ns of open GLIC short simulations. e anesthetic volume has
been calculated with Epock. e pocket crystal volume condence intervals are calculated from the ve
pockets that the pentamer displays.
Figure 5.4 – Volume of the intrasubunit
pocketW1 occupied by 3 dierent anesthetics.
Volume of the pocket W1 occupied by propofol
(PFL, red), desurane (DSF, green) or bromo-
form (MBR, blue). Error bars represent stan-
dard errors calculated from standard deviations
with signicance level α = 0.05.
Figure 5.5 – Volume of the intersubunit
pocket B1 occupied by bromoform.Volume of
the intersubunit pocket created by the mutant
F238A in GLIC. Error bars represent standard
errors calculated from standard deviations with
signicance level α = 0.05.
appears slightly lower than in the MD simulations, except for propofol for which the pocket volume is
higher in the simulations than in the crystal (see appendix D.3).
e volume of the intersubunit pocket B1 in the GLIC F238A mutant in presence of a bromoform
molecule is (101 ± 1)Å3 compared to (102 ± 1)Å3 in absence of bromoform (gure 5.5). Notably, this value
is signicantly lower than the volume observed in the crystal structure, in which the calculated volume of
this pocket is (194 ± 12)Å3.
5.1.5 Ligand binding does not impact neighboring cavities
I used simulations in which only one anesthetic molecule was bound in GLIC’s intrasubunit pocket to
assert if an eect of the anesthetic can be detected on the pockets located in the other subunits. Pockets
that neighbor a cavity lled with an anesthetic will be referred to as neighboring cavities, while the two
cavities in between two neighboring cavities will be referred to as empty.
Figure 5.6 shows the volume of intrasubunit pockets lled with an anesthetic, neighboring or empty.
Neighboring cavities display an average volume of (148 ± 1)Å3 and (125 ± 1)Å3 for propofol and desurane,
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Figure 5.6 – Inuence of propofol binding on
neighboring pockets. Volume of the intrasub-
unit pocket W1 lled with propofol (red), neigh-
boring a pocket lled with propofol (pink) or
empty (black). Error bars represent standard
errors calculated from standard deviations with
signicance level α = 0.05.
Figure 5.7 – Inuence of bromoform binding
to B1 onW1.Volume of the intrasubunit pocket
if B1 is lled with a bromoform molecule (blue)
or empty (black). Error bars represent standard
errors calculated from standard deviations with
signicance level α = 0.05.
respectively. Empty pockets in simulations display a shi of approximately the same range with (139 ± 1)Å3
and (120 ± 2)Å3 for propofol and desurane, respectively.
e data collected also permitted to search for a potential eect of ligand binding in the intersubunit
pocket on the intrasubunit pocket volume. Figure 5.7 compares the volume of the empty intrasubunit
pocket when the intersubunit pocket B1 is lled with bromoform and when it is empty. e volume of
the empty intrasubunit pocket is (129 ± 1)Å3 (calculated by averaging of propofol and desurane data)
compared to (163 ± 1)Å3 when a bromoform is bound to the intersubunit pocket.
5.1.6 Tyrosine 197 conformations are stabilized by hydrogen bonds
As observed with bromoform simulations, the Y197 residue side chain switched between up and down
conformations in simulations of propofol and desurane bound to GLIC. Each conformation turned out
to be stabilized through hydrogen bonds.
e up conformation is dened by a Y197 side chain orientation toward the ECD. It is stabilized mainly
by hydrogen bonding with D32 (gure 5.8), which is located on the β1-β2 loop. Since pKa calculations
suggest that D32 is most probably deprotonated, it would act as an acceptor of hydrogen bonds. While D32
and Y197 are at a distance of more than 5Å in the open GLIC crystal structure, the exibility of the β1-β2
loop makes hydrogen bonding with Y197 not only possible but quite frequent.
e down conformation is dened by a Y197 side chain orientation perpendicular to the M1 helix axis.
Notably, in down conformation, Y197’s side chain can face either the M3 helix and make hydrogen bonds
with residue T255 or face the M2 helix and make hydrogen bonds with residue N245. In GLIC’s open form,
Y197 and N245 are more than 5Å apart from each other and N245 faces the neighboring intersubunit.
Hydrogen bonding between the two residues is greatly facilitated in GLIC’s LC conformation since the
bending of the top of the M2 helices brings a few residues, including N245, toward the intrasubunit pocket.
Finally, a fourth residue is found to make hydrogen bonds with Y197, namely Y119, which is located on
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Figure 5.8 – Y197 hydrogen bonds to surrounding residues. A) Frequency of hydrogen bonds made
with tyrosine 197 in down and up conformation in simulations of bromoform, propofol and desurane
bound to WT GLIC. Error estimates calculated by boostrapping are lower than 10−3.
B) Residues forming hydrogen bonding with Y197. Y197 up and down conformations are colored in yellow
and magenta, respectively. e protein backbone atoms are represented as a white cartoon.
the β6-β7 loop. Interestingly, this residue is close enough to Y197 to make hydrogen bonds when Y197 is
in up as well as in down conformation. Y119 is itself stabilized by hydrogen bonds with D32. Y197’s up
conformation therefore depends directly and indirectly on the position of D32, and more generally of the
β1-β2 loop.
5.1.7 Y197’s stability is modulated by the T255A mutation
Simulations of open GLIC display a clear picture in which the two modes of the distributions of the Y197
side chain orientation are virtually perfectly centered around the same values: (73.8 ± 1.2)° for the down
conformation and (173.1 ± 0.8)° for the up conformation (gure 5.9). For both desurane and propofol
and both WT and T255A GLIC, the up conformation is favored over the down conformation with a
frequency of over 80 % (except for the desurane bound to the T255A GLIC mutant simulations in which
this probability reaches 77 %).
Transitions from up to down conformation have however been occasionally observed at this timescale
and the down conformation appears quite stable as depicted by the lifetime of this conformation which is
regularly greater than 5 ns.
Simulations of LC GLIC were carried out with Y197 side chains initially placed essentially in down
conformation. Simulations of WT-LC GLIC display similar behaviors for both anesthetics with 21 % and
23% in up conformation for desurane and propofol, respectively. In contrast, simulations of T255A GLIC
show a displaced equilibrium in favor of the up conformation, especially for propofol simulations that
display 65 % in up conformation vs 36 % in up conformation for desurane.
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Figure 5.9 – Tyrosine 197 side chain orientation in open and LC GLIC. Distribution of the dihedral
angle between Y197 C − Cα − Cβ − Cγ atoms for propofol, desurane, wild-type and T255A GLIC variants
in open (A) and LC (B) conformations. Each distribution is made of 100,125 values.
5.2 Discussion
5.2.1 Binding to the intersubunit site B2 confirmed
A connection between the intrasubunit site W1 and intersubunit site B2 had been detected for a desurane
(DSF) molecule in Nury et al. (2011). However, this observation was based on a single 30 ns long MD
simulation in which the movements of M2 helices might have been important. A major nding concerning
the characterization of bromoform binding to GLIC is that this transition from site W1 to site B2 via
site W3 has also been observed for bromoform in several 8 ns long MD simulations, meaning in a GLIC
conformation close to the crystal structure. Still, bromoform as well as desurane are relatively small
molecules and a very important question to ask is: “can a bigger anesthetic, such as propofol, travel the same
way and bind the intersubunit site B2?”. e results presented here not only conrm that desurane can
bind to site B2 but that propofol, a much larger molecule (193 Å3 vs 88Å3 vs 84Å3 for propofol, desurane
and bromoform respectively), can bind this site despite the steric hindrance. is result, supported by a
recent photolabeling of propofol bound to the site B2 of a GABAAR (Yip et al., 2013), suggests that general
anesthetics could bind and play a role in pLGICs modulation through this site, despite the diversity of
their physico-chemical properties. Although the exact consequence of GA binding to this site is to be
explored, the work I realized on bromoform suggests that site B2 could be a transient location prior to
pore entry (see chapter 4).
Another major point of this work is the high mobility of desurane bound to GLIC. While all simula-
tions started with anesthetics bound to the intrasubunit pocket, desurane showed an increased tendency
to leave the pocket and bind the surface of the protein, at the interface with the lipid phase. Importantly,
desurane could bind the intersubunit region of site B2 without passing through site W3 but passing
between theM2 andM3 helices, a behavior that contrasts with both propofol and bromoform which almost
never took this route, despite the sampling that could be considered higher for the two latter anesthetics,
since they rarely exit the intrasubunit pocket. A possible explanation for this contrast between propofol
and desurane are the stronger steric constraints that apply to propofol compared to desurane. e
dierence of behavior between desurane and bromoform is to be investigated, as both anesthetics have
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similar volume, desurane is even slightly more bulky than bromoform.
5.2.2 A more detailed contact map: the role of Y197 confirmed
All simulations reect the important number of contacts between anesthetics and Y197 compared to other
residues. As it is a reasonable assumption that a residue which is oen in contact with a ligand plays a
role in its binding, it is quite important to investigate the role of Y197 because of the critical impact the
orientation of its side chain has on the accessibility of both the intrasubunit pocket and therefore the
intersubunit site B2.
Simulations of open GLIC show two well distinct Y197 side chain orientations, with modes that do not
depend neither on the anesthetic nor GLIC type (WT or T255Amutant). Interestingly, while the side chain
of Y197 is in up conformation more than 80 % of the time, the probability of contact with the anesthetic
is high, over 40 % for desurane and close to 60 % for propofol. ere are two main reasons for this
observation: i) the anesthetic can contact Y197’s backbone when its side chain is oriented toward the ECD
and ii) even when in up conformation, only small variations in orientation can result in contacts between
the Y197 side chain and molecules inside the intrasubunit pocket, especially if molecules are bulky such
as propofol. Finally, because of its location at the top of the M1 helix, Y197 has privileged relations with
the ligand when bound, as just stated with respect to site W1-2, but also when bound to site W3 which is
located between the M1 and M2 helices.
In contrast, simulations of LC GLIC display marked dierences between the wild-type and the T255A
forms of GLIC. As the Y197 side chain was initially imposed in down conformation, it is not surprising that
simulations of WT GLIC show a higher propensity to adopt this conformation (or more probably to stay
in this conformation as the simulations last 8 ns each). In the same fashion as in open GLIC the Y197 side
chain switched from up to down conformation, in simulations of LCGLICY197 occasionally switched from
down to up conformation. Notably, in the GLIC T255A mutant simulations, the equilibrium is displaced in
favor of the up conformation. In the case of propofol, the probability of being in up conformation is even
higher than the one of being in down conformation. Since the Y197 down conformation is mainly stabilized
by hydrogen bonding to T255, it is expected that the lifetime of the Y197 down conformation would be
reduced in a mutant in which T255 is replaced by a residue that cannot form an hydrogen bond with Y197.
e reason why this behavior is enhanced in GLIC’s locally closed conformation could be related to the
number of contacts with the residues of the intrasubunit pocket: desurane has 2 times more contacts with
these residues in the T255A mutant compared to WT for LC GLIC; for propofol, this ratio increases to 7.
More specically, the number of contacts between the anesthetic and residue 255 is signicantly higher
in the T255A mutant than in the WT form. ese observations support the hypothesis of a competition
between Y197-T255 hydrogen bonding and anesthetic binding. More data is however needed to investigate
this particular point, especially long simulations of anesthetics bound to the intrasubunit pockets in WT
and T255A GLIC variants would generate valuable data.
5.2.3 Influence of the ligand binding symmetry
e data collected allowed to clearly demonstrate an eect of the anesthetic on the binding pocket geometry,
especially its volume. is eect seems highly correlated with the anesthetic’s volume, bigger anesthetics
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causing more stretching of the binding pocket than smaller ones.
To assess whether this eect impacts neighboring cavities, I compared the volume of empty neighboring
binding pockets to the volume of empty non-neighboring pockets. Interestingly, dierent average volumes
were calculated in simulations of propofol anddesurane bound toGLIC, with (148 ± 1)Å3 and (125 ± 1)Å3,
respectively. eses values, however, are not consistent with the hypothesis of an impact of anesthetics on
neighboring binding pockets since the expected eect would be a decrease of the volume due to anesthetic
stretching of its own binding pocket, resulting in the compression of neighboring cavities. is hypothesis
implies that neighboring pocket volume would be maximal when no anesthetic is bound to a neighboring
pocket, lower when desurane is bound to a neighboring pocket, and minimal when propofol is bound to
a neighboring pocket, which is not the case here. Moreover, volume dierences observed here are quite
low, with a maximum dierence of 23 Å3 between propofol and desurane. It is important to consider that
this value is small at the atomic scale, as it is lower than the volume of a single water molecule which is
on the order of 30Å3. e dierences of volume observed here are therefore to be considered within the
range of the method uncertainty and probably do not reect a real eect of the anesthetic on neighboring
cavities.
e data collected on bromoform binding to intersubunit B1 suggest a possible eect on the neighboring
intrasubunit volume, as the volume of the intrasubunit pocket calculated in these simulations is 34Å3 lower
when bromoform is bound to B1 and when it is not. However, the remarks on the method uncertainty
apply here too and more data is needed to investigate a possible eect of ligand binding to B1 on the
intrasubunit pocket volume. Simulations of larger anesthetic molecules (e.g. propofol) bound to B1 would
be of great help for this purpose.
e data collected did not allow to unambiguously detect any signicant dierence in anesthetic
behavior with either one or ve anestheticmolecules bound to GLIC. Interestingly, an earlier study suggests
that an asymmetric ligand binding would facilitate conformational transitions in pLGICs (Mowrey et al.,
2013b). In this work, the authors compared the speed of open GLIC pore dehydration in presence of a
varying number of propofol molecules bound to the intrasubunit pocket to assess whether the symmetry
of ligand binding impacts the channel closure. Based on 100 ns long MD simulations, the authors suggest
that the channel closure speed is maximal when two to three propofol molecules are bound to GLIC. e
results I present in this manuscript are not in contradiction with Mowrey et al.’s results, since my data is
based on 8 ns long MD simulations. At this timescale, it is not surprising that, to date, I have detected
no signicant eect either on the anesthetic itself or the protein dynamics. However, these data require
in-depth investigation to conclude with condence.
5.2.4 Understanding anesthetic’s action
Desurane vs propofol vs bromoform
Desurane showed markedly higher mobility than propofol. Desurane was able to enter the intersubunit
region of B2 by passing between the M2 and M3 helices, under the M2-M3 loop. Notably, bromoform,
which is smaller than desurane, did not show similar behavior. Several reasons may explain that. First,
desurane sampling may be considered higher than bromoform sampling, considering that the initial
poses of the anesthetic were extracted from a 30 ns long MD simulation for desurane whereas they were
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randomly generated within a cuto of the crystal binding sites for bromoform. Hence, desurane poses are
more varied than bromoform ones and desurane may explore additional regions. Note that this argument
is two-edged since, as bromoform residence time in the binding pocket is higher, the sampling could
actually be considered higher for bromoform than for desurane. Second, the protein initial conformation
has been equilibrated without restraints for desurane, which was not the case for bromoform. As a result,
the protein dynamics in bromoform and in desurane MD simulations are not perfectly comparable
and may have inuenced the results. Finally, desurane’s mobility may simply reect a lower anity for
anesthetic binding sites in GLIC which would increase its relative mobility compared to bromoform. To
summarize, the incapacity of bromoform to enter the B2 regions by passing between M2 and M3 helices as
seen for desurane is unlikely to be due to a steric eect. A sampling bias or signicantly higher anity
for the intrasubunit pocket are more probable in this case. Our current data can however not answer this
question. Propofol sampling, in contrast, is probably adequate. Although propofol entered the intersubunit
site B2, it certainly did not pass between the M2 and M3 helices, but rather between the M1 and M2 helices,
through site W3. As a consequence, propofol bound site B2 only in GLIC’s open form since the position
of both Y197 and the M2-M3 loop in the LC form prevent entering site B2 from site W3. Again, if steric
contraints are more likely to apply to propofol, more sampling (e.g. longer simulations) might be needed
to investigate propofol’s capacity to enter the B2 region in the same fashion as desurane.
is work clearly shows that anesthetics of diverse physico-chemical nature can enter the intersubunit
site B2 in GLIC’s open form. e role of this site in GLIC’s inhibition process in still unclear. As i)
desurane enters B2 more oen than propofol does and ii) desurane binds B2 in both GLIC open and LC
states, desurane would probably be expected to be a stronger inhibitor of GLIC’s activity than propofol.
Yet, both anesthetics have very similar half maximal inhibitory concentrations (see table 5.1). Notably,
propofol and desurane are dierent molecules that may have dierent local eects on the protein, as
I demonstrated on the volume of the intrasubunit binding pocket for example. e only capacity of a
molecule to access a potential inhibitory site with ease is therefore probably not the only factor that aects
GLIC’s inhibition.
Wild-type vs T255A variants
Very few signicant dierences have been detected between WT and T255A GLIC variants. Among them,
the number of contacts with the pocket residues in GLIC locally closed form is oen higher for the T225A
mutant than for the WT form (see appendix D.1). More importantly, a marked dierence of the Y197 side
chain orientation has been detected: in WT GLIC, the Y197 down conformation is stabilized by hydrogen
bonding with T255 which, by denition, is not possible in the T255A mutant. e possible eect of Y197
would be to prevent anesthetics from binding the deeper intrasubunit cavity when in down conformation.
As a result, the down conformation is expected to be disadvantaged in the T255A mutant, therefore the
accessibility to sites W3 and B2 is favored. e inhibition of GLIC is then expected to be more important
in the T255A mutant than in the WT form. Notably, propofol is one order of magnitude more ecient
in the T255A mutant than in the WT form of GLIC, consistently with the mechanism suggested above.
e same tendency is observed with desurane which would imply the same eect on GLIC’s inhibition.
However, GLIC’s inhibition by desurane is at least one order of magnitude lower in the T255A mutant
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than in WT GLIC.
is apparent paradox can be explained by assuming a central role of the Y197 side chain. For propofol,
because of its bulky size, the passage is generally hindered by the down conformation of Y197 and the
T255A mutant induces a higher frequency of possible passages, increasing the inhibiting eect of the
anesthetic. Desurane on the other hand, a small and very mobile anesthetic as we showed previously, has
no trouble to overcome the Y197-controlled passage even in wild type. e Y197 down conformation may
help to mechanically keep it within the intersubunit binding pocket once it has reached it, whereas the
T255A mutant may increase the probability of escape for this very mobile ligand, hence the decrease in
inhibition compared to WT. To test this hypothesis, directed mutagenesis experiments might be of great
help. Unfortunately, this mutant is unlikely to transmit electrical current in electrophysiology experiments
realized by Pierre-Jean Corringer’s team at Institut Pasteur. Yet, other mutations may help to understand
the role of Y197. Unlike the T255A mutant which probably favors the Y197 side chain up conformation,
mutations D32A and Y119A (and possibly their combined action) are expected to favor Y197 side chain
down conformation. According to the hypothesis formulated above, these mutants are expected to produce
an opposite action at those of the T255A mutant as summarized in table 5.6.
Desurane Propofol
WT ++ ++
T255A + +++
D32A/Y119A +++ +
Table 5.6 – Predictive eect of mutant D32A and Y119A on GLIC’s inhibition by propofol and desu-
rane. Inhibition potency is illustrated with + symbols: the more symbols, the more inhibition potency.
According to the hypothesis developed in section 5.2.4, these mutations would have an opposite action to
those recognized of the T255A mutation.
5.3 Conclusion
is study aimed to
• verify whether the mechanisms highlighted in the context of the characterization of bromoform
binding to GLIC were applicable to other anesthetics,
• understand dierences of action of propofol and desurane in WT and T255A GLIC variants.
Several observations made in the context of the bromoform study turn out to be applicable to both
propofol and desurane. e three anesthetics have been found to bind the site B2 located at the interface
between subunits and between the channel ECD and TMD. is observation is a major result because
propofol is signicantly more bulky than bromoform and desurane and would not have been expected to
bind this site. In GLIC locally closed form, access to site B2 from site W3 (located between M1 and M2
helices) is prevented by both Y197 side chain orientation and residues from the M2-M3 loop that face the
intrasubunit pocket specically in the channel LC form. Desurane is the only anesthetic we scanned that
90 Chapter 5. Insights from propofol & desurane
was able to nd a way to the intersubunit site B2 not passing between M1 and M2 helices but between M2
and M3 helices, below the M2-M3 loop.
e key residues of the intrasubunit cavity contacted by the three anesthetics are the same, a signicant
number of contacts beingmadewithY197. Consistently with crystallographic data, this residue is conrmed
to adopt two distinct conformations, up and down, the down conformation preventing deep access to the
intrasubunit pocket (i.e. siteW3), therefore site B2. e up conformation is mainly stabilized by hydrogen
bonding to residues D32 and Y119, while in the down conformation hydrogen bonds are made with N245
and T255. e T255A mutation is consequently found to modulate the up-down equilibrium in favor of
the up conformation, especially in GLIC locally-closed form, as longer simulations of GLIC open form
would provide adequate data to compare the up-down equilibrium in WT and T255A channels.
To date, more insights into pLGICs modulation by anesthetics and alcohols are needed to fully under-
stand their action mechanism. More specically, if this study highlights the dierence of mobility between
propofol and desurane, to my knowledge no currently proposed mechanism of action of anesthesia can
explain the dual modulation of GLIC T255A mutant by desurane and propofol. However, I present in
this study an innovative hypothesis in which residue Y197 would act as a gate, preventing propofol from
entering the intrasubunit pocket on one hand, and preventing desurane from exiting the intersubunit
region on the other hand. is hypothesis requires directed mutagenesis coupled with electrophysiology
measurements to be veried.
6Concluding Remarks,Perspectives & Thoughts
6.1 Conclusions
In quite few years, it is amazing how our knowledge of pLGICs developed. In 2004, no complete structure
of any member of this family was solved. Today, tens of structures have been released of GLIC, ELIC
and GluCl including wild type, mutants, apo-form or co-crystallized structures with ligands. To date, the
channel for which the most data has been acquired is probably GLIC, which is an amazing coincidence
when thinking about it. Gloeobacter violaceus (Gv) is the only cyanobacteria that does not have thylakoids,
an intracellular membrane-bound compartment where light-dependent reactions of photosynthesis take
place in other cyanobacteria (and in chloroplasts). It is this unique feature that pushed scientists to
sequence Gv’s genome in the rst place (Nakamura et al., 2003), at a time where no intensive work was
being done on the bacteria. e results of this work were published only a few months prior to Tasneem
et al.’s search for bacterial homologs to the human nicotinic receptors which led to the discovery of GLIC.
Few years later, when I joined Marc Baaden’s group for my rst master internship in 2009, the rst two
structures of GLIC had just been released (Bocquet et al., 2009; Hilf and Dutzler, 2009) and when I started
to work on this project, in October 2010, the crystal structures of desurane and propofol bound to GLIC
were not even released.
More than three years have passed now and the picture of pLGICs action mechanism is step by step
made clearer. In particular, this work provides signicant insights on interactions between anesthetics
and GLIC, which I believe is a good model for the whole pLGIC superfamily. I think that it is clear now
that anesthetics can bind, and probably actually do bind, multiple parts of those channels. Extensive free
energy of binding calculations have proven the relatively high anity of bromoform for GLIC’s pore, intra-
and intersubunit pockets, with roughly equal energies of binding. Unconstrained ooding simulations
have proven the spontaneous accessibility of all pockets on the hundred nanoseconds timescale. Since
anesthetics can bind the channel pore, it is very intuitive to think of anesthetics as channel blockers, that
would either sterically block ion ow, either provoke the pore closing (or stabilize the closed state) by
binding to the pore. However, the opposite inuence of desurane and propofol on the GLIC T255A
mutant cannot be explained by anesthetics binding to the pore alone. A more distant allosteric mechanism
initiated from within the intrasubunit pocket probably occurs. Moreover, the extensive sampling provided
by both ooding and short molecular dynamics simulations allowed me to detect and quantify transitions
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between binding sites. us, numerous transitions from the intrasubunit pocket to the intersubunit site
B2 have been detected for all three anesthetic molecules I tested, providing reasonable condence on
the existence of this site in a biological context. Taken together, the study of bromoform, desurane
and propofol suggests that B2 cannot be entered by the bulkiest anesthetics in the closed state of GLIC,
as residues from the M2-M3 loop occlude the passage between M1 and M2 helices. Less voluminous
anesthetics may still access B2’s region by passing between M2 and M3 helices and under the M2-M3 loop,
as depicted for desurane. Larger timescale simulations suggested that B2 could be a transient site since
the intersubunit site B1, which has been described as potentiating site in the glycine and GABAA receptors
and in GLIC’s F238A mutant, can been reached from site B2. e same set of simulations showed that
anesthetic molecules can as well enter the channel pore vestibule from site B2. Yet, the precise role of this
intersubunit region remains to be further investigated.
e data collected also highlighted the critical role of the Y197 residue in the deep insertion of anesthet-
ics in the intrasubunit pocket. is very conserved residue among cationic pLGICs1 lies at the intrasubunit
pocket entrance. I clearly show in this study that the Y197 side chain can adopt two distinct conformations
referred to in this manuscript as up and down. In the down conformation, the Y197 side chain lies down
into the intrasubunit pocket, partially overlapping sites W2 and W3 and therefore dramatically reducing
the pocket volume. is conformation is stabilized by hydrogen bonding mainly with T255. e possible
role of Y197 in anesthetic binding to GLIC is still actively investigated thanks to simulations of anesthetics
bound to the GLIC T255A mutant. More mutagenesis data would be critical for a better understanding of
Y197’s role.
6.2 Perspectives
In my opinion, the understanding of the action mechanism of anesthetics would be made a lot easier by
the detailed comprehension of the pLGIC gating process. e recent structure of GLIC’s resting state will
probably lead to major breakthroughs in a near future. Molecular dynamics simulations have proven their
ability to improve our knowledge of atomic scale mechanisms and is, in my opinion, a tool of choice to
study pLGICs at atomistic scale. Simulations of GLIC full opening and closure will allow to understand
the details of these processes. Extensive simulations of GLIC’s full gating with anesthetics bound to the
intrasubunit, intersubunit and pore sites will probably allow to understand anesthetics actions.
However, running such simulations is challenging. A single full gating process would possibly take
place between two and ve microseconds in an MD simulation. As an example, let us use the performance
values described in section 3.1: the simulation soware was run on 544 cores, calculates 21 ns/day and
uses 630,000 h/µs computed. A single gating simulation would then consume between 1.3 and 3.2 millions
hours in CPU time and would take between 3 and 8 months to run. Of course, condence in subsequent
discoveries would only come with the simulation of several anesthetics bound to WT GLIC and possibly
mutants, andwith anesthetics bound to dierent binding sites, as stated above. Furthermore, the complexity
of analyzing such an ensemble of simulations should not be underestimated.
To date, the data collected on anesthetic dynamics while bound to a member of the pLGIC family are
1In anionic pLGICs, this tyrosine is substituted by a phenylalanine, a residue that has similar properties, especially considering
it’s volume.
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still insucient to guide research of more ecient and less risked anesthetic molecule. Many years of eort
will be necessary to understand the full complexity of anesthetic action mechanism, and it is not even clear
that signicant drug design could be made from subsequent discoveries, since anesthetics are likely to
bind numerous targets on numbers of neuroreceptors. Still, major improvements in clinical anesthesia
will most probably require this crucial step and the hypotheses and ideas developed within this thesis may
be useful in this context.
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AAppendices to chapter 1
Below are supplementary materials that complement chapter “Biological Background”.
A.1 Comparing nAChR and GLIC packing
Figure A.1 – Compared packing of the nAChR andGLIC structures.View of the extracellular half of the
transmembrane domains of the nAChR (le) and GLIC (right) receptors. e nAChR structure displays a
signicantly lower packing than GLIC inducing gaps in the structure that may be lled with cholesterol
(see section 1.1.5).

BAppendices to chapter 2
Below are supplementary materials that complement chapter “Molecular Modeling: eory And Practice”.
B.1 Bromoform parameters in GROMACS format
;
; Gromacs file for Bromoform parameters calculated with TIP3P water.
;
[ atomtypes ]
; name at.num mass charge ptype sigma epsilon
CX 6 12.0110 0.0 A 0.339967 0.457730
HCMM 1 1.0079 0.0 A 0.247135 0.0656888
BR 35 79.9040 0.0 A 0.347000 1.966480
[ moleculetype ]
; Name nrexcl
MBR 3
[ atoms ]
; nr type resnr resid atom cgnr charge mass
1 CX 1 MBR C1 1 0.5841 12.0110
2 BR 1 MBR Br1 2 0.0713 78.9183
3 BR 1 MBR Br2 3 0.0713 78.9183
4 BR 1 MBR Br3 4 0.0713 78.9183
5 HCMM 1 MBR H1 5 0.3702 1.0079
[ bonds ]
; ai aj fu b0 kb, b0 kb
1 2 1 0.1924 152300.1 0.1924 152300.1
1 3 1 0.1924 152300.1 0.1924 152300.1
1 4 1 0.1924 152300.1 0.1924 152300.1
1 5 1 0.1110 287014.9 0.1110 287014.9
[ angles ]
; ai aj ak fu th0 kth ub0 kub th0 kth ub0 kub
2 1 3 1 111.7000 658.21 111.7000 658.21
2 1 4 1 111.7000 658.21 111.7000 658.21
3 1 4 1 111.7000 658.21 111.7000 658.21
2 1 5 1 107.1380 369.15 107.1380 369.15
3 1 5 1 107.1380 369.15 107.1380 369.15
4 1 5 1 107.1380 369.15 107.1380 369.15
#ifdef POSRES_LIGAND
[ position_restraints ]
; atom type fx fy fz
1 1 1000 1000 1000
2 1 1000 1000 1000
3 1 1000 1000 1000
4 1 1000 1000 1000
#endif
Figure B.1 – Bromoform parameters for GROMACS.
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B.2 Pure and Applied Chemistry review
is paper is a review I wrote in 2012 and that has been published in Laurent, B., Murail, S., Da Silva, F.,
Corringer, P.-J., and Baaden, M. (2013). Modeling complex biological systems: From solution chemistry
to membranes and channels. Pure and Applied Chemistry, 85(1):1–13. It aims at describing common
diculties in biological systems modeling and forms the basis for part of chapter 2.
1Pure Appl. Chem., Vol. 85, No. 1, pp. 1–13, 2013.
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Abstract: Complex biological systems are intimately linked to their environment, a very
crowded and equally complex solution compartmentalized by fluid membranes. Modeling
such systems remains challenging and requires a suitable representation of these solutions
and their interfaces. Here, we focus on particle-based modeling at an atomistic level using
molecular dynamics (MD) simulations. As an example, we discuss important steps in mod-
eling the solution chemistry of an ion channel of the ligand-gated ion channel receptor fam-
ily, a major target of many drugs including anesthetics and addiction treatments. The bacte-
rial pentameric ligand-gated ion channel (pLGIC) called GLIC provides clues about the
functional importance of solvation, in particular for mechanisms such as permeation and gat-
ing. We present some current challenges along with promising novel modeling approaches. 
Keywords: cys-loop receptors; biomolecular chemistry; membranes; molecular dynamics;
solution chemistry.
INTRODUCTION 
Biological solutions are intrinsically complex and crowded mixtures. Some groups aim at modeling
such systems in their full complexity, as illustrated by a snapshot of a recent simulation by McGuffee
and Elcock endeavoring to understand diffusion properties of the bacterial cytoplasm (see Fig. 1A; [1]).
However, such studies are currently limited to simplified approaches, such as Brownian dynamics of
rigid molecules. Here, we investigate the more common case of studying a single protein in a realistic
environment, using a fully flexible atomistic force field representation. For this purpose, we describe
the example of a pentameric ligand-gated ion channel (pLGIC) called GLIC, illustrating how modeling
may nowadays attempt to capture the complex “solutions” involved in biological processes. 
pLGICs are membrane receptors widespread in the animal kingdom. The members of this fam-
ily, the γ-aminobutyric acid receptor of type A (GABAAR), glycine (GlyR), serotonin (5-HT3R), andnicotinic acetylcholine receptors (nAChRs), play a leading role in the nervous signal transduction. Upon
specific ligand binding (drawing the receptor name), an allosteric transition occurs leading to an open-
*Pure Appl. Chem. 85, 1–305 (2013). A collection of invited papers based on presentations at the 32nd International Conference
on Solution Chemistry (ICSC-32), La Grande Motte, France, 28 August–2 September 2011.
‡Corresponding author 
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ing of the pore at the membrane level. This transition allows ions to enter the cell, producing a change
in the electric potential across the membrane. The effect depends on the channel selectivity. In the case
of cationic channels (nAChRs and 5-HT3R), the entry of ions into the cell will lead to the depolariza-tion of the cell and, if the membrane potential crosses a certain threshold (related to the number of open
channels), the depolarization will propagate to initiate the action potential. On the other hand, the open-
ing of anionic channels (GABAAR and GlyR) will induce a hyperpolarization of the membrane poten-tial and thus inhibits the action of cationic channels. Numerous compounds are known to modulate
pLGIC function and channel activity, including some alcohols, steroids, cannabinoids, barbiturates, and
general anesthetics. Membrane composition has also been shown to interfere with the activity of a few
pLGICs. The example of nAChR is particularly striking, as cholesterol and anionic lipids are required
for its activity [2]. 
Rational design of drugs acting on pLGICs recently came within reach owing to the crystalliza-
tion of bacterial homologues, including the first open-channel structure of GLIC in 2009 [3,4]. While
the role of the channel remains unclear for the bacteria, in vitro studies showed that GLIC is cation-
selective and that its “gating”, the process of opening and closing the channel, is regulated by pH vari-
ations [5]. The bacterial channel displayed several common characteristics with eukaryotic pLGICs, for
instance, a very close 3-dimensional structure compared to a nematode glutamate-gated channel [6]. It
also displayed sensitivity to alcohols and anesthetics [7,8]. 
pLGICs are transmembrane proteins constituted by five symmetrically organized subunits. The
symmetry axis coincides with the central pore of the channel, where ion permeation takes place. The
extracellular domain (ECD) of the protein contains the activating ligand-binding site and harbors a large
vestibule for ions. The transmembrane domain (TMD) is structured in 4 helices per subunit called M1
to M4. The pore of the channel is lined by the M2 helices (Fig. 1B). Theoretical works suggest that the
effective closure is due to a global twisting motion of the channel combined with local motions of the
B. LAURENT et al.
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Fig. 1 (A) Snapshot of a bacterial cytoplasm model whose dynamics has been studied by Brownian dynamics
(courtesy of Dr. Adrian Elcock [1]). (B) The GLIC system we study using MD simulations. The side view (top)
displays the GLIC protein embedded in a phosphatidylcholine membrane in the presence of 150 mM NaCl. In the
online version, the membrane is shown as an ochre surface, the protein is shown as yellow, cyan, orange, magenta,
and blue surfaces, each color representing one of the five subunits. Sodium and chloride ions are displayed as blue
and red spheres, while water is not shown for clarity. The top view (middle) depicts the five subunits, symmetrically
arranged around the pore formed by the M2 helices (bottom panel showing two of the five helices lining the pore). 
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transmembrane helices. In particular, the local motions comprise tilting associated with the bending of
M2 [9–11]. 
Focusing on the case of GLIC, we discuss several challenges for the study of biological mem-
brane protein solutions. Simplifications are necessary in constructing the model, in defining the com-
position of the system, and in choosing the concentration of each species. Uncertainties remain since
neither experiments nor calculations can resolve issues such as reliably choosing the protonation states
of each of GLIC’s titratable groups. We discuss intrinsic properties of the models that remain unclear
at this time such as the behavior of water in hydrophobic nanoconfinement. 
THE COMPOSITION OF BIOLOGICAL “SOLUTIONS” IS COMPLEX 
Biological solutions of interest contain several ingredients including proteins, nucleic acids, sugars,
ions, water and other small molecules (alcohols, anesthetics, etc.). Depending on the goal a study aims
to achieve, it might be necessary to include all these compounds in a model used for molecular dynam-
ics (MD) simulations. 
Cells communicate with each other thanks to membrane-embedded receptors whose hydrophobic
TMDs are stabilized by the membrane environment. Hence, lipid bilayers or bilayer mimetics have to
be included in a realistic model. Typical biological membranes are themselves complex ensembles com-
posed of lipids, carbohydrates, proteins, and cholesterol in the case of eukaryotic cells [12]. The pro-
portion of each molecular species depends on the cell type. Furthermore, different types of phospho-
lipids are mixed in the membranes, with proportions again depending on the cell type and possible
leaflet asymmetry. Matrix protein networks may further structure the membrane. To make the mem-
brane picture more intricate, microdomains enriched in cholesterol, also called “lipid rafts”, could play
a role in the cellular function by compartmentalizing specific lipids and membrane proteins. However,
the existence and role of such microdomains are very controversial. 
Although some MD simulation studies now attempt to accurately model the complexity of, e.g.,
the Escherichia coli bacterial membranes [13], generally speaking such a complexity is very difficult to
reproduce and the composition of the membrane is often simplified by using a single type of phospho-
lipid. As an example, the GLIC simulation system is composed of the protein embedded in a fully
hydrated phosphatidylcholine membrane, whereas a typical synaptic plasma membrane contains cho-
lesterol (29 %), phosphatidylcholine (28 %), phosphatidylethanolamine (26 %), phosphatidylserine
(10 %), phosphatidylinositol (2 %), sphingomyelin (2 %), and glycolipids (3 %) [14]. Unfortunately,
our knowledge about lipid compositions of various organisms and cell types is still very limited, yet it
is established that lipid “building blocks” have the potential to generate up to tens of thousands of dif-
ferent molecular species [15]. This situation may improve with recent efforts in the field of lipidomics
[16]. 
When appropriate, ligands such as alcohols or general anesthetics are included in the model in
order to study binding to the channel and modulation of its functional properties related to permeation
and gating. The ligands may have indirect effects on the channel by interacting with the membrane and
altering its behavior. 
On the order of 150 mM NaCl or KCl ions are typically added to mimic physiologic electrolyte
concentration. Sometimes higher concentrations up to 1 M are used to enhance the probability of
processes such as ion permeation. These processes may be driven by cross-membrane potentials, which
are typically in the range of –90 to –40 mV. To reproduce such a potential in the simulation may require
special methods such as applying an electric field using additional forces on all charged particles [17].
Maintaining a charge imbalance between two solution compartments has initially been proposed by
Sachs et al. [18]. This approach has subsequently been used by several groups to study the permeation
of ion channels [19,20]. Herrera and Pantano proposed a variation of the method where ionic motion is
restricted anisotropically to one side of the system [21]. Finally, Bostick et al. used vacuum slabs to sep-
arate the compartments of a single unit cell [22]. A set-up to study ion permeation through GLIC using
© 2012, IUPAC Pure Appl. Chem., Vol. 85, No. 1, pp. 1–13, 2013
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the double bilayer approach is shown in Fig. 2. The intrinsic electrostatic field of GLIC guiding the ions
through its center is illustrated in the following movie.
An animation of the electrostatic field around GLIC was generated using BioBlender
(http://bioblender.eu/) followed by post-processing in our in-house UnityMol tool. A movie illustrates
the flow of electric field lines through the ion channel. It is available at http://www.baaden.ibpc.fr/
pub/glic/pac.mov.
CONCENTRATION 
Defining molecular concentrations at the microscopic level is not straightforward. Most simulation
studies aim to match experimental conditions. Yet, due to limited computational resources, simulation
“boxes” are typically designed as small as possible, focusing on the immediate membrane environment
of the channel of interest and minimizing the bulk solvent part. This introduces a bias in the calculation
of concentrations. 
In many experiments involving membrane proteins, a salt concentration of about 150 mM NaCl
is required to warrant an appropriate osmotic pressure. The number of Na+ and Cl– ions to add to a sim-
ulation system may be calculated using eq. 1 with Cwater = 55 M. The calculated number of ions isadjusted to neutralize the global charge of the system (i.e., protein charges), hence in this case
NNa ≠ NCl. For the highly charged GLIC channel, there is an important imbalance between positive andnegative ions, in our simulations typically about 90 Cl– and 50 Na+ are present. These numbers corre-
spond to a concentration of about 150 mM when calculated on the basis of the Cl– ions or 80 mM on
the basis of the Na+ ions. If the system was much larger (as in Fig. 3B), with an extensive bulk solvent
part, this difference would progressively become negligible, tending toward NNa~NCl. 
NNa = NCl = Nwater × CNaCl/Cwater (1) 
B. LAURENT et al.
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Fig. 2 System set-up used to study ion permeation through GLIC according to the double bilayer method [19]. The
two compartments display different ion concentrations that create an electric potential between them, driving the
ions through the channel. Only three of the five protein subunits and half of the membrane are represented in order
to expose the pore interior, displayed as a blue transparent surface (in the online version). 
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Ion concentration could in principle constitute a way to study the influence of pH by explicitly
adding protons to the simulation system [23]. However, this approach is impractical in the present case
because a huge simulation box would be required: at pH 4.6, a box containing 2189 589 water mole-
cules is necessary to observe a single H+ ion, i.e., 50 times the actual simulation box size we use for
GLIC. This echoes the fact that the number of water molecules in simulations is generally too low to
mimic dilute solutions. A higher ratio of water to (protein + membrane) would be required to properly
account for bulk concentrations. 
Furthermore, concentration is a dynamic property. Brannigan et al. reported simulations in which
they flooded both GLIC and nAChR receptors with isoflurane, a general anesthetic. During the simu-
lation an important number of the hydrophobic isoflurane molecules partition into the lipid bilayer.
Hence, at the end of the simulation, the concentration of isoflurane in the solvent is significantly lower
(<10 mM) than when it started (>100 mM). This process is depicted on Fig. 4 along with data for alco-
hol partitioning [24]. 
Brannigan’s study implies that a long equilibration of the system may be necessary before con-
centrations can be measured reliably in order to allow solute molecules to partition between aqueous
and membrane phases. It may be debated whether concentrations should be calculated with respect to
the water phase only, with respect to water and membrane or with respect to the entire simulation box. 
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Fig. 3 (A) The 150000 atoms atoms GLIC simulation system used for MD (colorized in the online version)
surrounded by its periodic images. Since the simulation box is relatively tight, the replicates are very close to the
original system, minimizing the bulk water and restricting membrane fluctuations. (B) An imaginary system in
which the bulk water is extended and the membrane is large enough to allow for medium-range fluctuations,
leading to a significant increase in the number of atoms beyond 4000000. For comparison, the periodic box of the
150000 atoms system is also represented. 
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PROTONATION STATE 
Knowing the protonation state of ionizable residues is a key issue to reliably model a protein. The pro-
tonation state depends on a residue’s local environment. Standard pKa values measured in bulk cannotbe applied to buried protein residues, in particular for membrane proteins with an environment that
largely differs from aqueous solution. GLIC is constituted of five symmetric protomers, and the loca-
tion of its 81 × 5 ionizable residues is shown in Fig. 5. We may consider that equivalent residues in each
subunit bear identical protonation states. This assumption leads to approximately 281 = 1019 possible
combinations of protonation states. Tang and co-workers suggest that the protonation state of some
titratable groups may be different from one protomer to another leading to up to 1098 different combi-
nations [25,26], a figure exceeding the number of particles in the universe! 
The development of methods for calculating pKa values of titratable groups in proteins was pio-neered by Tanford and Kirkwood who proposed to represent the protein as an impenetrable sphere,
which allows one to analytically solve the Poisson–Boltzmann equation (PBE) [27]. The increase in
computing performances has facilitated the development of many PBE solvers, including the widely
used APBS software [28,29]. Nielsen and co-workers showed that a finite difference
Poisson–Boltzmann method yields better results when adding an explicit step to optimize the hydrogen-
bond network [30]. Ideally, protein conformational flexibility should be taken into consideration for cal-
culating pKa values. Specific terms have been included in some algorithms [31] and, more recently,methods based on the λ-dynamics approach using constant pH MDs and replica exchange MD emerged
[32–34]. These latter methods are currently still under development and have so far only been tested on
small nonmembrane peptides or proteins. PROPKA [35,36] may be one of the most commonly used
empirical approaches because it is very fast. 
B. LAURENT et al.
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Fig. 4 Isoflurane (black and red in the online version) and ethanol (green in the online version) partition into the
membrane during the equilibration of a GLIC, a nAChR and a GlyR system, respectively. The aqueous
concentration of isoflurane (top) decreases for the benefit of the fraction in the membrane (bottom). The same
behavior is observed for the partitioning of ethanol during the equilibration of a GlyR system (green in the online
version) but to a lesser extent. Due to its more hydrophilic properties, ethanol concentration decreased to half the
initial one (~300 mM) at the end of the simulation. This is in contrast to isoflurane: its concentration drops to less
than 10 % of the starting one (~10 mM). 
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In order to set up simulations of the GLIC system, we assessed the results of several widely used
programs and web services. These pKa predictions yielded widely varying pKa shifts as illustrated inFig. 6. We settled on the use of the Yasara software [37] mixing Ewald summation and hydrogen-bond-
ing network optimization to determine if a titratable group should be protonated or not [38]. The Yasara
results remain in a reasonable pKa shift range, whereas some of the other methods suggest huge shifts(Fig. 6). We applied a consensus approach, only protonating residues that were simultaneously found
to change ionization state in all five subunits. Many efforts in improving the crystallization protocol for
GLIC recently lead to a higher-resolution structure in which ion binding can be predicted between
residue D86 and D88. This is a strong indication that these residues should not be protonated (unpub-
lished data). These findings allowed us to iteratively improve our protonation state estimate for GLIC. 
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Fig. 5 Localization of ionizable residues shown in a cross-section of the GLIC ion channel (gray). M2 helices, in
cartoon representation, line the pore through which cations (pink in the online version) cross the membrane (ochre
in the online version). 
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SOLVATION IN SPECIAL/UNUSUAL ENVIRONMENTS 
The complex shapes of proteins may feature channels and cavities providing special, potentially sol-
vated nano-environments. Water in such a hydrophobic nanoconfinement may be particularly unstable,
a phenomenon known as capillary evaporation. Several groups have observed and characterized dewet-
ting transitions in MD simulations, for example, in the context of nanopores [39,40] or in the bacterial
B. LAURENT et al.
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Fig. 6 pKa shift predictions with respect to standard values for all ionizable residues in GLIC obtained usingdifferent software packages. Residues are ordered according to ΔpKa = (pKasolution–pKacalc) with respect to theYasara software (A) or the PROPKA software (B), respectively. The bottom part of each panel indicates the amino
acid type of each residue. 
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mechanosensitive channels MscL and MscS [41,42]. Roth and co-workers suggest that capillary evap-
oration could constitute an intrinsic property of some channels [43] and may be a widespread biologi-
cal mechanism. 
In the case of GLIC, extensive sampling led us to observe an unexpected pore dewetting behav-
ior (see Fig. 7A), as did several other groups [26,44]. Yet we cannot currently conclude whether GLIC
belongs to a family of “bubble gated ion channels”, since ongoing studies in our lab suggest that sub-
tle changes in the simulation parameters may prevent dewetting from occurring (see Fig. 7B). Another
very recent study is more affirmative [45]. It should be noted that forcefield parameters generally have
not been tuned to reproduce the behavior of water in such special environments, which is in part due to
the lack of experimental data. 
SAMPLING, STATISTICS, TIMESCALE 
A fundamental question before starting any computational study is how to best spend the limited
amount of available computing time. Strategies may vary in between two extremes: (1) running many
short simulations from several starting points or (2) running an extended one-shot simulation. Shaw et
al. recently showed that the result of the second approach matches experimental data very well, when
the MD simulations are long enough [46]. 
In 2010, we studied GLIC gating in a 1 µs MD simulation suggesting a “domino” gating mecha-
nism in which subunits sequentially switch from an open to a closed conformation [9]. Despite the large
amount of computational resources (approx. 10 months of calculations on a supercomputer in 2009, i.e.,
tens of years on a recent desktop machine), only two protomers had fully undergone this transition to a
closed state at the end of the simulation, suggesting that a much longer simulation was required to
achieve a complete gating transition in all five protomers. Longer simulations are also needed to char-
acterize processes such as ion permeation. Since GLIC has a low conductivity of 8 pS, one should
observe an estimated passage of only 3 ions per microsecond at –65 mV. A computationally cheaper
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Fig. 7 Hydration traces of GLIC’s pore during two representative simulations. Minor changes in the simulation
parameters can make a noticeable difference between a fully hydrated channel (A) and a channel that dehydrates
spontaneously in the upper part of the M2 helix-lined pore (B). For both simulations, the protonation states were
identical [3], the only differences were the forcefield and the MD software used (amber99 and Gromacs for
simulation A, vs. Charmm22 and NAMD2 for simulation B). 
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alternative is to map the affinity of ions for a certain position along the channel pore. We have deter-
mined such a graph from the 1 µs gating simulation for a nonconductive state with a central barrier
(Fig. 8). It is usually admitted that a simulation should be run at least 10 times longer than the slowest
timescale of interest [47]. This is often impossible since many relevant biomolecular timescales exceed
1 µs. Typically, the neuro muscular acetylcholine receptor’s gating is expected to be in the range of
1–10 µs [48] which implies MD simulations from 10 to 100 µs. 
Running several short comparative simulations may be more appropriate for ligand binding stud-
ies, for example, involving drugs. An advantage of such short simulations is to remain close to a well-
defined state, e.g., a crystal structure, rather than moving away from the experimentally backed con-
formation to some transient intermediate state. Furthermore, one may reduce the number of
unproductive runs where the drug may diffuse out of the binding pocket into the solvent. Many short
simulations with slightly different ligand starting conformations improve statistics and sampling. We
employ such an approach to study two general anesthetics, propofol and desflurane, that have recently
been co-crystallized with GLIC [49]. This study revealed a binding site in the upper part of the TMD
of the protein. Other binding sites for general anesthetics and alcohols, including transmembrane, extra-
cellular, and pore sites, have been suggested [8,25,50,51]. Channel blocking by charged quaternary
ammonium compounds, divalent ions, and lidocaine has been shown using electrophysiology and X-ray
B. LAURENT et al.
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Fig. 8 Sodium ion occupancy and related relative Boltzmann energy accumulated during a 1-µs MD simulation. 
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crystallography [52], also suggesting binding sites located in the pore of the channel. These observa-
tions pose the problem of sampling from a combinatorial point of view: multiplying the number of sites
by the number of ligands, then by the number of mutants one wishes to test quickly leads to an
intractable required total simulation time. 
Lipids are crucial for the structure and function of membrane proteins. Bilayers with complex
compositions pose a particular sampling challenge [53]. A misplaced lipid in a simulation set-up might
have consequences on the whole trajectory, in particular if it were to play a specific biological role. With
a diffusion coefficient of the order of 10–8 cm2/s, a lipid embedded in a membrane is expected to have
a mean-square displacement of 4 nm2 for a 1-µs-long simulation. In our GLIC simulations, convergence
for this value sets on beyond 100 ns and fully stabilizes at about 500 ns. Hence, the timescale of most
current studies does not allow for an extensive reorganization of lipids around membrane proteins.
Parton et al. recently addressed this problem while simulating a whole vesicle, demonstrating the
importance of lipid diffusion for protein aggregation [54]. The authors, however, highlight that the
coarse-grained models are highly simplified and inevitably approximate the nature of the protein–lipid
and protein–protein interactions. De Meyer et al. previously suggested the role of cholesterol in protein
clustering using dissipative particle dynamics Monte Carlo and a more simplified model [55]. 
At last, the problem of simulation convergence should be raised briefly. Methods for the quan-
tification of sampling have been proposed for several decades, yet none has been widely adopted. In
2000, Berk Hess proposed a method based on principal component analysis [56] that has been used by
other groups to evaluate the convergence of a set of MD simulations [57,58]. Faraldo-Gómez and co-
workers focus on convergence of membrane protein simulations, and although the timescale is relatively
short by today’s standards, their main findings are likely still valid. Their work concludes that structured
TMDs converge relatively fast, even on a 10 ns timescale, but more mobile parts are undersampled.
Grossfield et al. calculated 26 independent 100 ns MD runs of rhodopsin and found similar results [58].
To date, despite new method proposals [59–61], sampling quality is often tentatively assessed based on
several simple criteria. A single descriptor may be monitored along a simulation until it reaches a sta-
ble value. The root mean square deviation (RMSD), which is a descriptor for molecular deformation, is
a common but controversial criterion. A variation consists in stopping a simulation after a descriptor
reaches an experimental reference value and remains close to it for a certain time. Another approach is
to use several independent MD simulations with different starting points. When these simulations con-
verge to a similar state, sampling is considered sufficient. 
CONCLUSION 
Accurately simulating complex biological systems such as the GLIC ion channel in a realistic environ-
ment remains a puzzle with some missing pieces. Choosing the composition of the model requires a
compromise between biological accuracy and technical constraints imposed by the limited size of sim-
ulation boxes. Even simple quantities such as concentrations are not easy to map from the macroscopic
world to the microscopic representation. For some systems, protonation state assessment is a particu-
larly tricky and largely unsolved problem. The behavior of water in special environments such as
nanocavities and pores is another open issue. Underlying these specific points is the general question of
sampling and timescale. Furthermore, the chosen GLIC example is a rather simple membrane system.
Other more challenging ones may include double bilayers [62], entire vesicles [63,64], fully decorated
virion particles [65–68], or huge bilayer patches, each adding a set of specific questions on its own. 
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CAppendices to chapter 3
Below are supplementary materials that complement chapter “High-Performance Computing And Large
Scale Data Analysis”.
C.1 A script to generate 25 slightly different simulations
is script aims to prepare several simulations for submission to run on a supercomputer. Prior to running
the script, the start conguration should have been calculated and placed in a directory which path is
dened in the variable ROOTPATH at the top of the script. e script handles the simulation preparation by
making a directory for each simulation with the appropriate start conformation for each trajectory. It also
takes care of the simulation input les, making all the names matching the actual lenames, which are
dierent in each simulation. Additionally, the submission scripts are generated according to the variables
dened at the top of the script that depend on the supercomputer I wanted to use.
Although these tasks might seem basic, it saved me an enormous amount of time in the preparation
and submission of these jobs and similar scripts were used at dierent steps of the project.
newjobs.py                                                                    Page 1
import os
import random
import shutil
import sys
ROOTPATH = "../01_prep/05_make_poses"
PARAMDIR = "../00_input"
USE_JADE = True
USE_TURING = not USE_JADE
# Option for runs on turing@idris.fr
NCPUS           = 512
BGSIZE          = 64
RANKS_PER_NODE  = 8
# Options for runs on jade@cines.fr
NNODES  = 23        # number of nodes to use
NCPUS   =  8        # number of CPUs to used per core
NMPI    =  8        # number of MPI processes per core
# So the total number of cores that will be used is NNODES * NCPUS
if USE_TURING:
    assert NCPUS == (BGSIZE * RANKS_PER_NODE)
def m4(s, **kwargs):
    for k, v in kwargs.iteritems():
        s = s.replace(k, v)
    return s
def make_job(prefix):
    inputdir = os.path.join(ROOTPATH, prefix)
    workdir = prefix
    # basenames
    coorbase    = prefix + "_mini_out.restart.coor"
    xscbase     = prefix + "_mini_out.restart.xsc"
    pdbbase     = prefix + ".pdb"
    psfbase     = "nachr_mbr46i.psf"
    ffparbase   = "par_all27_prot_lipid_na.inp"
    ligparbase  = "MBR.par"
    # full paths
    coor    = os.path.join(inputdir, coorbase)
    xsc     = os.path.join(inputdir, xscbase)
    pdb     = os.path.join(ROOTPATH, prefix, pdbbase)
    psf     = os.path.join(ROOTPATH, prefix, psfbase)
    ffpar   = os.path.join(PARAMDIR, ffparbase)
    ligpar  = os.path.join(PARAMDIR, ligparbase)
    # simulation output file prefix
    output_dir    = "output"
    output_prefix = os.path.join(output_dir, "mbr46.prod")
    # create the work directory
    os.mkdir(workdir)
    # create the output directory
    os.mkdir("output")
    # copy the run script in the work directory
    shutil.copy("run.bash", workdir)
    # copy the xsc and coor files from the minimization
    shutil.copy(xsc, workdir)
    shutil.copy(coor, workdir)
    # copy the pdb and psf files to the output directory
    shutil.copy(pdb, "output")
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    shutil.copy(psf, "output")
    # copy the parameter files in the work directory
    shutil.copy(ligpar, workdir)
    shutil.copy(ffpar, workdir)
    if USE_JADE:
        # manage the namd run files
        with open("glic.jade.namd.input", "rt") as f:
            content = f.read()
        content = m4(content,
                     __COOR__=coorbase,
                     __XSC__=xscbase,
                     __PDB__=os.path.join(output_dir, pdbbase),
                     __PSF__=os.path.join(output_dir, psfbase),
                     __FF_PAR__=ffparbase,
                     __LIG_PAR__=ligparbase,
                     __OUTPUT_PREFIX__=output_prefix,
                     __SEED__=str(random.randint(1, 5000)),
                     )
        with open(os.path.join(workdir, "glic0.namd"), "wt") as f:
            f.write(content)
        # manage the job submission script
        with open("namdjob.pbs.input", "rt") as f:
            content = f.read()
        content = m4(content,
                     __WALLTIME__="24:00:00",
                     __NNODES__=str(NNODES),
                     __NCPUS__=str(NCPUS),
                     __NMPI__=str(NMPI),
                     __JOBNAME__="prod_" + prefix,
                     __NAMD_SCRIPT__="glic0.namd",
                     )
        with open(os.path.join(workdir, "namdjob.pbs"), "wt") as f:
            f.write(content)
    else:
        # manage the namd run files
        with open("glic0.namd.input", "rt") as f:
            content = f.read()
        content = m4(content,
                     __COOR__=coorbase,
                     __XSC__=xscbase,
                     __PDB__=os.path.join(output_dir, pdbbase),
                     __PSF__=os.path.join(output_dir, psfbase),
                     __FF_PAR__=ffparbase,
                     __LIG_PAR__=ligparbase,
                     __OUTPUT_PREFIX__=output_prefix,
                     __SEED__=str(random.randint(1, 5000)),
                     )
        with open(os.path.join(workdir, "glic0.namd"), "wt") as f:
            f.write(content)
        with open("glic1.namd.input", "rt") as f:
            content = f.read()
        content = m4(content,
                     __PDB__=os.path.join(output_dir, pdbbase),
                     __PSF__=os.path.join(output_dir, psfbase),
                     __FF_PAR__=ffparbase,
                     __LIG_PAR__=ligparbase,
                     __OUTPUT_PREFIX__=output_prefix,
                     )
        with open(os.path.join(workdir, "glic1.namd"), "wt") as f:
            f.write(content)
        with open("glic2.namd.input", "rt") as f:
            content = f.read()
        content = m4(content,
                     __PDB__=os.path.join(output_dir, pdbbase),
                     __PSF__=os.path.join(output_dir, psfbase),
                     __FF_PAR__=ffparbase,
                     __LIG_PAR__=ligparbase,
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                     __OUTPUT_PREFIX__=output_prefix,
                     )
        with open(os.path.join(workdir, "glic2.namd"), "wt") as f:
            f.write(content)
        # manage the job submission script
        with open("namdjob.ll.input", "rt") as f:
            content = f.read()
        content = m4(content,
                     __WALLTIME__="20:00:00",
                     __BGSIZE__=str(BGSIZE),
                     __NCPUS__=str(NCPUS),
                     __RANKS_PER_NODE__=str(RANKS_PER_NODE),
                     __JOBNAME__="prod_" + prefix,
                     __NAMD_SCRIPT0__="glic0.namd",
                     __NAMD_SCRIPT1__="glic1.namd",
                     __NAMD_SCRIPT2__="glic2.namd",
                     )
        with open(os.path.join(workdir, "namdjob.ll"), "wt") as f:
            f.write(content)
    # move the output directory to the work directory
    os.rename("output", os.path.join(workdir, "output"))
if __name__ == '__main__':
    com = " ".join(arg for arg in sys.argv)
    if not com == "{0} go".format(sys.argv[0]):
        usage = "usage: python {0} go".format(sys.argv[0])
        usage += "\nModify the source code to control the script's behavior."
        print usage
        exit()
    first, last = 12, 24
    prefix_list = ["model_{0:03d}".format(i) for i in xrange(first, last + 1)]
    for prefix in prefix_list:
        print "preparing {0}...".format(prefix),
        sys.stdout.flush()
        make_job(prefix)
        print "done"
        sys.stdout.flush()
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DAppendices to chapter 5
Below are supplementary materials that complement chapter “Propofol & desurane simulations provide
new insights into anesthetic action at the atomic scale”.
D.1 Contact maps
T(A
)25
5
A
T(A
)25
5
B
Figure D.1 – Contact maps of anesthetics bound to locally closed GLIC variants. Most contacted
residues by anesthetics propofol (A) and desurane (B) along short MD simulations.
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D.2 Pocket exploration by bromoform
Intrasubunit
Intersubunit
Top view Side view
B1
W1W2
P1B2W3
Figure D.2 – Pocket exploration by bromoform in short MD simulations. Top (le) and side (right)
views of bromoform exploration of binding intra- (top) and intersubunit (bottom) binding pockets in
open F238A GLIC. e TMD of 3 subunits (blue and green and purple) are represented here for clarity. 3
occupancies corresponding to as many occupancy cutos are represented here: 0.1, 0.01 and 0.001 in red
opaque surface, yellow mesh and white transparent surface, respectively.
D.3 Pocket volumes in crystal structures of GLIC
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Sequence Form Ligand PDB id Resolution (Å) Volume (Å3)
WT Open None 4HFI 2.40 273.95 ± 12.82
WT Open None 3EAM 2.90 268.73 ± 29.94
WT Open Desurane 3P4W 3.20 324.73 ± 25.56
WT Open Propofol 3P50 3.30 348.55 ± 22.32
H235F LC I None 3TLT 3.30 328.70 ± 89.24
E243P LC II None 3TLS 3.20 556.60 ± 39.94
K33C-L246C LC III None 3TLV 2.90 586.68 ± 66.32
WT Open Bromoform 4HFH 2.75 308.92 ± 28.55
F238A Open None 4HFB 2.65 294.65 ± 16.22
F238A Open Bromoform 4HFD 3.10 343.23 ± 37.53
F238A Open Ethanol 4HFE 2.80 273.25 ± 15.75
Table D.1 – Volume of the intrasubunit pocket W1 in GLIC crystal structures. Average volume calcu-
lated on the ve subunit with the Epock soware. LC I, II, & III are locally closed subtype forms as depicted
in Prevost et al. (2012).
Sequence Form Ligand PDB id Resolution (Å) Volume (Å3)
WT Open None 4HFI 2.40 42.22 ± 5.31
WT Open None 3EAM 2.90 59.32 ± 8.19
WT Open Desurane 3P4W 3.20 53.57 ± 10.00
WT Open Propofol 3P50 3.30 63.90 ± 5.22
H235F LC I None 3TLT 3.30 12.15 ± 17.86
E243P LC II None 3TLS 3.20 11.43 ± 10.38
K33C-L246C LC III None 3TLV 2.90 5.35 ± 6.74
WT Open Bromoform 4HFH 2.75 52.10 ± 4.97
F238A Open None 4HFB 2.65 190.17 ± 12.97
F238A Open Bromoform 4HFD 3.10 193.80 ± 12.32
F238A Open Ethanol 4HFE 2.80 187.90 ± 11.58
Table D.2 – Volume of the intersubunit pocket W1 in GLIC crystal structures. See also table D.1.
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Résumé
Pendant des milliers d’années, l’Homme a utilisé des décoctions de plantes et l’alcool pour leur vertu sédative. La
découverte des anesthésiques dans les derniers siècles représente un progrès majeur, rendu possible principalement
par l’observation empirique de leurs eets sur les humains et les animaux. Des expériences in vitro ont révélées les
neurorécepteurs comme cibles possibles des anesthésiques. Ces récepteurs sont des canaux membranaires localisés
sur les cellules cibles aux terminaisons nerveuses. Au cours des dernières années, des homologues bactériens de
neurorécepteurs ont été identiés. Le récepteur GLIC, un homopentamère homologue au récepteur nicotinique
humain, a été co-cristallisé avec des anesthésiques généraux liés à lui, dont le bromoforme, le desurane et le propofol.
Dans cette thèse, j’utilise les simulations de dynamique moléculaire et la programmation de logiciels pour
caractériser les interactions entre les anesthésiques généraux et la forme sauvage de GLIC, ainsi qu’avec diérents
mutants. En 2011, le propofol et le desurane ont été co-cristallisés dans un site de liaison intra-sous-unité localisé
dans le domaine transmembranaire de GLIC. Plus récemment, il a été montré que le bromoforme se lie à ce site
ainsi qu’à un site inter-sous-unités. Dans ce travail, je décris des simulations d’une nouvelle structure cristalline
montrant un site de liaison supplémentaire situé dans le pore du canal. Des simulations dans lesquelles GLIC est
noyé de bromoforme ont démontré l’accessibilité spontanée des sites cristallographiques dans un environnement non
cristallin. Des calculs d’énergie libre exhaustifs corroborent ces données mettant en évidence des diérences d’énergie
de liaison entre les sites et entre des mutants de GLIC. Un échantillonnage complet des poches de liaison m’a permis
de détecter un deuxième site de liaison inter-sous-unité duquel l’accessibilité est probablement modulée par un
résidu en particulier. Ensemble, les données accumulées au cours de ce projet fournissent une image grandissante de
l’action des anesthésiques à l’échelle atomique.
Abstract
For thousands of years, Humans have been using plant decoctions and alcohol for their sedative eect. e discovery
of anesthetic molecules in recent centuries represents a notable advance, mostly enabled by empirically observing
their eect on humans and animals. In vitro experiments uncovered neuroreceptors as possible target for anesthetic
molecules. ose are membrane-bound ion channels located on the target cells at nervous endings. In the last few
years, bacterial neuroreceptor homologs were identied. e GLIC receptor, a homopentamer homologue to the
human nicotinic receptor, was co-crystallized with bound general anesthetics, including bromoform, desurane and
propofol.
In this thesis, I use molecular dynamics simulations and soware programming to characterize interactions
of general anesthetics with the wild type form of GLIC as well as with several mutants. In 2011, propofol and
desurane were co-crystallized in an intrasubunit binding site located in GLIC’s transmembrane domain. More
recently, bromoform was shown to bind this site as well as an intersubunit site. In this work I describe simulations of
a new crystal structure displaying an additional binding site located in the channel’s pore. Simulations in which
GLIC is ooded by bromoform demonstrate the spontaneous accessibility of crystallographic binding sites in a
non-crystalline environment. Exhaustive free energy calculations corroborate this data highlighting dierences
of binding energy between sites and between GLIC variants. Extensive sampling of binding pockets allowed me
to detect a second intersubunit binding site, the accessibility of which is possibly modulated by a specic residue.
Alltogether, data accumulated in this project provide a growing picture of anesthetic action at the atomic scale.
